BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 045553
(1082 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 199 bits (507), Expect = 5e-51, Method: Composition-based stats.
Identities = 101/280 (36%), Positives = 162/280 (57%), Gaps = 3/280 (1%)
Query: 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHP 857
A+ F+ +N +G GGFG YK + G +VAVKRL R QG + QF E+ + H
Sbjct: 36 ASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHR 95
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT--VEWSMLHKIALDVARALAYL 915
NL+ L G+ ++ E L+Y Y+ G++ +++RP ++W +IAL AR LAYL
Sbjct: 96 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 155
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
HD C P+++HRD+K +NILLD A + DFGLA+L+ + H V GT G++APEY
Sbjct: 156 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYL 215
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035
T + S+K DV+ +GV+LLELI+ ++A D + + + ++ W LL + +
Sbjct: 216 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 275
Query: 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L +++ +++ +A++CT S RP M +V + L+
Sbjct: 276 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant
Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 196 bits (498), Expect = 6e-50, Method: Composition-based stats.
Identities = 100/280 (35%), Positives = 160/280 (57%), Gaps = 3/280 (1%)
Query: 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHP 857
A+ F +N +G GGFG YK + G +VAVKRL R QG + QF E+ + H
Sbjct: 28 ASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHR 87
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT--VEWSMLHKIALDVARALAYL 915
NL+ L G+ ++ E L+Y Y+ G++ +++RP ++W +IAL AR LAYL
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
HD C P+++HRD+K +NILLD A + DFGLA+L+ + H V G G++APEY
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYL 207
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035
T + S+K DV+ +GV+LLELI+ ++A D + + + ++ W LL + +
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDV 267
Query: 1036 GLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L +++ +++ +A++CT S RP M +V + L+
Sbjct: 268 DLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 154 bits (390), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 103/281 (36%), Positives = 151/281 (53%), Gaps = 10/281 (3%)
Query: 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
AT F+ + IG G FG YK + G VA+KR + QG+++F EI TL +HP+
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLH 916
LV+LIG+ EM LIY Y+ GNL++ + D P ++ W +I + AR L YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS--ETHATTDVAGTFGYVAPEY 974
++HRD+K NILLD N ++DFG+++ GT +TH V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELGQTHLXXVVKGTLGYIDPEY 212
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ R+++K+DVYSFGVVL E++ + A+ S N+ WA G+ +
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVD 270
Query: 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L D + L + + A+ C S RPSM V +L+
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 154 bits (390), Expect = 2e-37, Method: Compositional matrix adjust.
Identities = 103/281 (36%), Positives = 151/281 (53%), Gaps = 10/281 (3%)
Query: 799 ATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
AT F+ + IG G FG YK + G VA+KR + QG+++F EI TL +HP+
Sbjct: 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH 96
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLH 916
LV+LIG+ EM LIY Y+ GNL++ + D P ++ W +I + AR L YLH
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS--ETHATTDVAGTFGYVAPEY 974
++HRD+K NILLD N ++DFG+++ GT +TH V GT GY+ PEY
Sbjct: 157 TRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLXXVVKGTLGYIDPEY 212
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ R+++K+DVYSFGVVL E++ + A+ S N+ WA G+ +
Sbjct: 213 FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVD 270
Query: 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L D + L + + A+ C S RPSM V +L+
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 154 bits (388), Expect = 3e-37, Method: Compositional matrix adjust.
Identities = 188/635 (29%), Positives = 274/635 (43%), Gaps = 77/635 (12%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S +K+SG++ + L L ++ N FS +P +G S L+ LD+S N G
Sbjct: 183 SGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRA 239
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+ C+ L+L+N+S NQF G IP +S Q +SL+ N +G +P+ C +L +
Sbjct: 240 ISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTGEIPDFLSGACDTLTGLD 297
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP-SSFGQLVNLEVLDLSRNFLSGIVP 272
L+ N G++PP G+C+ L SL LSSN G++P + ++ L+VLDLS N SG +P
Sbjct: 298 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 357
Query: 273 SELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPN--L 330
L L +L D N F G + ++ + P L
Sbjct: 358 ESL---TNLSASLLTLDLSS---------------------NNFSGPILPNLCQNPKNTL 393
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
+ + N G P CS+L L+L+ N+ +G IP+SLG+ L L L N L G
Sbjct: 394 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 453
Query: 391 LLPEE-VSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNW-SMSQVDLIGFYTAFF--Y 446
+P+E + V + + N L+GEIP S C+ + NW S+S L G +
Sbjct: 454 EIPQELMYVKTLETLILDFNDLTGEIPS-GLSNCTNL--NWISLSNNRLTGEIPKWIGRL 510
Query: 447 ENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGN 506
EN L IL SNN F+G +P L D SL WL N+ N
Sbjct: 511 EN--------------LAILK-LSNNSFSGNIPAELGDCRSL-------IWLDLNTNLFN 548
Query: 507 LSTYPFDLCLSLDGLIFDIGNNKLIGEVPSD-MGSHCKCMKFLSMAGN--EFVGLIPQSF 563
T P + + + K + +D M C AGN EF G+ +
Sbjct: 549 -GTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG------AGNLLEFQGIRSEQL 601
Query: 564 TNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623
G + + FL +S N +G IP E+ + L +L L
Sbjct: 602 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 661
Query: 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNS 683
N +SG IP E L LN+L L N L GRIP + L+ D+S NNLSG P
Sbjct: 662 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 721
Query: 684 LIKC---ENVQGNPNL---QLCHTDPSSSEWERQH 712
+ NP L L DPS+++ H
Sbjct: 722 QFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 756
Score = 129 bits (323), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 172/608 (28%), Positives = 258/608 (42%), Gaps = 121/608 (19%)
Query: 136 LEILDLSFNSFHGPIP--PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPG------FQVV 187
L LDLS NS GP+ +L +CS L+ +N+S N + F G+ G +V+
Sbjct: 99 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD-----FPGKVSGGLKLNSLEVL 153
Query: 188 SLSFNLLSGS--VPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG 245
LS N +SG+ V D C L+H+ ++ N ++G + + C L L +SSN
Sbjct: 154 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFST 211
Query: 246 DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND--YGPLYSREHGDLPI 303
IP G L+ LD+S N LSG + C +LK+L + ++ GP+ LP+
Sbjct: 212 GIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-----LPL 265
Query: 304 QPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNF 363
+ + N F G +PD ++ C L L+L+ N
Sbjct: 266 KSLQYLSLAENKFTGEIPDFLSG-----------------------ACDTLTGLDLSGNH 302
Query: 364 FTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE--VSVPCMAVFNVSQNLLSGEIPRISHS 421
F G +P G+C L L LSSNN +G LP + + + + V ++S N SGE+P S +
Sbjct: 303 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE-SLT 361
Query: 422 ECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPF 481
S + +S + G +N P N L L+ NN FTG +PP
Sbjct: 362 NLSASLLTLDLSSNNFSGPILPNLCQN----------PKNTLQELY-LQNNGFTGKIPPT 410
Query: 482 LIDSDSLSSRPYYGFWLSGN--SLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMG 539
L + L S +LSG S G+LS DL L L N L GE+P ++
Sbjct: 411 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-DLKLWL---------NMLEGEIPQEL- 459
Query: 540 SHCKCMKFLSMAGNEFVGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLS 599
+ K ++ L + N+ G IP +N L G +P +I ++E+L L LS
Sbjct: 460 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 519
Query: 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPS-------------------------- 633
N+F+G IP EL SL L+L+ N +G IP+
Sbjct: 520 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 579
Query: 634 ------------EFSKLEHLNVLRLDHN---NLTGRI-----PPGFGTRSSLSIFDVSFN 673
EF + + RL N+T R+ P F S+ D+S+N
Sbjct: 580 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 639
Query: 674 NLSGSAPR 681
LSG P+
Sbjct: 640 MLSGYIPK 647
Score = 126 bits (317), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 146/485 (30%), Positives = 222/485 (45%), Gaps = 64/485 (13%)
Query: 207 VSLEHILLAANSLTGSIPP--SLGNCTELRSLLLSSNMLQGDIPSSFG---QLVNLEVLD 261
SL + L+ NSL+G + SLG+C+ L+ L +SSN L D P +L +LEVLD
Sbjct: 97 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--DFPGKVSGGLKLNSLEVLD 154
Query: 262 LSRNFLSG--IVPSELG-MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDG 318
LS N +SG +V L C +LK L + + + GD+ + V+ F D
Sbjct: 155 LSANSISGANVVGWVLSDGCGELKHLAISGN------KISGDVDVSRCVN----LEFLDV 204
Query: 319 GLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSL 378
+ T +P L CS L+ L+++ N +G ++ C L
Sbjct: 205 SSNNFSTGIPFLGD------------------CSALQHLDISGNKLSGDFSRAISTCTEL 246
Query: 379 YFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLI 438
L++SSN G +P + + + ++++N +GEIP C +++ +DL
Sbjct: 247 KLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFTGEIPDFLSGACD------TLTGLDLS 299
Query: 439 G--FYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGF 496
G FY A PF + L L SNN F+G +P +D+ L R
Sbjct: 300 GNHFYGA---------VPPFFGSCSLLESLALSSNN-FSGELP---MDT-LLKMRGLKVL 345
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCK-CMKFLSMAGNEF 555
LS N G L +L SL L D+ +N G + ++ + K ++ L + N F
Sbjct: 346 DLSFNEFSGELPESLTNLSASL--LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 403
Query: 556 VGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
G IP + +N +L G +PS + + L+ L L LN G IP EL +
Sbjct: 404 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 463
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
+LE L L N L+GEIPS S +LN + L +N LTG IP G +L+I +S N+
Sbjct: 464 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 523
Query: 676 SGSAP 680
SG+ P
Sbjct: 524 SGNIP 528
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 59/120 (49%)
Query: 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILD 140
QL++ N + +S G+ S + + L +++N SG +P EIG + L IL+
Sbjct: 600 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 659
Query: 141 LSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPE 200
L N G IP + + L +++LS N+ +G IP + LS N LSG +PE
Sbjct: 660 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 719
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 153 bits (386), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 180/598 (30%), Positives = 262/598 (43%), Gaps = 71/598 (11%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S +K+SG++ + L L ++ N FS +P +G S L+ LD+S N G
Sbjct: 186 SGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRA 242
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+ C+ L+L+N+S NQF G IP +S Q +SL+ N +G +P+ C +L +
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLSLAENKFTGEIPDFLSGACDTLTGLD 300
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIP-SSFGQLVNLEVLDLSRNFLSGIVP 272
L+ N G++PP G+C+ L SL LSSN G++P + ++ L+VLDLS N SG +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 273 SELGMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPN--L 330
L L +L D N F G + ++ + P L
Sbjct: 361 ESL---TNLSASLLTLDL---------------------SSNNFSGPILPNLCQNPKNTL 396
Query: 331 RVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
+ + N G P CS+L L+L+ N+ +G IP+SLG+ L L L N L G
Sbjct: 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456
Query: 391 LLPEE-VSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNW-SMSQVDLIGFYTAFF--Y 446
+P+E + V + + N L+GEIP S C+ + NW S+S L G +
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPS-GLSNCTNL--NWISLSNNRLTGEIPKWIGRL 513
Query: 447 ENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGN 506
EN L IL SNN F+G +P L D SL WL N+ N
Sbjct: 514 EN--------------LAILK-LSNNSFSGNIPAELGDCRSL-------IWLDLNTNLFN 551
Query: 507 LSTYPFDLCLSLDGLIFDIGNNKLIGEVPSD-MGSHCKCMKFLSMAGN--EFVGLIPQSF 563
T P + + + K + +D M C AGN EF G+ +
Sbjct: 552 -GTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG------AGNLLEFQGIRSEQL 604
Query: 564 TNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELS 623
G + + FL +S N +G IP E+ + L +L L
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 624 ANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPR 681
N +SG IP E L LN+L L N L GRIP + L+ D+S NNLSG P
Sbjct: 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
Score = 128 bits (322), Expect = 2e-29, Method: Compositional matrix adjust.
Identities = 172/608 (28%), Positives = 258/608 (42%), Gaps = 121/608 (19%)
Query: 136 LEILDLSFNSFHGPIP--PTLQNCSSLRLINLSGNQFNGTIPAFFGQSPG------FQVV 187
L LDLS NS GP+ +L +CS L+ +N+S N + F G+ G +V+
Sbjct: 102 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD-----FPGKVSGGLKLNSLEVL 156
Query: 188 SLSFNLLSGS--VPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLLSSNMLQG 245
LS N +SG+ V D C L+H+ ++ N ++G + + C L L +SSN
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFST 214
Query: 246 DIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRND--YGPLYSREHGDLPI 303
IP G L+ LD+S N LSG + C +LK+L + ++ GP+ LP+
Sbjct: 215 GIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-----LPL 268
Query: 304 QPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNF 363
+ + N F G +PD ++ C L L+L+ N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSG-----------------------ACDTLTGLDLSGNH 305
Query: 364 FTGQIPASLGNCKSLYFLDLSSNNLTGLLPEE--VSVPCMAVFNVSQNLLSGEIPRISHS 421
F G +P G+C L L LSSNN +G LP + + + + V ++S N SGE+P S +
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPE-SLT 364
Query: 422 ECSKMSVNWSMSQVDLIGFYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPF 481
S + +S + G +N P N L L+ NN FTG +PP
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQN----------PKNTLQELY-LQNNGFTGKIPPT 413
Query: 482 LIDSDSLSSRPYYGFWLSGN--SLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMG 539
L + L S +LSG S G+LS DL L L N L GE+P ++
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLR-DLKLWL---------NMLEGEIPQEL- 462
Query: 540 SHCKCMKFLSMAGNEFVGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLS 599
+ K ++ L + N+ G IP +N L G +P +I ++E+L L LS
Sbjct: 463 MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522
Query: 600 LNNFTGAIPWELTQLASLEVLELSANSLSGEIPS-------------------------- 633
N+F+G IP EL SL L+L+ N +G IP+
Sbjct: 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 582
Query: 634 ------------EFSKLEHLNVLRLDHN---NLTGRI-----PPGFGTRSSLSIFDVSFN 673
EF + + RL N+T R+ P F S+ D+S+N
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 674 NLSGSAPR 681
LSG P+
Sbjct: 643 MLSGYIPK 650
Score = 126 bits (316), Expect = 8e-29, Method: Compositional matrix adjust.
Identities = 146/485 (30%), Positives = 222/485 (45%), Gaps = 64/485 (13%)
Query: 207 VSLEHILLAANSLTGSIPP--SLGNCTELRSLLLSSNMLQGDIPSSFG---QLVNLEVLD 261
SL + L+ NSL+G + SLG+C+ L+ L +SSN L D P +L +LEVLD
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTL--DFPGKVSGGLKLNSLEVLD 157
Query: 262 LSRNFLSG--IVPSELG-MCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDG 318
LS N +SG +V L C +LK L + + + GD+ + V+ F D
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGN------KISGDVDVSRCVN----LEFLDV 207
Query: 319 GLPDSITRLPNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSL 378
+ T +P L CS L+ L+++ N +G ++ C L
Sbjct: 208 SSNNFSTGIPFLGD------------------CSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 379 YFLDLSSNNLTGLLPEEVSVPCMAVFNVSQNLLSGEIPRISHSECSKMSVNWSMSQVDLI 438
L++SSN G +P + + + ++++N +GEIP C +++ +DL
Sbjct: 250 KLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFTGEIPDFLSGACD------TLTGLDLS 302
Query: 439 G--FYTAFFYENALTSCAPFSSPSNGLFILHDFSNNLFTGPVPPFLIDSDSLSSRPYYGF 496
G FY A PF + L L SNN F+G +P +D+ L R
Sbjct: 303 GNHFYGA---------VPPFFGSCSLLESLALSSNN-FSGELP---MDT-LLKMRGLKVL 348
Query: 497 WLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEVPSDMGSHCK-CMKFLSMAGNEF 555
LS N G L +L SL L D+ +N G + ++ + K ++ L + N F
Sbjct: 349 DLSFNEFSGELPESLTNLSASL--LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
Query: 556 VGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLA 615
G IP + +N +L G +PS + + L+ L L LN G IP EL +
Sbjct: 407 TGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVK 466
Query: 616 SLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNL 675
+LE L L N L+GEIPS S +LN + L +N LTG IP G +L+I +S N+
Sbjct: 467 TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526
Query: 676 SGSAP 680
SG+ P
Sbjct: 527 SGNIP 531
Score = 79.3 bits (194), Expect = 9e-15, Method: Compositional matrix adjust.
Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 54/232 (23%)
Query: 94 SSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPT 153
S+++L+G + + IG L L +L L+ N FSG +P E+G L LDL+ N F+G IP
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
Query: 154 ----------------------------------------------LQNCSSLRLINLSG 167
L S+ N++
Sbjct: 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 168 NQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL---LAANSLTGSIP 224
+ G F + + +S+N+LSG +P+E G S+ ++ L N ++GSIP
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIG----SMPYLFILNLGHNDISGSIP 673
Query: 225 PSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
+G+ L L LSSN L G IP + L L +DLS N LSG +P E+G
Sbjct: 674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMG 724
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 37/120 (30%), Positives = 59/120 (49%)
Query: 81 QLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEIGQLSLLEILD 140
QL++ N + +S G+ S + + L +++N SG +P EIG + L IL+
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662
Query: 141 LSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPE 200
L N G IP + + L +++LS N+ +G IP + LS N LSG +PE
Sbjct: 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 129 bits (323), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 93/284 (32%), Positives = 144/284 (50%), Gaps = 29/284 (10%)
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
N +G GGFG YK + VAVK+L+ + + QQF EI+ + + QH NLV L
Sbjct: 37 NKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 863 IGYHVSEAEMFLIYNYLPGGN-LEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+G+ ++ L+Y Y+P G+ L++ + W M KIA A + +LH+
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEYAMT 977
+HRDIK +NILLD A +SDFGLAR SE A T + GT Y+APE A+
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMXSRIVGTTAYMAPE-ALR 208
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD----PSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
++ K+D+YSFGVVLLE+I+ A+D P + + + ++
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-------LDIKEEIEDEEKTIEDYI 261
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ D + M ++A C E + RP +++V Q L+++
Sbjct: 262 DKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 129 bits (323), Expect = 1e-29, Method: Compositional matrix adjust.
Identities = 93/284 (32%), Positives = 144/284 (50%), Gaps = 29/284 (10%)
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
N +G GGFG YK + VAVK+L+ + + QQF EI+ + + QH NLV L
Sbjct: 37 NKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 863 IGYHVSEAEMFLIYNYLPGGN-LEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+G+ ++ L+Y Y+P G+ L++ + W M KIA A + +LH+
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEYAMT 977
+HRDIK +NILLD A +SDFGLAR SE A T + GT Y+APE A+
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQTVMXXRIVGTTAYMAPE-ALR 208
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD----PSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
++ K+D+YSFGVVLLE+I+ A+D P + + + ++
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-------LDIKEEIEDEEKTIEDYI 261
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ D + M ++A C E + RP +++V Q L+++
Sbjct: 262 DKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 126 bits (317), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 92/284 (32%), Positives = 143/284 (50%), Gaps = 29/284 (10%)
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
N +G GGFG YK + VAVK+L+ + + QQF EI+ + + QH NLV L
Sbjct: 31 NKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 89
Query: 863 IGYHVSEAEMFLIYNYLPGGN-LEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+G+ ++ L+Y Y+P G+ L++ + W M KIA A + +LH+
Sbjct: 90 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 146
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA----TTDVAGTFGYVAPEYAMT 977
+HRDIK +NILLD A +SDFGLAR SE A + GT Y+APE A+
Sbjct: 147 HHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQXVMXXRIVGTTAYMAPE-ALR 202
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD----PSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
++ K+D+YSFGVVLLE+I+ A+D P + + + ++
Sbjct: 203 GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-------LDIKEEIEDEEKTIEDYI 255
Query: 1034 TAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
+ D + M ++A C E + RP +++V Q L+++
Sbjct: 256 DKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 119 bits (297), Expect = 1e-26, Method: Compositional matrix adjust.
Identities = 80/207 (38%), Positives = 112/207 (54%), Gaps = 17/207 (8%)
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLS----VGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
N G GGFG YK + VAVK+L+ + + QQF EI+ + QH NLV L
Sbjct: 28 NKXGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL 86
Query: 863 IGYHVSEAEMFLIYNYLPGGN-LEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
+G+ ++ L+Y Y P G+ L++ + W KIA A + +LH+
Sbjct: 87 LGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHEN--- 143
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA----TTDVAGTFGYVAPEYAMT 977
+HRDIK +NILLD A +SDFGLAR SE A + + GT Y APE A+
Sbjct: 144 HHIHRDIKSANILLDEAFTAKISDFGLAR---ASEKFAQXVXXSRIVGTTAYXAPE-ALR 199
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD 1004
++ K+D+YSFGVVLLE+I+ A+D
Sbjct: 200 GEITPKSDIYSFGVVLLEIITGLPAVD 226
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 110 bits (275), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 72/219 (32%), Positives = 115/219 (52%), Gaps = 9/219 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLV 860
N++ IG+G FG ++AE G VAVK L F V +F E+ + R++HPN+V
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDEC 919
+G + ++ YL G+L + + R ++ +A DVA+ + YLH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
P ++HRD+K N+L+D + DFGL+R L S + AGT ++APE
Sbjct: 158 PP-IVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEP 215
Query: 980 VSDKADVYSFGVVLLELISDKKA---LDPSFCSFGNGFN 1015
++K+DVYSFGV+L EL + ++ L+P+ GF
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 109 bits (272), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 9/219 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLV 860
N++ IG+G FG ++AE G VAVK L F V +F E+ + R++HPN+V
Sbjct: 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR-PRRTVEWSMLHKIALDVARALAYLHDEC 919
+G + ++ YL G+L + + R ++ +A DVA+ + YLH+
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
P ++HR++K N+L+D + DFGL+RL S ++ AGT ++APE
Sbjct: 158 PP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 980 VSDKADVYSFGVVLLELISDKKA---LDPSFCSFGNGFN 1015
++K+DVYSFGV+L EL + ++ L+P+ GF
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK 254
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 107 bits (266), Expect = 5e-23, Method: Compositional matrix adjust.
Identities = 75/241 (31%), Positives = 119/241 (49%), Gaps = 38/241 (15%)
Query: 801 AGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRF-------QGVQQFAAEIRTLGR 853
A ++ IG GGFG Y+A I G VAVK R Q ++ E +
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVK---AARHDPDEDISQTIENVRQEAKLFAM 62
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWSMLHKIALDVAR 910
++HPN++ L G + E + L+ + GG L + + + P V W A+ +AR
Sbjct: 63 LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIAR 116
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLN--------AYLSDFGLARLLGTSETHATTD 962
+ YLHDE + ++HRD+K SNIL+ + ++DFGLAR E H TT
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTK 171
Query: 963 V--AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK---KALDPSFCSFGNGFNIV 1017
+ AG + ++APE S +DV+S+GV+L EL++ + + +D ++G N +
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL 231
Query: 1018 A 1018
A
Sbjct: 232 A 232
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 100 bits (248), Expect = 6e-21, Method: Composition-based stats.
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAV-VS 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++D R ++ L +A VA +AY+ +HRD+
Sbjct: 75 EEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDL 131
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ N L ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL++ + P
Sbjct: 192 FGILLTELVTKGRVPYP 208
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of 8-Anilino-1-Naphthalene
Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 99.0 bits (245), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 129
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G T +V T Y APE + C+
Sbjct: 130 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 186
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 187 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 223
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 98.6 bits (244), Expect = 1e-20, Method: Compositional matrix adjust.
Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G T +V T Y APE + C+
Sbjct: 124 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 180
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor Efp
With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor Efq
With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With 3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine,
Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 98.2 bits (243), Expect = 2e-20, Method: Composition-based stats.
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 71 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 126
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 185
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 186 DIWSLGCIFAEMVT-RRALFP 205
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With Cell
Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The Inhibitor
Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex
With 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In Complex
With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In Complex
With 4-[(6-amino-4-pyrimidinyl) Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2 (Cdk2)
In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-2-
Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The
Inhibitor 2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The
Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2- Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1,
5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A Pyrazolo[1,
5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The
Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With The
Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar Study,
Crystal Structure In Complex With Cdk2, Selectivity, And
Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide (At7519),
A Novel Cyclin Dependent Kinase Inhibitor Using Fragment-
Based X-Ray Crystallography And Structure Based Drug
Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl Pyrimidine,
Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea (At9283),
A Multi-Targeted Kinase Inhibitor With Potent Aurora
Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At Its
Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At Its
Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole Type
Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole Type
Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole Type
Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of 2-Anilino-4-(Thiazol-5-Yl)
Pyrimidine Transcriptional Cdk Inhibitors As Anticancer
Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of 2-Anilino-4-(Thiazol-5-Yl)
Pyrimidine Transcriptional Cdk Inhibitors As Anticancer
Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 98.2 bits (243), Expect = 2e-20, Method: Composition-based stats.
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 185 DIWSLGCIFAEMVT-RRALFP 204
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 98.2 bits (243), Expect = 2e-20, Method: Composition-based stats.
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 185 DIWSLGCIFAEMVT-RRALFP 204
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 98.2 bits (243), Expect = 2e-20, Method: Composition-based stats.
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 71 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 126
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 185
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 186 DIWSLGCIFAEMVT-RRALFP 205
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 98.2 bits (243), Expect = 2e-20, Method: Composition-based stats.
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 15 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 75 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 130
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 131 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 189
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 190 DIWSLGCIFAEMVT-RRALFP 209
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 97.4 bits (241), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + L++ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH- 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G T +V T Y APE + C+
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 179
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin
A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin
A3 Complex With Atp
Length = 301
Score = 97.1 bits (240), Expect = 4e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 126 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp
From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 97.1 bits (240), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 77/288 (26%), Positives = 142/288 (49%), Gaps = 40/288 (13%)
Query: 806 QNCIGSGGFGATYKAEIIPGV-VVAVKRLSVGRFQG-------VQQFAAEIRTLGRVQHP 857
+ IG GGFG +K ++ VVA+K L +G +G Q+F E+ + + HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N+V L G + M + ++P G+L + D+ ++WS+ ++ LD+A + Y+ +
Sbjct: 84 NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 918 ECVPRVLHRDIKPSNIL---LDNN--LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
+ P ++HRD++ NI LD N + A ++DFGL++ H+ + + G F ++AP
Sbjct: 141 QNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 973 EY--AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG-RP 1029
E A ++KAD YSF ++L +++ + D S+G + + +M+ +G RP
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE--YSYGK----IKFINMIREEGLRP 249
Query: 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
DC P + N+ +C RP + ++L ++
Sbjct: 250 -----TIPEDCPPR-----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin
A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 97.1 bits (240), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 124 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 180
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 125 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 181
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 125 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 181
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT Peptide
From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT Peptide
From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization Of
Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization Of
Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization Of
Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization Of
Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 69 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 126
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 127 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 183
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 184 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 220
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 125 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 181
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4-
Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 124 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 180
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 96.7 bits (239), Expect = 6e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The
Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The
Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 96.7 bits (239), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 179
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A Gamma-
Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A Gamma-
Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With A
Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With A
Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN Complex
With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN Complex
With The Inhibitor N-&-N1
Length = 299
Score = 96.7 bits (239), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 179
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex
With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex
With Atp
Length = 299
Score = 96.7 bits (239), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 123
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 124 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 180
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 181 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 217
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 96.7 bits (239), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 179
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 96.3 bits (238), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 68/218 (31%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+KF+ + ++ + + LA+ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 123 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 179
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap) In
Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site Phosphorylation:
Cdk2 Y15p T160p In Complex With Cyclin A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site Phosphorylation:
Cdk2 Y15p T160p In Complex With Cyclin A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium Ion
Length = 298
Score = 96.3 bits (238), Expect = 9e-20, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G +V T Y APE + C+ S
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 185 DIWSLGCIFAEMVT-RRALFP 204
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS
Length = 296
Score = 96.3 bits (238), Expect = 9e-20, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G +V T Y APE + C+ S
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 185 DIWSLGCIFAEMVT-RRALFP 204
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 96.3 bits (238), Expect = 9e-20, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 12 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 72 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 127
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G +V T Y APE + C+ S
Sbjct: 128 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCKYYSTAV 186
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 187 DIWSLGCIFAEMVT-RRALFP 206
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 95.9 bits (237), Expect = 1e-19, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+ ++ + +GV A EI L + HPN+V L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 71 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 126
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 185
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 186 DIWSLGCIFAEMVT-RRALFP 205
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 95.9 bits (237), Expect = 1e-19, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+ ++ + +GV A EI L + HPN+V L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 185 DIWSLGCIFAEMVT-RRALFP 204
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 95.5 bits (236), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ ++ +L+KF+ + ++ + + LA+ H
Sbjct: 68 VKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 95.1 bits (235), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 76/288 (26%), Positives = 141/288 (48%), Gaps = 40/288 (13%)
Query: 806 QNCIGSGGFGATYKAEIIPGV-VVAVKRLSVGRFQG-------VQQFAAEIRTLGRVQHP 857
+ IG GGFG +K ++ VVA+K L +G +G Q+F E+ + + HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N+V L G + M + ++P G+L + D+ ++WS+ ++ LD+A + Y+ +
Sbjct: 84 NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 918 ECVPRVLHRDIKPSNIL---LDNN--LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
+ P ++HRD++ NI LD N + A ++DFG ++ H+ + + G F ++AP
Sbjct: 141 QNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGLLGNFQWMAP 195
Query: 973 EY--AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG-RP 1029
E A ++KAD YSF ++L +++ + D S+G + + +M+ +G RP
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE--YSYGK----IKFINMIREEGLRP 249
Query: 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
DC P + N+ +C RP + ++L ++
Sbjct: 250 -----TIPEDCPPR-----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 95.1 bits (235), Expect = 2e-19, Method: Composition-based stats.
Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 9/199 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSV---GRFQGVQQFAAEIRTLGRVQHPN 858
+ + + +G GG Y AE I + VA+K + + + + +++F E+ ++ H N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V++I + +L+ Y+ G L ++I+ +V+ ++ + + + HD
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFTNQILDGIKHAHDM 130
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R++HRDIKP NIL+D+N + DFG+A+ L + T V GT Y +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 979 RVSDKADVYSFGVVLLELI 997
+ D+YS G+VL E++
Sbjct: 188 ATDECTDIYSIGIVLYEML 206
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin
A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin
A3 Complex With Atp
Length = 302
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+ F+ + ++ + + LA+ H
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 94.7 bits (234), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 9/195 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSV-GRFQGVQQFA-AEIRTLGRVQHPNLVTLIGYH 866
+G G +G YKA+ G +VA+KR+ + +G+ A EI L + HPN+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
SE + L++ ++ +L+K + D + ++ S + + R +A+ H R+LHR
Sbjct: 89 HSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
D+KP N+L++++ L+DFGLAR G T +V T Y AP+ M + + S D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 986 VYSFGVVLLELISDK 1000
++S G + E+I+ K
Sbjct: 203 IWSIGCIFAEMITGK 217
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin
A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin
A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin
A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin
A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 94.7 bits (234), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+ F+ + ++ + + LA+ H
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 124
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 125 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 181
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 182 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 218
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 94.7 bits (234), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 63/195 (32%), Positives = 107/195 (54%), Gaps = 9/195 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSV-GRFQGVQQFA-AEIRTLGRVQHPNLVTLIGYH 866
+G G +G YKA+ G +VA+KR+ + +G+ A EI L + HPN+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
SE + L++ ++ +L+K + D + ++ S + + R +A+ H R+LHR
Sbjct: 89 HSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHR 143
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
D+KP N+L++++ L+DFGLAR G T +V T Y AP+ M + + S D
Sbjct: 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVD 202
Query: 986 VYSFGVVLLELISDK 1000
++S G + E+I+ K
Sbjct: 203 IWSIGCIFAEMITGK 217
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
Length = 287
Score = 94.7 bits (234), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 76/288 (26%), Positives = 141/288 (48%), Gaps = 40/288 (13%)
Query: 806 QNCIGSGGFGATYKAEIIPGV-VVAVKRLSVGRFQG-------VQQFAAEIRTLGRVQHP 857
+ IG GGFG +K ++ VVA+K L +G +G Q+F E+ + + HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N+V L G + M + ++P G+L + D+ ++WS+ ++ LD+A + Y+ +
Sbjct: 84 NIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN 140
Query: 918 ECVPRVLHRDIKPSNIL---LDNN--LNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
+ P ++HRD++ NI LD N + A ++DF L++ H+ + + G F ++AP
Sbjct: 141 QNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 973 EY--AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQG-RP 1029
E A ++KAD YSF ++L +++ + D S+G + + +M+ +G RP
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE--YSYGK----IKFINMIREEGLRP 249
Query: 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQI 1077
DC P + N+ +C RP + ++L ++
Sbjct: 250 -----TIPEDCPPR-----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+ F+ + ++ + + LA+ H
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 125
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 126 --RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 182
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 183 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 219
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 332
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 389
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 450 FGILLTELTTKGRVPYP 466
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 10/218 (4%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFA-AEIRTLGRVQHPNL 859
F IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
V L+ +E +++L++ +L +L+ F+ + ++ + + LA+ H
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 122
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
RVLHRD+KP N+L++ L+DFGLAR G +V T Y APE + C+
Sbjct: 123 --RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGCK 179
Query: 980 -VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNI 1016
S D++S G + E+++ ++AL P F I
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRI 216
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ ++ +L+ F+ + ++ + + LA+ H RVLH
Sbjct: 70 IHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + C+ S
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYSTAV 184
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 185 DIWSLGCIFAEMVT-RRALFP 204
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src, In
Complex With Amp-pnp
Length = 452
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 367 FGILLTELTTKGRVPYP 383
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 367 FGILLTELTTKGRVPYP 383
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor
2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of 6-cyclohexylmethoxy-8-isopropyl-9h-
Purin-2-ylamine And Monomeric Cdk2
Length = 299
Score = 94.0 bits (232), Expect = 4e-19, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 71 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 126
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + + S
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGXKYYSTAV 185
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 186 DIWSLGCIFAEMVT-RRALFP 205
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole Inhibitor
469
Length = 266
Score = 94.0 bits (232), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + ++ HP LV L G +
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L++ ++ G L +++ + R L + LDV +AYL + CV +HRD+
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDL 129
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE R S K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 190 FGVLMWEVFSEGK 202
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 93.6 bits (231), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + ++ HP LV L G +
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L++ ++ G L +++ + R L + LDV +AYL + CV +HRD+
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDL 132
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE R S K+DV+S
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 193 FGVLMWEVFSEGK 205
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 93.6 bits (231), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + ++ HP LV L G +
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L++ ++ G L +++ + R L + LDV +AYL + CV +HRD+
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDL 127
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE R S K+DV+S
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 188 FGVLMWEVFSEGK 200
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant)
In Complex With N6-Benzyl Adp
Length = 452
Score = 93.6 bits (231), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 367 FGILLTELTTKGRVPYP 383
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 93.2 bits (230), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G F E + ++ HP LV L G +
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L++ ++ G L +++ + R L + LDV +AYL + CV +HRD+
Sbjct: 94 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDL 149
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE R S K+DV+S
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 210 FGVLMWEVFSEGK 222
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 93.2 bits (230), Expect = 7e-19, Method: Composition-based stats.
Identities = 65/201 (32%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVG-RFQGVQQFAA-EIRTLGRVQHPNLVTLIGY 865
IG G +G YKA + G VVA+K++ + +GV A EI L + HPN+V L+
Sbjct: 18 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 77
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+E +++L++ +L +L+KF+ + ++ + + LA+ H RVLH
Sbjct: 78 IHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLH 133
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR-VSDKA 984
RD+KP N+L++ L+DFGLAR G T +V T Y APE + + S
Sbjct: 134 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGXKYYSTAV 192
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + E+++ ++AL P
Sbjct: 193 DIWSLGCIFAEMVT-RRALFP 212
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src Tyrosine
Kinase Domain Complexed With Pyrazolopyrimidine 5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src Tyrosine
Kinase Domain Complexed With Pyrazolopyrimidine 5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src Tyrosine
Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src Tyrosine
Kinase Domain Complexed With Dasatinib
Length = 286
Score = 93.2 bits (230), Expect = 7e-19, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 93.2 bits (230), Expect = 8e-19, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 76
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 77 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 133
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 194 FGILLTELTTKGRVPYP 210
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 93.2 bits (230), Expect = 8e-19, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 92.8 bits (229), Expect = 1e-18, Method: Composition-based stats.
Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 78 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 134
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 988 SFGVVLLEL----ISDKKALDPS 1006
+FGV+L E+ +S +DPS
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPS 217
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc1
Length = 275
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 72
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 129
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 190 FGILLTELTTKGRVPYP 206
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 75 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 131
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 192 FGILLTELTTKGRVPYP 208
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex
With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In Complex
With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds That
Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds That
Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 92.4 bits (228), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHEKLVQLYAV-VS 250
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 307
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGL RL+ +E A + APE A+ R + K+DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 368 FGILLTELTTKGRVPYP 384
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With
Imidazo[1,5-A]quinoxaline
Length = 267
Score = 91.7 bits (226), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + ++ HP LV L G +
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L+ ++ G L +++ + R L + LDV +AYL + CV +HRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE R S K+DV+S
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 191 FGVLMWEVFSEGK 203
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 73
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E + ++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 74 EEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 191 FGILLTELTTKGRVPYP 207
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 78 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 134
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 988 SFGVVLLEL----ISDKKALDPS 1006
+FGV+L E+ +S +DPS
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPS 217
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 91.3 bits (225), Expect = 2e-18, Method: Composition-based stats.
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L ++ +A +AY+ +HRD+
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 198 FGILLTELTTKGRVPYP 214
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Inhibitor
Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Inhibitor
Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 91.3 bits (225), Expect = 3e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 91.3 bits (225), Expect = 3e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 91.3 bits (225), Expect = 3e-18, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G L F++ + + L +A +A +AY+ +HRD+
Sbjct: 84 EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 201 FGILLTELTTKGRVPYP 217
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 90.9 bits (224), Expect = 3e-18, Method: Composition-based stats.
Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 5/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G G FG + VA+K L G + F E + + +++H LV L VS
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV-VS 80
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G+L F++ + + L ++ +A +AY+ +HRD+
Sbjct: 81 EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERM---NYVHRDL 137
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ NL ++DFGLARL+ +E A + APE A+ R + K+DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 989 FGVVLLELISDKKALDP 1005
FG++L EL + + P
Sbjct: 198 FGILLTELTTKGRVPYP 214
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 90.9 bits (224), Expect = 3e-18, Method: Composition-based stats.
Identities = 75/234 (32%), Positives = 114/234 (48%), Gaps = 22/234 (9%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE 847
GV L EN+ + + G FG +KA+++ VAVK + Q Q E
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQN-EYE 68
Query: 848 IRTLGRVQHPNLVTLIGYHVS----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
+ +L ++H N++ IG + +++LI + G+L F++ V W+ L
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCH 125
Query: 904 IALDVARALAYLHDEC-------VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956
IA +AR LAYLH++ P + HRDIK N+LL NNL A ++DFGLA +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 957 THATTD-VAGTFGYVAPEY---AMTCRVSD--KADVYSFGVVLLELISDKKALD 1004
+ T GT Y+APE A+ + + D+Y+ G+VL EL S A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 90.9 bits (224), Expect = 4e-18, Method: Composition-based stats.
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 809 IGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG K G V+ +K L + + F E++ + ++HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ + I Y+ GG L I+ + WS A D+A +AYLH ++HRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSM---NIIHRD 133
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-------------DVAGTFGYVAPEY 974
+ N L+ N N ++DFGLARL+ +T V G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
+K DV+SFG+VL E+I A DP +
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA-DPDY 225
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 90.9 bits (224), Expect = 4e-18, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 9/203 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 78 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 134
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 194
Query: 988 SFGVVLLEL----ISDKKALDPS 1006
+FGV+L E+ +S +DPS
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDPS 217
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 90.5 bits (223), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 5/212 (2%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA 846
GV Y+ +++ +G G +G Y+ + VAVK L + V++F
Sbjct: 207 GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 265
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL 906
E + ++HPNLV L+G E ++I ++ GNL ++++ R+ V +L +A
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
++ A+ YL + +HR++ N L+ N ++DFGL+RL+ A
Sbjct: 326 QISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE + S K+DV++FGV+L E+ +
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 90.5 bits (223), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 5/212 (2%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA 846
GV Y+ +++ +G G +G Y+ + VAVK L + V++F
Sbjct: 246 GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 304
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL 906
E + ++HPNLV L+G E ++I ++ GNL ++++ R+ V +L +A
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
++ A+ YL + +HR++ N L+ N ++DFGL+RL+ A
Sbjct: 365 QISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 421
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE + S K+DV++FGV+L E+ +
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 90.5 bits (223), Expect = 5e-18, Method: Composition-based stats.
Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 27/285 (9%)
Query: 801 AGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFA---AEIRTLGRVQH 856
A F ++ IG G F Y+A ++ GV VA+K++ + + A EI L ++ H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHKIALDVARALAY 914
PN++ + + E+ ++ G+L + I+ + +R + + K + + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+H RV+HRDIKP+N+ + L D GL R +S+T A + GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 207
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ K+D++S G +L E+ AL F +G+ N+ + + C++
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLYSLCKKI----EQCDYPP 257
Query: 1035 AGLWDCGPHDDLIEML-NLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
P D E L L MC RP + V K++
Sbjct: 258 L------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 90.5 bits (223), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 5/212 (2%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA 846
GV Y+ +++ +G G +G Y+ + VAVK L + V++F
Sbjct: 204 GVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 262
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL 906
E + ++HPNLV L+G E ++I ++ GNL ++++ R+ V +L +A
Sbjct: 263 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 322
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
++ A+ YL + +HR++ N L+ N ++DFGL+RL+ A
Sbjct: 323 QISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 379
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE + S K+DV++FGV+L E+ +
Sbjct: 380 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 411
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 90.1 bits (222), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 15 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 75 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 186
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMT 209
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 90.1 bits (222), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 12 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 71
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 72 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 126
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 183
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMT 206
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 90.1 bits (222), Expect = 6e-18, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 15 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 75 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 129
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 186
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMT 209
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 70 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 181
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT 204
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG + + VA+K + G + F E + ++ HP LV L G +
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+A + L++ ++ G L +++ + R L + LDV +AYL + V+HRD+
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDL 129
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+ N +SDFG+ R + + ++T + +PE R S K+DV+S
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 989 FGVVLLELISDKK 1001
FGV++ E+ S+ K
Sbjct: 190 FGVLMWEVFSEGK 202
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 14 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 73
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA AR + YLH +
Sbjct: 74 MGYS-TKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS--- 128
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L + + DFGLA + S +H ++G+ ++APE R+
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 185
Query: 982 D------KADVYSFGVVLLELIS 998
D ++DVY+FG+VL EL++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMT 208
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 89.7 bits (221), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 38 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 98 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 209
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT 232
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 89.7 bits (221), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 37 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 96
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 97 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 151
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 208
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMT 231
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 151
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 210
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 211 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 270
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 271 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 308
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 138
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 139 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 197
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 198 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 257
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 258 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 295
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 140
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 141 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 199
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 200 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 259
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 260 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 297
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 139
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 140 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 198
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 199 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 258
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 259 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 296
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl
Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl
Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 133
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 192
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 253 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 151
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 152 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 210
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 211 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 270
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 271 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 308
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 164
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 223
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 284 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 132
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 133 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 191
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 192 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 251
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 252 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 289
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 131
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 132 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 190
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 191 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 250
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 251 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 288
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 137
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 138 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 196
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 197 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 256
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 257 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 294
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 136
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 255
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 256 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 293
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor
Length = 301
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 133
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 192
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 253 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 89.4 bits (220), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY + ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 70 MGYSTA-PQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA + S +H ++G+ ++APE R+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 181
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT 204
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 89.4 bits (220), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 13/223 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F V N +G G F Y+AE I G+ VA+K + ++ + VQ+ E++ +++HP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L Y ++L+ G + +++++R + E H + + + YLH
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSH 131
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMT 977
+ LHRD+ SN+LL N+N ++DFGLA L E H T + GT Y++PE A
Sbjct: 132 GI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATR 186
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWA 1020
++DV+S G + L+ + D + N N V A
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTD--TVKNTLNKVVLA 227
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 40 LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E +++ Y+P GNL ++++ R V +L +A ++ A+ YL + +HRD
Sbjct: 99 LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKK---NFIHRD 155
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE S K+DV+
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVW 215
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 216 AFGVLLWEIAT 226
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 81 REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 137
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 138 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 197
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 198 AFGVLLWEIAT 208
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS-QICKGMEYLGTK--- 136
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 255
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 256 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 293
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 202 AFGVLLWEIAT 212
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 5/212 (2%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAA 846
G+ Y+ +++ +G G +G Y+ + VAVK L + V++F
Sbjct: 1 GMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 59
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL 906
E + ++HPNLV L+G E ++I ++ GNL ++++ R+ V +L +A
Sbjct: 60 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
++ A+ YL + +HRD+ N L+ N ++DFGL+RL+ A
Sbjct: 120 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFP 176
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ APE + S K+DV++FGV+L E+ +
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 138
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 199 AFGVLLWEIAT 209
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor
Nvp-Bbt594
Length = 295
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 84/291 (28%), Positives = 128/291 (43%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 133
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTES 192
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 253 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 85 REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 202 AFGVLLWEIAT 212
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 14/217 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNL 859
+ V IG+G +G K G ++ K L G Q +E+ L ++HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 860 VTLIGYHV--SEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYL 915
V + + ++++ Y GG+L I + R+ ++ + ++ + AL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 916 H--DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
H + VLHRD+KP+N+ LD N L DFGLAR+L + A T V GT Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPE 186
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010
++K+D++S G +L EL AL P F +F
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAF 219
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 202 AFGVLLWEIAT 212
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 88.6 bits (218), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 26 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA AR + YLH +
Sbjct: 86 MGYS-TKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L + + DFGLA S +H ++G+ ++APE R+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 197
Query: 982 D------KADVYSFGVVLLELIS 998
D ++DVY+FG+VL EL++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMT 220
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 202 AFGVLLWEIAT 212
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 93 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 149
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 150 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 209
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 210 AFGVLLWEIAT 220
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 201
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 202 AFGVLLWEIAT 212
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 140
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 200
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 201 AFGVLLWEIAT 211
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 196
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 197 AFGVLLWEIAT 207
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 138
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 199 AFGVLLWEIAT 209
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 56/191 (29%), Positives = 97/191 (50%), Gaps = 5/191 (2%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++I ++ GNL ++++ R+ V +L +A ++ A+ YL + +HRD
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRD 138
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
+ N L+ N ++DFGL+RL+ A + APE + S K+DV+
Sbjct: 139 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 198
Query: 988 SFGVVLLELIS 998
+FGV+L E+ +
Sbjct: 199 AFGVLLWEIAT 209
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI +LP G+L +++Q R +L + + + + YL +
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 136
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HRD+ NIL++N + DFGL ++L + G F Y APE
Sbjct: 137 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTES 195
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 196 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 255
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 256 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 293
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 88.6 bits (218), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 70 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 124
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA S +H ++G+ ++APE R+
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 181
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT 204
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 38 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 98 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 152
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA S +H ++G+ ++APE R+
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 209
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT 232
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 30 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 89
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY ++ ++ ++ + G +L + + E L IA A+ + YLH +
Sbjct: 90 MGYS-TKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS--- 144
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L +L + DFGLA S +H ++G+ ++APE R+
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 201
Query: 982 DK------ADVYSFGVVLLELIS 998
DK +DVY+FG+VL EL++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMT 224
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 88.2 bits (217), Expect = 2e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNL 859
+ V IG+G +G K G ++ K L G Q +E+ L ++HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 860 VTLIGYHV--SEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYL 915
V + + ++++ Y GG+L I + R+ ++ + ++ + AL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 916 H--DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
H + VLHRD+KP+N+ LD N L DFGLAR+L E A + GT Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA-KEFVGTPYYMSPE 186
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010
++K+D++S G +L EL AL P F +F
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAF 219
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 88.2 bits (217), Expect = 2e-17, Method: Composition-based stats.
Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 39/291 (13%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G VVAVK+L + ++ F EI L +QH N+V
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + LI YLP G+L ++Q R +L + + + + YL +
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICKGMEYLGTK--- 134
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMTC 978
R +HR++ NIL++N + DFGL ++L + + G F Y APE
Sbjct: 135 RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTES 193
Query: 979 RVSDKADVYSFGVVLLEL---ISDKKALDPSFCSF-GNGF--NIVAWASMLLLQG----- 1027
+ S +DV+SFGVVL EL I K+ F GN ++ + + LL+
Sbjct: 194 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 253
Query: 1028 RPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQ 1078
RP D P E+ + C +++ RPS R +A ++ QI+
Sbjct: 254 RP---------DGCPD----EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 291
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 88.2 bits (217), Expect = 2e-17, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGLAR+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 87.8 bits (216), Expect = 3e-17, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
V IGSG FG YK + V V + ++ Q +Q F E+ L + +H N++
Sbjct: 26 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+GY + ++ ++ + G +L + + E L IA AR + YLH +
Sbjct: 86 MGYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKS--- 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGT-SETHATTDVAGTFGYVAPEYAMTCRVS 981
++HRD+K +NI L + + DFGLA S +H ++G+ ++APE R+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE---VIRMQ 197
Query: 982 D------KADVYSFGVVLLELIS 998
D ++DVY+FG+VL EL++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMT 220
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 87.4 bits (215), Expect = 4e-17, Method: Composition-based stats.
Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 809 IGSGGFGATYKAEIIPG----VVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y E I + A+K LS + Q V+ F E + + HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 864 GYHVS-EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + E ++ Y+ G+L +FI+ P+R L L VAR + YL ++ +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---K 144
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE-------THATTDVAGTFGYVAPEYA 975
+HRD+ N +LD + ++DFGLAR + E HA V + A E
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK----WTALESL 200
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
T R + K+DV+SFGV+L EL++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLT 223
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 196 FGILLTEIVT 205
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 86
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 87 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 143
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 204 FGILLTEIVT 213
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 84
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 85 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 202 FGILLTEIVT 211
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 79
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 80 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 136
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 197 FGILLTEIVT 206
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 80
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 81 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 137
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 198 FGILLTEIVT 207
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 87.0 bits (214), Expect = 5e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 196 FGILLTEIVT 205
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 87.0 bits (214), Expect = 5e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 87
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 88 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 144
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 205 FGILLTEIVT 214
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase In
Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase In
Complex With Arq 197
Length = 318
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y ++ + AVK L+ + V QF E + HPN+++
Sbjct: 54 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+G + SE ++ Y+ G+L FI++ ++ L VA+ + YL +
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK-- 170
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMT 977
+ +HRD+ N +LD ++DFGLAR + E ++ + G ++A E T
Sbjct: 171 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ + K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 272
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 87.0 bits (214), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 87.0 bits (214), Expect = 6e-17, Method: Composition-based stats.
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 806 QNCIGSGGFGATYKAEIIPG-----VVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNL 859
Q IG+G FG YK + V VA+K L G + + F E +G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLHD 917
+ L G M +I Y+ G L+KF++++ E+S+L + + +A + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLAN 165
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYA 975
+HRD+ NIL+++NL +SDFGL+R+L T+ T+ + APE
Sbjct: 166 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+SFG+V+ E+++
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 87.0 bits (214), Expect = 6e-17, Method: Composition-based stats.
Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IG G FG + G VAVK + Q F AE + +++H NLV L+G V
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 869 E-AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ Y+ G+L +++ R R + L K +LDV A+ YL +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 127
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAPEYAMTCRVSDKADV 986
+ N+L+ + A +SDFGL T E +T D + APE + S K+DV
Sbjct: 128 LAARNVLVSEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 987 YSFGVVLLELIS 998
+SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 87.0 bits (214), Expect = 6e-17, Method: Composition-based stats.
Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IG G FG + G VAVK + Q F AE + +++H NLV L+G V
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 869 E-AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ Y+ G+L +++ R R + L K +LDV A+ YL +HRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 142
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAPEYAMTCRVSDKADV 986
+ N+L+ + A +SDFGL T E +T D + APE + S K+DV
Sbjct: 143 LAARNVLVSEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 987 YSFGVVLLELIS 998
+SFG++L E+ S
Sbjct: 198 WSFGILLWEIYS 209
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 84
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 85 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 141
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 202 FGILLTEIVT 211
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 88
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 89 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 145
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 206 FGILLTEIVT 215
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 196 FGILLTEIVT 205
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 73
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 74 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 191 FGILLTEIVT 200
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 83
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 84 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 140
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 201 FGILLTEIVT 210
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 18 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 78 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 135 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMS 216
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 14/217 (6%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNL 859
+ V IG+G +G K G ++ K L G Q +E+ L ++HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 860 VTLIGYHV--SEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYL 915
V + + ++++ Y GG+L I + R+ ++ + ++ + AL
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 916 H--DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
H + VLHRD+KP+N+ LD N L DFGLAR+L + A V GT Y++PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPE 186
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010
++K+D++S G +L EL AL P F +F
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELC----ALMPPFTAF 219
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 86.7 bits (213), Expect = 6e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 35 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 95 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 152 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 208
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 209 AIAYRKFTSASDVWSYGIVLWEVMS 233
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y ++ + AVK L+ + V QF E + HPN+++
Sbjct: 55 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+G + SE ++ Y+ G+L FI++ ++ L VA+ + YL +
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK-- 171
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMT 977
+ +HRD+ N +LD ++DFGLAR + E ++ + G ++A E T
Sbjct: 172 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ + K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 273
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 30 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + YL + +
Sbjct: 90 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK---K 145
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E ++ + G ++A E T +
Sbjct: 146 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 205
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 206 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 246
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 86.7 bits (213), Expect = 7e-17, Method: Composition-based stats.
Identities = 61/225 (27%), Positives = 114/225 (50%), Gaps = 24/225 (10%)
Query: 792 TYENVVRATAGF---------NVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRF 838
TYE+ +A F ++ IG+G FG + +PG + VA+K L VG
Sbjct: 4 TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 839 QGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
+ ++ F E +G+ HPN++ L G + ++ Y+ G+L+ F++ + +
Sbjct: 64 EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQ 120
Query: 898 WSMLHKIAL--DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955
++++ + + ++ + YL D +HRD+ NIL+++NL +SDFGL+R+L
Sbjct: 121 FTVIQLVGMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 956 ETHATTDVAGTFG--YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
A T G + APE + + +DV+S+G+V+ E++S
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 86.7 bits (213), Expect = 7e-17, Method: Composition-based stats.
Identities = 63/192 (32%), Positives = 95/192 (49%), Gaps = 13/192 (6%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IG G FG + G VAVK + Q F AE + +++H NLV L+G V
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 869 E-AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ Y+ G+L +++ R R + L K +LDV A+ YL +HRD
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 133
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAPEYAMTCRVSDKADV 986
+ N+L+ + A +SDFGL T E +T D + APE S K+DV
Sbjct: 134 LAARNVLVSEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 987 YSFGVVLLELIS 998
+SFG++L E+ S
Sbjct: 189 WSFGILLWEIYS 200
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + YL + +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK---K 153
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E ++ + G ++A E T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 213
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 254
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 86.7 bits (213), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 106/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 45 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 162 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 218
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 219 AIAYRKFTSASDVWSYGIVLWEVMS 243
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 86.3 bits (212), Expect = 7e-17, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ Y+ G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL R+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 76 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 76 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 130
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of
C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain Of
C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With 4-(
3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With 4-(
(6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y ++ + AVK L+ + V QF E + HPN+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+G + SE ++ Y+ G+L FI++ ++ L VA+ + YL +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK-- 149
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMT 977
+ +HRD+ N +LD ++DFGLAR + E ++ + G ++A E T
Sbjct: 150 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ + K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 251
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 44 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 104 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 158
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 219 SASDVWMFGVCMWEIL 234
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 19 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 79 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 133
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 194 SASDVWMFGVCMWEIL 209
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 81 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 135
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 196 SASDVWMFGVCMWEIL 211
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 73 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 127
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 188 SASDVWMFGVCMWEIL 203
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1
Length = 302
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y ++ + AVK L+ + V QF E + HPN+++
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+G + SE ++ Y+ G+L FI++ ++ L VA+ + YL +
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK-- 150
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMT 977
+ +HRD+ N +LD ++DFGLAR + E ++ + G ++A E T
Sbjct: 151 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ + K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 252
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 86.3 bits (212), Expect = 9e-17, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S TD+ GT Y+
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 178
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 86.3 bits (212), Expect = 9e-17, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S TD+ GT Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 173
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 86.3 bits (212), Expect = 9e-17, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S TD+ GT Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 173
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis Of
A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 86.3 bits (212), Expect = 9e-17, Method: Composition-based stats.
Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S TD+ GT Y+
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYL 174
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 86.3 bits (212), Expect = 9e-17, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y ++ + AVK L+ + V QF E + HPN+++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+G + SE ++ Y+ G+L FI++ ++ L VA+ + YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK-- 147
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMT 977
+ +HRD+ N +LD ++DFGLAR + E ++ + G ++A E T
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ + K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 249
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 86.3 bits (212), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 18 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 78 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--- 132
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 193 SASDVWMFGVCMWEIL 208
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 86.3 bits (212), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA-AEIRTLGRVQH 856
+++ F +G+G + YK GV VA+K + + +G A EI + ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR----RTVEWSMLHKIALDVARAL 912
N+V L +E ++ L++ ++ +L+K++ R R +E +++ + + L
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
A+ H+ ++LHRD+KP N+L++ L DFGLAR G +++V T Y AP
Sbjct: 122 AFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAP 177
Query: 973 EYAMTCRV-SDKADVYSFGVVLLELISDK 1000
+ M R S D++S G +L E+I+ K
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGK 206
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRVQHPN 858
F++ +G G FG Y A E ++A+K L + + GV+ Q E+ ++HPN
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L GY ++LI Y P G + + +Q R + + + ++A AL+Y H +
Sbjct: 74 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY--ITELANALSYCHSK 131
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
RV+HRDIKP N+LL +N ++DFG + +S T + GT Y+ PE
Sbjct: 132 ---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEMIEGR 185
Query: 979 RVSDKADVYSFGVVLLELI 997
+K D++S GV+ E +
Sbjct: 186 MHDEKVDLWSLGVLCYEFL 204
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor
13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + YL + +
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK---K 152
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E ++ + G ++A E T +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK 212
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 253
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 21/231 (9%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
IG G FG Y ++ + AVK L+ + V QF E + HPN+++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 862 LIGYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L+G + SE ++ Y+ G+L FI++ ++ L VA+ + YL +
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK-- 152
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT---FGYVAPEYAMT 977
+ +HRD+ N +LD ++DFGLAR + E ++ + G ++A E T
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ + K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 254
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase In
Complex With An Mk-2461 Analog
Length = 307
Score = 85.9 bits (211), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 68/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + YL + +
Sbjct: 97 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKYLASK---K 152
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 153 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQK 212
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 213 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 253
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 4/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G VQ F E + +QH LV L
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E +++I Y+ G+L F++ V L + +A +AY+ + +HRD+
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 136
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +N+L+ +L ++DFGLAR++ +E A + APE + K+DV+S
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 989 FGVVLLELISDKKALDP 1005
FG++L E+++ K P
Sbjct: 197 FGILLYEIVTYGKIPYP 213
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 85.5 bits (210), Expect = 1e-16, Method: Composition-based stats.
Identities = 62/225 (27%), Positives = 112/225 (49%), Gaps = 24/225 (10%)
Query: 792 TYENVVRATAGF---------NVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRF 838
TYE+ RA F ++ IG+G FG + +PG V VA+K L VG
Sbjct: 25 TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 839 QGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
+ ++ F E +G+ HPN+V L G + ++ ++ G L+ F++ + +
Sbjct: 85 EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR---KHDGQ 141
Query: 898 WSMLHKIAL--DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955
++++ + + +A + YL D +HRD+ NIL+++NL +SDFGL+R++
Sbjct: 142 FTVIQLVGMLRGIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 956 ETHATTDVAGTFG--YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T G + APE + + +DV+S+G+V+ E++S
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 13/192 (6%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IG G FG + G VAVK + Q F AE + +++H NLV L+G V
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 869 E-AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ Y+ G+L +++ R R + L K +LDV A+ YL +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVSDKADV 986
+ N+L+ + A +SDFGL T E +T D + APE + S K+DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGL-----TKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 987 YSFGVVLLELIS 998
+SFG++L E+ S
Sbjct: 370 WSFGILLWEIYS 381
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 57/206 (27%), Positives = 110/206 (53%), Gaps = 17/206 (8%)
Query: 804 NVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPN 858
++ IG+G FG + +PG + VA+K L G + ++ F +E +G+ HPN
Sbjct: 36 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 95
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLH 916
++ L G + +I ++ G+L+ F++ + +++++ + + +A + YL
Sbjct: 96 VIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGT--FGYVAP 972
D +HRD+ NIL+++NL +SDFGL+R L TS+ T+ + G + AP
Sbjct: 153 DM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 209
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E + + +DV+S+G+V+ E++S
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMS 235
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 85.5 bits (210), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN++ L GY ++LI Y P G + + +Q + + + + ++A AL+Y
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 149
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H + RV+HRDIKP N+LL + ++DFG + +S D+ GT Y+ PE
Sbjct: 150 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPPEM 203
Query: 975 AMTCRVSDKADVYSFGVVLLELISDK 1000
+K D++S GV+ E + K
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGK 229
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its
Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 85.1 bits (209), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
V+ +G G FG KA+ VA+K++ + + F E+R L RV HPN+V L G
Sbjct: 12 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFI---QDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
++ + L+ Y GG+L + + P T +M L ++ +AYLH
Sbjct: 69 ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM--SWCLQCSQGVAYLHSMQPK 124
Query: 922 RVLHRDIKPSNILL-DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRD+KP N+LL + DFG A + +TH T + G+ ++APE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNY 180
Query: 981 SDKADVYSFGVVLLELISDKKALD----PSF 1007
S+K DV+S+G++L E+I+ +K D P+F
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 85.1 bits (209), Expect = 2e-16, Method: Composition-based stats.
Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ G + A K + + ++ + EI L HP +V L+G +
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ +++++ + PGG ++ + + R E + + + AL +LH + R++HRD
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVVCRQMLEALNFLHSK---RIIHRD 134
Query: 928 IKPSNILLDNNLNAYLSDFGL-ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD---- 982
+K N+L+ + L+DFG+ A+ L T + + GT ++APE M + D
Sbjct: 135 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 192
Query: 983 -KADVYSFGVVLLEL 996
KAD++S G+ L+E+
Sbjct: 193 YKADIWSLGITLIEM 207
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 85.1 bits (209), Expect = 2e-16, Method: Composition-based stats.
Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ G + A K + + ++ + EI L HP +V L+G +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ +++++ + PGG ++ + + R E + + + AL +LH + R++HRD
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVVCRQMLEALNFLHSK---RIIHRD 142
Query: 928 IKPSNILLDNNLNAYLSDFGL-ARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD---- 982
+K N+L+ + L+DFG+ A+ L T + + GT ++APE M + D
Sbjct: 143 LKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYD 200
Query: 983 -KADVYSFGVVLLEL 996
KAD++S G+ L+E+
Sbjct: 201 YKADIWSLGITLIEM 215
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 76 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + ++APE R +
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 68/261 (26%), Positives = 124/261 (47%), Gaps = 24/261 (9%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G K + P G+++A K + + ++ Q E++ L P +V G
Sbjct: 24 LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ +++ R + +L K+++ V R LAYL ++ +++HR
Sbjct: 84 YSDGEISICMEHMDGGSLDQVLKEAKR--IPEEILGKVSIAVLRGLAYLREKH--QIMHR 139
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y+APE S ++D+
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMAPERLQGTHYSVQSDI 196
Query: 987 YSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWDCGPHDDL 1046
+S G+ L+EL + + P + + GRP G PH
Sbjct: 197 WSMGLSLVELAVGRYPIPPPDAK-----------ELEAIFGRPVVDGEEG----EPHSIS 241
Query: 1047 IEMLNLAIMCTGESLSSRPSM 1067
+G + SRP+M
Sbjct: 242 PRPRPPGRPVSGHGMDSRPAM 262
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 85.1 bits (209), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN++ L GY ++LI Y P G + + +Q + + + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H + RV+HRDIKP N+LL + ++DFG + +S T++ GT Y+ PE
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLPPEM 177
Query: 975 AMTCRVSDKADVYSFGVVLLELISDK 1000
+K D++S GV+ E + K
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 85.1 bits (209), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
V+ +G G FG KA+ VA+K++ + + F E+R L RV HPN+V L G
Sbjct: 13 VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 69
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFI---QDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
++ + L+ Y GG+L + + P T +M L ++ +AYLH
Sbjct: 70 ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAM--SWCLQCSQGVAYLHSMQPK 125
Query: 922 RVLHRDIKPSNILL-DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRD+KP N+LL + DFG A + +TH T + G+ ++APE
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNY 181
Query: 981 SDKADVYSFGVVLLELISDKKALD----PSF 1007
S+K DV+S+G++L E+I+ +K D P+F
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEIGGPAF 212
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 98/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G F AE + ++QH LV L V+
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HR++
Sbjct: 75 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNL 131
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 192 FGILLTEIVT 201
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) With
Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) With
Inhibitor
Length = 350
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 8/221 (3%)
Query: 788 GVQLTYENVV-RATAGFNVQNCIGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFA 845
GV L EN+ ++ + IG G FG A G +K +++ R ++
Sbjct: 10 GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREE 69
Query: 846 A--EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
+ E+ L ++HPN+V ++++ +Y GG+L K I + + +
Sbjct: 70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ + AL ++HD ++LHRDIK NI L + L DFG+AR+L ++ A +
Sbjct: 130 WFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
GT Y++PE ++K+D+++ G VL EL + K A +
Sbjct: 187 -GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 84.7 bits (208), Expect = 3e-16, Method: Composition-based stats.
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 793 YENVVRATAGFNVQNCIGS-GGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRT 850
YE+V R + IG G FG YKA+ V+ A K + + ++ + EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI 60
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
L HPN+V L+ E ++++ + GG ++ + + R E S + +
Sbjct: 61 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQVVCKQTLD 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL YLHD +++HRD+K NIL + + L+DFG++ + GT ++
Sbjct: 120 ALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPYWM 176
Query: 971 APEYAMTCRVSD------KADVYSFGVVLLEL 996
APE M C S KADV+S G+ L+E+
Sbjct: 177 APEVVM-CETSKDRPYDYKADVWSLGITLIEM 207
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 84.7 bits (208), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ +N L DFGL+R + S + + ++APE R +
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 60/226 (26%), Positives = 108/226 (47%), Gaps = 7/226 (3%)
Query: 775 GLVRKEVVICNNIGVQLTYENVVRA--TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKR 832
GL +K V C + Q +E ++ +G+G FG + A VAVK
Sbjct: 160 GLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 219
Query: 833 LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP 892
+ G V+ F AE + +QH LV L V++ +++I ++ G+L F++
Sbjct: 220 MKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDE 277
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
L + +A +A++ +HRD++ +NIL+ +L ++DFGLAR++
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 334
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+E A + APE + K+DV+SFG++L+E+++
Sbjct: 335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 84.3 bits (207), Expect = 3e-16, Method: Composition-based stats.
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV-VVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLV 860
+ +Q IGSG A P VA+KR+++ + Q + + EI+ + + HPN+V
Sbjct: 12 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQ------DRPRRTVEWSMLHKIALDVARALAY 914
+ V + E++L+ L GG++ I+ + ++ S + I +V L Y
Sbjct: 72 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT----SETHATTDVAGTFGYV 970
LH +HRD+K NILL + + ++DFG++ L T + GT ++
Sbjct: 132 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 971 APEYAMTCRVSD-KADVYSFGVVLLELIS 998
APE R D KAD++SFG+ +EL +
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELAT 217
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 84.3 bits (207), Expect = 3e-16, Method: Composition-based stats.
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV-VVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLV 860
+ +Q IGSG A P VA+KR+++ + Q + + EI+ + + HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQ------DRPRRTVEWSMLHKIALDVARALAY 914
+ V + E++L+ L GG++ I+ + ++ S + I +V L Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGT----SETHATTDVAGTFGYV 970
LH +HRD+K NILL + + ++DFG++ L T + GT ++
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 971 APEYAMTCRVSD-KADVYSFGVVLLELIS 998
APE R D KAD++SFG+ +EL +
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELAT 222
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With A
Pyrrolotriazine Based Inhibitor
Length = 373
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + +L + +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---K 212
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 273 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 313
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 84.3 bits (207), Expect = 3e-16, Method: Composition-based stats.
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN++ L GY ++LI Y P G + K +Q + + + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSY 128
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+ PE
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEM 182
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALD 1004
+K D++S GV+ E + K +
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 84.3 bits (207), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 91/304 (29%), Positives = 133/304 (43%), Gaps = 52/304 (17%)
Query: 1 KNALLQLKSAITEDPLGLTSNWNPKDTDSC--SWHGVTCDPLSGRVXXXXXXXXXXXXXX 58
K ALLQ+K + +P L+S W P TD C +W GV CD
Sbjct: 8 KQALLQIKKDL-GNPTTLSS-WLPT-TDCCNRTWLGVLCD--------TDTQTYRVNNLD 56
Query: 59 XXXXXPPAAGPGGNFSFHFPCLQLHQHDRGNINSNSSDKLSGNLSRAIGDLTQLRVLLLA 118
P P + + P L G IN+ L G + AI LTQL L +
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLY--IGGINN-----LVGPIPPAIAKLTQLHYLYIT 109
Query: 119 FNGFSGELPLEIGQLSLLEILDLSFNSFHGPIPPTLQNCSSLRLINLSGNQFNGTIPAFF 178
SG +P + Q+ L LD S+N+ G +PP++ + L NL G F+G
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS-----LPNLVGITFDG------ 158
Query: 179 GQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLAANSLTGSIPPSLGNCTELRSLLL 238
N +SG++P+ +G + ++ N LTG IPP+ N L + L
Sbjct: 159 -------------NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDL 204
Query: 239 SSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQLKVLVLRNDYGPLYSREH 298
S NML+GD FG N + + L++N L+ + ++G+ K L L LRN+ R +
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNN------RIY 257
Query: 299 GDLP 302
G LP
Sbjct: 258 GTLP 261
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 39/104 (37%), Positives = 61/104 (58%), Gaps = 1/104 (0%)
Query: 578 HLQGPLPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSK 637
+L GP+P I K+ L +L ++ N +GAIP L+Q+ +L L+ S N+LSG +P S
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 638 LEHLNVLRLDHNNLTGRIPPGFGTRSSL-SIFDVSFNNLSGSAP 680
L +L + D N ++G IP +G+ S L + +S N L+G P
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 4/148 (2%)
Query: 534 VPSDMGSHCKCMKFLSMAG-NEFVGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMED 592
+PS + ++ + FL + G N VG IP + ++ G +P ++++++
Sbjct: 68 IPSSL-ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 593 LKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHL-NVLRLDHNNL 651
L L S N +G +P ++ L +L + N +SG IP + L + + N L
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
Query: 652 TGRIPPGFGTRSSLSIFDVSFNNLSGSA 679
TG+IPP F +L+ D+S N L G A
Sbjct: 187 TGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 34/207 (16%)
Query: 475 TGPVPPFLIDSDSLSSRPYYGFWLSGNSLKGNLSTYPFDLCLSLDGLIFDIGNNKLIGEV 534
+G +P FL +L + + LSG +L ++S+ P +L G+ FD N++ G +
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSG-TLPPSISSLP-----NLVGITFD--GNRISGAI 165
Query: 535 PSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDXXXXXXXXXXHLQGPLPSYINKMEDLK 594
P GS K ++++ N G IP +F N + L
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-------------------------LA 200
Query: 595 FLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRLDHNNLTGR 654
F+ LS N G + + + L+ NSL+ ++ + ++LN L L +N + G
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGT 259
Query: 655 IPPGFGTRSSLSIFDVSFNNLSGSAPR 681
+P G L +VSFNNL G P+
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/170 (31%), Positives = 72/170 (42%), Gaps = 28/170 (16%)
Query: 223 IPPSLGNCTELRSLLLSS-NMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELGMCKQL 281
IP SL N L L + N L G IP + +L L L ++ +SG +P L K L
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 282 KVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRLPNLRVFWAPNLNLE 341
L D+ YN G LP SI+ LPNL +
Sbjct: 128 VTL----DF---------------------SYNALSGTLPPSISSLPNLVGITFDGNRIS 162
Query: 342 GIFPQNWELCSKL-EMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNNLTG 390
G P ++ SKL + ++ N TG+IP + N +L F+DLS N L G
Sbjct: 163 GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEG 211
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 1/100 (1%)
Query: 582 PLPSYINKMEDLKFLSLS-LNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEH 640
P+PS + + L FL + +NN G IP + +L L L ++ ++SG IP S+++
Sbjct: 67 PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126
Query: 641 LNVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAP 680
L L +N L+G +PP + +L N +SG+ P
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 217 NSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSELG 276
N+L G IPP++ T+L L ++ + G IP Q+ L LD S N LSG +P +
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 277 MCKQLKVLV---------LRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPDSITRL 327
L + + + YG +S+ + I N G +P + L
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGS-FSKLFTSMTIS--------RNRLTGKIPPTFANL 197
Query: 328 PNLRVFWAPNLNLEGIFPQNWELCSKLEMLNLAHNFFTGQIPASLGNCKSLYFLDLSSNN 387
V + N+ LEG + + ++LA N + +G K+L LDL +N
Sbjct: 198 NLAFVDLSRNM-LEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNR 255
Query: 388 LTGLLPEEVS-VPCMAVFNVSQNLLSGEIPR 417
+ G LP+ ++ + + NVS N L GEIP+
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 84.3 bits (207), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 43 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + +L + +
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---K 158
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 159 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 218
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 219 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 259
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 22/265 (8%)
Query: 774 PGLVRKEVVICNNIGVQLTYENVVRATAGF-NVQNCIGSGGFGATYKAEII----PGVVV 828
PG V ++ N VQ V+ ++ + IG G FG Y ++ +
Sbjct: 2 PGTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 61
Query: 829 AVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV-SEAEMFLIYNYLPGGNLEK 886
AVK L+ + V QF E + HPN+++L+G + SE ++ Y+ G+L
Sbjct: 62 AVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 121
Query: 887 FIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDF 946
FI++ ++ L VA+ + +L + + +HRD+ N +LD ++DF
Sbjct: 122 FIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADF 177
Query: 947 GLARLLGTSE---THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKAL 1003
GLAR + E H T ++A E T + + K+DV+SFGV+L EL++
Sbjct: 178 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 237
Query: 1004 DPSFCSFGNGFNIVAWASMLLLQGR 1028
P N F+I + LLQGR
Sbjct: 238 YPDV----NTFDITVY----LLQGR 254
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ + G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + +L + +
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---K 154
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 255
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRVQHPN 858
F++ +G G FG Y A E ++A+K L + + GV+ Q E+ ++HPN
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L GY ++LI Y P G + + +Q R + + + ++A AL+Y H +
Sbjct: 74 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATY--ITELANALSYCHSK 131
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
RV+HRDIKP N+LL +N ++DFG + +S + GT Y+ PE
Sbjct: 132 ---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPEMIEGR 185
Query: 979 RVSDKADVYSFGVVLLELI 997
+K D++S GV+ E +
Sbjct: 186 MHDEKVDLWSLGVLCYEFL 204
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ V+ A K + + ++ + EI L HPN+V L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ + GG ++ + + R E S + + AL YLHD +++HRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQVVCKQTLDALNYLHDN---KIIHRD 160
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD----- 982
+K NIL + + L+DFG++ T GT ++APE M C S
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFIGTPYWMAPEVVM-CETSKDRPYD 218
Query: 983 -KADVYSFGVVLLEL 996
KADV+S G+ L+E+
Sbjct: 219 YKADVWSLGITLIEM 233
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IGSG FG YK + V V + ++ + Q F E+ L + +H N++ +GY ++
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ + ++ + G +L K + + + + ++ IA A+ + YLH ++HRD+
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI-DIARQTAQGMDYLH---AKNIIHRDM 158
Query: 929 KPSNILLDNNLNAYLSDFGLA----RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD-- 982
K +NI L L + DFGLA R G+ + T G+ ++APE R+ D
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAPE---VIRMQDNN 212
Query: 983 ----KADVYSFGVVLLELIS 998
++DVYS+G+VL EL++
Sbjct: 213 PFSFQSDVYSYGIVLYELMT 232
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 792 TYENVVRATAGF---------NVQNCIGSGGFGAT-YKAEIIPG---VVVAVKRLSVGRF 838
TYE RA F +++ IGSG G Y +PG V VA+K L G
Sbjct: 31 TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 839 QGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
+ ++ F +E +G+ HPN++ L G ++ Y+ G+L+ F++ +
Sbjct: 91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---Q 147
Query: 898 WSMLHKIAL--DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955
++++ + + V + YL D +HRD+ N+L+D+NL +SDFGL+R+L
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 956 ETHATTDVAGTFG--YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
A T G + APE S +DV+SFGVV+ E+++
Sbjct: 205 PDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ V+ A K + + ++ + EI L HPN+V L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ + GG ++ + + R E S + + AL YLHD +++HRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQVVCKQTLDALNYLHDN---KIIHRD 160
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD----- 982
+K NIL + + L+DFG++ T GT ++APE M C S
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVM-CETSKDRPYD 218
Query: 983 -KADVYSFGVVLLEL 996
KADV+S G+ L+E+
Sbjct: 219 YKADVWSLGITLIEM 233
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G G + VAVK L G F AE + ++QH LV L V+
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAV-VT 78
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I Y+ G+L F++ + + L +A +A +A++ + +HRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ + L+ ++DFGLARL+ +E A + APE + K+DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 989 FGVVLLELIS 998
FG++L E+++
Sbjct: 196 FGILLTEIVT 205
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + +L + +
Sbjct: 96 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---K 151
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 152 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 211
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 212 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 252
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic
Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic
Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 84.0 bits (206), Expect = 5e-16, Method: Composition-based stats.
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGT 966
AL+Y H + RV+HRDIKP N+LL + ++DFG + HA + D+ GT
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGT 172
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
Y+ PE +K D++S GV+ E + K +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 84.0 bits (206), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN++ L GY ++LI Y P G + + +Q + + + + ++A AL+Y
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 123
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+ PE
Sbjct: 124 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPEM 177
Query: 975 AMTCRVSDKADVYSFGVVLLELISDK 1000
+K D++S GV+ E + K
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK 203
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The
Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The
Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The
Structure Of The Cdk6-P16ink4a Tumor Suppressor Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 84.0 bits (206), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 18/222 (8%)
Query: 791 LTYENVVRATAGFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSV-----GRFQGVQQ 843
+ + + RA + IG G +G +KA + G VA+KR+ V G +
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR 60
Query: 844 FAAEIRTLGRVQHPNLVTL-----IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEW 898
A +R L +HPN+V L + E ++ L++ ++ +L ++ P V
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT 119
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
+ + + R L +LH RV+HRD+KP NIL+ ++ L+DFGLAR+ S
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQM 174
Query: 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
A T V T Y APE + + D++S G + E+ K
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 84.0 bits (206), Expect = 5e-16, Method: Composition-based stats.
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 809 IGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG YKA+ V+ A K + + ++ + EI L HPN+V L+
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E ++++ + GG ++ + + R E S + + AL YLHD +++HRD
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTE-SQIQVVCKQTLDALNYLHDN---KIIHRD 160
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD----- 982
+K NIL + + L+DFG++ T GT ++APE M C S
Sbjct: 161 LKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDXFIGTPYWMAPEVVM-CETSKDRPYD 218
Query: 983 -KADVYSFGVVLLEL 996
KADV+S G+ L+E+
Sbjct: 219 YKADVWSLGITLIEM 233
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With A
Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With A
Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With A
Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepat
Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 83.6 bits (205), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + +L + +
Sbjct: 98 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---K 153
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 154 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 213
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 214 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 254
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 83.6 bits (205), Expect = 5e-16, Method: Composition-based stats.
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 805 VQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNL 859
++ IG G FG + +PG + VA+K L G ++ F +E +G+ HPN+
Sbjct: 33 IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 92
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLHD 917
+ L G + +I Y+ G+L+ F++ R ++++ + + + + YL D
Sbjct: 93 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKYLSD 149
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--YVAPEYA 975
+HRD+ NIL+++NL +SDFG++R+L A T G + APE
Sbjct: 150 M---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+V+ E++S
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMS 229
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 83.6 bits (205), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 21/229 (9%)
Query: 809 IGSGGFGATYKAEII----PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
IG G FG Y ++ + AVK L+ + V QF E + HPN+++L+
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 864 GYHV-SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G + SE ++ Y+ G+L FI++ ++ L VA+ + +L + +
Sbjct: 99 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI-GFGLQVAKGMKFLASK---K 154
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE---THATTDVAGTFGYVAPEYAMTCR 979
+HRD+ N +LD ++DFGLAR + E H T ++A E T +
Sbjct: 155 FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQK 214
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGR 1028
+ K+DV+SFGV+L EL++ P N F+I + LLQGR
Sbjct: 215 FTTKSDVWSFGVLLWELMTRGAPPYPDV----NTFDITVY----LLQGR 255
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 83.6 bits (205), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 18 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ + G+L+ F++ + +++++ + + +A + YL
Sbjct: 78 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 135 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 191
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 192 AIAYRKFTSASDVWSYGIVLWEVMS 216
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 83.6 bits (205), Expect = 6e-16, Method: Composition-based stats.
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 24/225 (10%)
Query: 792 TYENVVRATAGF---------NVQNCIGSGGFGAT-YKAEIIPG---VVVAVKRLSVGRF 838
TYE RA F +++ IGSG G Y +PG V VA+K L G
Sbjct: 31 TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90
Query: 839 QGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
+ ++ F +E +G+ HPN++ L G ++ Y+ G+L+ F++ +
Sbjct: 91 ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---Q 147
Query: 898 WSMLHKIAL--DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS 955
++++ + + V + YL D +HRD+ N+L+D+NL +SDFGL+R+L
Sbjct: 148 FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 956 ETHATTDVAGTFG--YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
A T G + APE S +DV+SFGVV+ E+++
Sbjct: 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 83.6 bits (205), Expect = 6e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T ++GT Y+
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGTLDYL 174
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 83.6 bits (205), Expect = 6e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 178
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 83.6 bits (205), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHP 857
++ +G+G FG + +P + VA+K L VG + ++ F E +G+ HP
Sbjct: 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYL 915
N++ L G + ++ + G+L+ F++ + +++++ + + +A + YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPE 973
D +HRD+ NIL+++NL +SDFGL+R+L A T G + +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+VL E++S
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMS 245
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 83.2 bits (204), Expect = 6e-16, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEII----PGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQ 855
F + +G+G FG + +I G A+K L V R + V+ E L V
Sbjct: 8 FQILRTLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HP ++ + G ++F+I +Y+ GG L ++ R + + A +V AL YL
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCLALEYL 122
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + +++RD+KP NILLD N + ++DFG A+ + T + GT Y+APE
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV 175
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
T + D +SFG+++ E+++
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLA 198
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 805 VQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNL 859
++ IG G FG + +PG + VA+K L G ++ F +E +G+ HPN+
Sbjct: 12 IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 71
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLHD 917
+ L G + +I Y+ G+L+ F++ R ++++ + + + + YL D
Sbjct: 72 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKYLSD 128
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--YVAPEYA 975
+HRD+ NIL+++NL +SDFG++R+L A T G + APE
Sbjct: 129 M---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+V+ E++S
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMS 208
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 15/203 (7%)
Query: 805 VQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNL 859
++ IG G FG + +PG + VA+K L G ++ F +E +G+ HPN+
Sbjct: 18 IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNI 77
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLHD 917
+ L G + +I Y+ G+L+ F++ R ++++ + + + + YL D
Sbjct: 78 IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR---FTVIQLVGMLRGIGSGMKYLSD 134
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--YVAPEYA 975
+HRD+ NIL+++NL +SDFG++R+L A T G + APE
Sbjct: 135 M---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + +DV+S+G+V+ E++S
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMS 214
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 83 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 136
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 137 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 190
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 191 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By A
Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine Aurora
Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 123
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 124 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 177
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 176
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea Inhibitor
Length = 267
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 118
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 119 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 172
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 124
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 125 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 178
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 176
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 8/199 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F+V +G G +G+ YKA G +VA+K++ V +Q+ EI + + P++V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G + +++++ Y G++ I+ R +T+ + I + L YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FM 144
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDIK NILL+ +A L+DFG+A L T V GT ++APE +
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQL-TDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 982 DKADVYSFGVVLLELISDK 1000
AD++S G+ +E+ K
Sbjct: 204 CVADIWSLGITAIEMAEGK 222
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYL 173
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 83.2 bits (204), Expect = 8e-16, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 96/190 (50%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + A VAVK + G V+ F AE + +QH LV L V+
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV-VT 80
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +++I ++ G+L F++ L + +A +A++ +HRD+
Sbjct: 81 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDL 137
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +NIL+ +L ++DFGLAR++ +E A + APE + K+DV+S
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197
Query: 989 FGVVLLELIS 998
FG++L+E+++
Sbjct: 198 FGILLMEIVT 207
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 82.8 bits (203), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN++ L GY ++LI Y P G + + +Q + + + + ++A AL+Y
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSY 126
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
H + RV+HRDIKP N+LL + ++DFG + +S A + GT Y+ PE
Sbjct: 127 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYLPPEM 180
Query: 975 AMTCRVSDKADVYSFGVVLLELISDK 1000
+K D++S GV+ E + K
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGK 206
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 82.8 bits (203), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 16 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 76 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK--- 130
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ L DFGL+R + S + + ++APE R +
Sbjct: 131 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLV 860
+ + IG+GGF A I+ G +VA+K + + + EI L ++H ++
Sbjct: 12 YELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHIC 71
Query: 861 TLIGYHVSEA--EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
L YHV E ++F++ Y PGG L +I + R + E + + + + A+AY+H +
Sbjct: 72 QL--YHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRV--VFRQIVSAVAYVHSQ 127
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGL-ARLLGTSETHATTDVAGTFGYVAPEYAM- 976
HRD+KP N+L D L DFGL A+ G + H T G+ Y APE
Sbjct: 128 GYA---HRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQT-CCGSLAYAAPELIQG 183
Query: 977 TCRVSDKADVYSFGVVLLELI 997
+ +ADV+S G++L L+
Sbjct: 184 KSYLGSEADVWSMGILLYVLM 204
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole Inhibitor
Length = 268
Score = 82.8 bits (203), Expect = 1e-15, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S A + GT Y+
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYL 173
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 82.8 bits (203), Expect = 1e-15, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 116
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 117 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 170
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 171 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 82.8 bits (203), Expect = 1e-15, Method: Composition-based stats.
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 4/197 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VAVK L G VQ F E + +QH LV L
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E +++I ++ G+L F++ V L + +A +AY+ + +HRD+
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDL 135
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
+ +N+L+ +L ++DFGLAR++ +E A + APE + K++V+S
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 989 FGVVLLELISDKKALDP 1005
FG++L E+++ K P
Sbjct: 196 FGILLYEIVTYGKIPYP 212
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 109/206 (52%), Gaps = 17/206 (8%)
Query: 804 NVQNCIGSGGFGATYKAEI-IPG---VVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPN 858
++ IG+G FG + +PG + VA+K L G + ++ F +E +G+ HPN
Sbjct: 10 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLH 916
++ L G + +I ++ G+L+ F++ + +++++ + + +A + YL
Sbjct: 70 VIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGT--FGYVAP 972
D +HR + NIL+++NL +SDFGL+R L TS+ T+ + G + AP
Sbjct: 127 DM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 183
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E + + +DV+S+G+V+ E++S
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMS 209
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 82.4 bits (202), Expect = 1e-15, Method: Composition-based stats.
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 32 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 92 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 145
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S T + GT Y+
Sbjct: 146 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYL 199
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 82.4 bits (202), Expect = 1e-15, Method: Composition-based stats.
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN++ L GY ++LI Y P G + K +Q + + + + ++A AL+Y
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSY 128
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD----VAGTFGYV 970
H + RV+HRDIKP N+LL + ++DFG + HA + + GT Y+
Sbjct: 129 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLXGTLDYL 178
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated
Protein Kinase Alpha-2 Subunit Mutant (T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 807 NCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
+ +G G FG E + G VAVK L+ + + V + EI+ L +HP+++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ + F++ Y+ GG L +I R VE ++ + A+ Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---M 131
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-- 980
V+HRD+KP N+LLD ++NA ++DFGL+ ++ S+ D G+ Y APE ++ R+
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGEFLRDSCGSPNYAAPE-VISGRLYA 188
Query: 981 SDKADVYSFGVVLLELISDKKALD 1004
+ D++S GV+L L+ D
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD 212
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 807 NCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLVT 861
CIG G FG ++ + P + VA+K V ++F E T+ + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
LIG ++E +++I G L F+Q R + +++ + L A ++ ALAYL +
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK--- 510
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
R +HRDI N+L+ L DFGL+R + S + + ++APE R +
Sbjct: 511 RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 982 DKADVYSFGVVLLELI 997
+DV+ FGV + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 81.6 bits (200), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 76 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 136 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHR 191
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 192 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 248
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 249 WSMGLSLVEMAVGRYPIPP 267
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 794 ENVVRATAGFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSV-----GRFQGVQQFAA 846
+ + RA + IG G +G +KA + G VA+KR+ V G + A
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 847 EIRTLGRVQHPNLVTL-----IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML 901
+R L +HPN+V L + E ++ L++ ++ +L ++ P V +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 902 HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961
+ + R L +LH RV+HRD+KP NIL+ ++ L+DFGLAR+ S A T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 177
Query: 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
V T Y APE + + D++S G + E+ K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent Kinase
6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 794 ENVVRATAGFNVQNCIGSGGFGATYKAEIIP--GVVVAVKRLSV-----GRFQGVQQFAA 846
+ + RA + IG G +G +KA + G VA+KR+ V G + A
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 847 EIRTLGRVQHPNLVTL-----IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML 901
+R L +HPN+V L + E ++ L++ ++ +L ++ P V +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 902 HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961
+ + R L +LH RV+HRD+KP NIL+ ++ L+DFGLAR+ S A T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALT 177
Query: 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDK 1000
V T Y APE + + D++S G + E+ K
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein
Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain)
Length = 276
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 807 NCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
+ +G G FG E + G VAVK L+ + + V + EI+ L +HP+++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ + F++ Y+ GG L +I R VE ++ + A+ Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH---M 131
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-- 980
V+HRD+KP N+LLD ++NA ++DFGL+ ++ E T+ G+ Y APE ++ R+
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLYA 188
Query: 981 SDKADVYSFGVVLLELISDKKALD 1004
+ D++S GV+L L+ D
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFD 212
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic
Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A Pentacyclic
Inhibitor
Length = 268
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + +V+HRDIKP N+LL + ++DFG + +S A + GT Y+
Sbjct: 120 ALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA---LCGTLDYL 173
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + +++FG + +S T + GT Y+
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYL 175
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor
Length = 272
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + +++FG + +S T + GT Y+
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYL 176
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp
Length = 333
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 187 WSMGLSLVEMAVGRYPIPP 205
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212 Interactions
Length = 341
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 187 WSMGLSLVEMAVGRYPIPP 205
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex
With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex
With Ch4858061 And Mgatp
Length = 307
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 187 WSMGLSLVEMAVGRYPIPP 205
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 62/199 (31%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G +VAVK+L + F EI+ L + +V
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y E+ L+ YLP G L F+Q R R ++ S L + + + + YL
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 130
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAMTCR 979
R +HRD+ NIL+++ + ++DFGLA+LL + G + APE
Sbjct: 131 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNI 190
Query: 980 VSDKADVYSFGVVLLELIS 998
S ++DV+SFGVVL EL +
Sbjct: 191 FSRQSDVWSFGVVLYELFT 209
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 121
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD----VAGT 966
AL+Y H + RV+HRDIKP N+LL + ++DFG + HA + + GT
Sbjct: 122 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGT 171
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
Y+ PE +K D++S GV+ E + K +
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 120
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL+Y H + RV+HRDIKP N+LL + ++DFG + +S + GT Y+
Sbjct: 121 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGTLDYL 174
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
PE +K D++S GV+ E + K +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 119
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD----VAGT 966
AL+Y H + RV+HRDIKP N+LL + ++DFG + HA + + GT
Sbjct: 120 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGT 169
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
Y+ PE +K D++S GV+ E + K +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRV 854
A F + +G G FG Y A E ++A+K L + + GV+ Q E+ +
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGN----LEKFIQDRPRRTVEWSMLHKIALDVAR 910
+HPN++ L GY ++LI Y P G L+K + +RT + ++A
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY------ITELAN 122
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD----VAGT 966
AL+Y H + RV+HRDIKP N+LL + ++DFG + HA + + GT
Sbjct: 123 ALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRXXLCGT 172
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALD 1004
Y+ PE +K D++S GV+ E + K +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+GSG FG + VAVK + G +F E +T+ ++ HP LV G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
E ++++ Y+ G L +++ + +E S L ++ DV +A+L + +HRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+D +L +SDFG+ R + + ++ + APE + S K+DV++
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190
Query: 989 FGVVLLELIS 998
FG+++ E+ S
Sbjct: 191 FGILMWEVFS 200
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 81.3 bits (199), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 46/291 (15%)
Query: 809 IGSGGFGATYKAEII---PG---VVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLV 860
+G FG YK + PG VA+K L + +G ++F E R+QHPN+V
Sbjct: 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP----------RRTVEWSM-----LHKIA 905
L+G + + +I++Y G+L +F+ R RTV+ ++ +H +A
Sbjct: 93 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DVA 964
+A + YL V+H+D+ N+L+ + LN +SD GL R + ++ + +
Sbjct: 153 -QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024
++APE M + S +D++S+GVVL E+ S L P +C + N + + +
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQP-YCGYSNQDVVEMIRNRQV 265
Query: 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L PC P D + L I C E S RP + + +L+
Sbjct: 266 L---PC-----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK--HKIMHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 187 WSMGLSLVEMAVGRYPIPP 205
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK--HKIMHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 186
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 187 WSMGLSLVEMAVGRYPIPP 205
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 46/291 (15%)
Query: 809 IGSGGFGATYKAEII---PG---VVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNLV 860
+G FG YK + PG VA+K L + +G ++F E R+QHPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK-DKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP----------RRTVEWSM-----LHKIA 905
L+G + + +I++Y G+L +F+ R RTV+ ++ +H +A
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DVA 964
+A + YL V+H+D+ N+L+ + LN +SD GL R + ++ + +
Sbjct: 136 -QIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLL 1024
++APE M + S +D++S+GVVL E+ S L P +C + N + + +
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQP-YCGYSNQDVVEMIRNRQV 248
Query: 1025 LQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLK 1075
L PC P D + L I C E S RP + + +L+
Sbjct: 249 L---PC-----------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 52/190 (27%), Positives = 101/190 (53%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 17 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 77 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK--HKIMHR 132
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ G + GT Y++PE S ++D+
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVS---GQLIDEMANEFVGTRSYMSPERLQGTHYSVQSDI 189
Query: 987 YSFGVVLLEL 996
+S G+ L+E+
Sbjct: 190 WSMGLSLVEM 199
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 80.9 bits (198), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 803 FNVQNCIGSGGFGAT-----YKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
F + IG G FG + + + K+ V R V+ E++ + ++HP
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER-NEVRNVFKELQIMQGLEHP 75
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
LV L E +MF++ + L GG+L +Q E L ++ AL YL +
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL--FICELVMALDYLQN 133
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ R++HRD+KP NILLD + + +++DF +A +L ET TT +AGT Y+APE +
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT-MAGTKPYMAPEMFSS 188
Query: 978 CR---VSDKADVYSFGVVLLELISDKK 1001
+ S D +S GV EL+ ++
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound
1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a And
Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 80.9 bits (198), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 54/199 (27%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH--KIMHR 156
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 157 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 213
Query: 987 YSFGVVLLELISDKKALDP 1005
+S G+ L+E+ + + P
Sbjct: 214 WSMGLSLVEMAVGRYPIPP 232
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 80.5 bits (197), Expect = 5e-15, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 99/190 (52%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA++++++ + + EI + ++PN+V + ++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E +++ GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 988 SFGVVLLELI 997
S G++ +E+I
Sbjct: 201 SLGIMAIEMI 210
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 80.1 bits (196), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 53/190 (27%), Positives = 103/190 (54%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
+G+G G +K P G+V+A K + + ++ Q E++ L P +V G
Sbjct: 33 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
S+ E+ + ++ GG+L++ ++ R + +L K+++ V + L YL ++ +++HR
Sbjct: 93 YSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK--HKIMHR 148
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
D+KPSNIL+++ L DFG++ L S ++ GT Y++PE S ++D+
Sbjct: 149 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSDI 205
Query: 987 YSFGVVLLEL 996
+S G+ L+E+
Sbjct: 206 WSMGLSLVEM 215
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 80.1 bits (196), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G +VAVK+L + F EI+ L + +V
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + L+ YLP G L F+Q R R ++ S L + + + + YL
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 134
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAMTCR 979
R +HRD+ NIL+++ + ++DFGLA+LL + + G + APE
Sbjct: 135 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 194
Query: 980 VSDKADVYSFGVVLLELIS 998
S ++DV+SFGVVL EL +
Sbjct: 195 FSRQSDVWSFGVVLYELFT 213
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain
From Human
Length = 314
Score = 80.1 bits (196), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 810 GSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS- 868
G FG +KA+++ V AVK + Q Q EI + ++H NL+ I
Sbjct: 24 ARGRFGCVWKAQLMNDFV-AVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 869 ---EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC------ 919
E E++LI + G+L +++ + W+ L +A ++R L+YLH++
Sbjct: 82 SNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 920 --VPRVLHRDIKPSNILLDNNLNAYLSDFGLA-RLLGTSETHATTDVAGTFGYVAPEY-- 974
P + HRD K N+LL ++L A L+DFGLA R T GT Y+APE
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 975 -AMTCRVSD--KADVYSFGVVLLELISDKKALD 1004
A+ + + D+Y+ G+VL EL+S KA D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 80.1 bits (196), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G +VAVK+L + F EI+ L + +V
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + L+ YLP G L F+Q R R ++ S L + + + + YL
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 133
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAMTCR 979
R +HRD+ NIL+++ + ++DFGLA+LL + + G + APE
Sbjct: 134 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 193
Query: 980 VSDKADVYSFGVVLLELIS 998
S ++DV+SFGVVL EL +
Sbjct: 194 FSRQSDVWSFGVVLYELFT 212
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 79.7 bits (195), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLI 863
+G G FG+ P G +VAVK+L + F EI+ L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 864 G--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
G Y + L+ YLP G L F+Q R R ++ S L + + + + YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAMTCR 979
R +HRD+ NIL+++ + ++DFGLA+LL + + G + APE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206
Query: 980 VSDKADVYSFGVVLLELIS 998
S ++DV+SFGVVL EL +
Sbjct: 207 FSRQSDVWSFGVVLYELFT 225
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 13/197 (6%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+GSG FG + E G+ +K ++ R Q ++Q AEI L + HPN++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 867 VSEAEMFLIYNYLPGGN-LEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHDECVPRVL 924
M+++ GG LE+ + + R + + + ++ + ALAY H + V+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 925 HRDIKPSNILL-DNNLNAYLS--DFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVS 981
H+D+KP NIL D + ++ + DFGLA L + E +T+ AGT Y+APE V+
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPE-VFKRDVT 203
Query: 982 DKADVYSFGVVLLELIS 998
K D++S GVV+ L++
Sbjct: 204 FKCDIWSAGVVMYFLLT 220
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 79.3 bits (194), Expect = 1e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA++++++ + + EI + ++PN+V + ++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 988 SFGVVLLELI 997
S G++ +E+I
Sbjct: 201 SLGIMAIEMI 210
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 79.3 bits (194), Expect = 1e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA++++++ + + EI + ++PN+V + ++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 988 SFGVVLLELI 997
S G++ +E+I
Sbjct: 201 SLGIMAIEMI 210
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 79.3 bits (194), Expect = 1e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA++++++ + + EI + ++PN+V + ++
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HRD
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 142
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 988 SFGVVLLELI 997
S G++ +E+I
Sbjct: 202 SLGIMAIEMI 211
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And
Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation And
Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And
Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation And
Specifity Of A Ste20p Map3k
Length = 348
Score = 79.0 bits (193), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 68/238 (28%), Positives = 108/238 (45%), Gaps = 29/238 (12%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IG G FGA Y A ++ VVA+K++S Q Q E+R L +++HPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 865 YHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
++ E +L+ Y G + + +P + VE + + AL + LAYLH +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NM 175
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC---RV 980
+HRD+K NILL L DFG A ++ + GT ++APE + +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 230
Query: 981 SDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLW 1038
K DV+S G+ +EL K L FN+ A +++ + +G W
Sbjct: 231 DGKVDVWSLGITCIELAERKPPL----------FNMNAMSALYHIAQNESPALQSGHW 278
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRF-QGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G +G YKA+ G A+K++ + + +G+ EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
++ + L++ +L +L+K + D +E L + +AY HD RVLHR
Sbjct: 70 HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
D+KP N+L++ ++DFGLAR G T +V T Y AP+ M + + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTID 183
Query: 986 VYSFGVVLLELIS 998
++S G + E+++
Sbjct: 184 IWSVGCIFAEMVN 196
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 58/193 (30%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRF-QGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G +G YKA+ G A+K++ + + +G+ EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
++ + L++ +L +L+K + D +E L + +AY HD RVLHR
Sbjct: 70 HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
D+KP N+L++ ++DFGLAR G T +V T Y AP+ M + + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTTID 183
Query: 986 VYSFGVVLLELIS 998
++S G + E+++
Sbjct: 184 IWSVGCIFAEMVN 196
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLV 860
++ ++ +G+G F AE +VA+K ++ +G + EI L +++HPN+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L + S ++LI + GG L I ++ T + ++ V A+ YLHD
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA--SRLIFQVLDAVKYLHDL-- 135
Query: 921 PRVLHRDIKPSNIL---LDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KP N+L LD + +SDFGL+++ +T GT GYVAPE
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQ 192
Query: 978 CRVSDKADVYSFGVV 992
S D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 78.6 bits (192), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 21/203 (10%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQ-HPNLVTL 862
V+ C+ G + +I+ V +RLS + + V++ E L +V HP+++TL
Sbjct: 110 VRRCVHRAT-GHEFAVKIME---VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
I + S + MFL+++ + G L ++ ++ + I + A+++LH
Sbjct: 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH---ANN 220
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
++HRD+KP NILLD+N+ LSDFG + L E ++ GT GY+APE + C + +
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEI-LKCSMDE 277
Query: 983 -------KADVYSFGVVLLELIS 998
+ D+++ GV+L L++
Sbjct: 278 THPGYGKEVDLWACGVILFTLLA 300
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLV 860
++ ++ +G+G F AE +VA+K ++ +G + EI L +++HPN+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L + S ++LI + GG L I ++ T + ++ V A+ YLHD
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA--SRLIFQVLDAVKYLHDL-- 135
Query: 921 PRVLHRDIKPSNIL---LDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KP N+L LD + +SDFGL+++ +T GT GYVAPE
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQ 192
Query: 978 CRVSDKADVYSFGVV 992
S D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLV 860
++ ++ +G+G F AE +VA+K ++ +G + EI L +++HPN+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L + S ++LI + GG L I ++ T + ++ V A+ YLHD
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA--SRLIFQVLDAVKYLHDL-- 135
Query: 921 PRVLHRDIKPSNIL---LDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KP N+L LD + +SDFGL+++ +T GT GYVAPE
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQ 192
Query: 978 CRVSDKADVYSFGVV 992
S D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 59/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLV 860
++ ++ +G+G F AE +VA+K ++ +G + EI L +++HPN+V
Sbjct: 20 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
L + S ++LI + GG L I ++ T + ++ V A+ YLHD
Sbjct: 80 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA--SRLIFQVLDAVKYLHDL-- 135
Query: 921 PRVLHRDIKPSNIL---LDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KP N+L LD + +SDFGL+++ +T GT GYVAPE
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQ 192
Query: 978 CRVSDKADVYSFGVV 992
S D +S GV+
Sbjct: 193 KPYSKAVDCWSIGVI 207
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 9/193 (4%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRF-QGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G +G YKA+ G A+K++ + + +G+ EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
++ + L++ +L +L+K + D +E L + +AY HD RVLHR
Sbjct: 70 HTKKRLVLVFEHL-DQDLKKLL-DVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHR 124
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
D+KP N+L++ ++DFGLAR G T ++ T Y AP+ M + + S D
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTID 183
Query: 986 VYSFGVVLLELIS 998
++S G + E+++
Sbjct: 184 IWSVGCIFAEMVN 196
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IG G FGA Y A ++ VVA+K++S Q Q E+R L +++HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 865 YHVSEAEMFLIYNYLPGGNLEKF-IQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
++ E +L+ Y G + + +P + VE + + AL + LAYLH +
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLHSH---NM 136
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC---RV 980
+HRD+K NILL L DFG A ++ + GT ++APE + +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 981 SDKADVYSFGVVLLELISDKKAL 1003
K DV+S G+ +EL K L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPL 214
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 56/190 (29%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G FG YK + VVA+K + + + + EI L + P + G +
Sbjct: 27 IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ ++++I YL GG+ ++ P +E + + I ++ + L YLH E R +HR
Sbjct: 87 LKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE---RKIHR 140
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ V F ++APE KAD+
Sbjct: 141 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQSAYDFKADI 199
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 200 WSLGITAIEL 209
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 61/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRF----QGVQQFA-AEIRTLGRVQHPNLVTL 862
+G G F YKA + +VA+K++ +G G+ + A EI+ L + HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ ++ + L+++++ +LE I+D + S + L + L YLH +
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWI-- 133
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
LHRD+KP+N+LLD N L+DFGLA+ G S A T Y APE R+
Sbjct: 134 -LHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 983 -KADVYSFGVVLLELI 997
D+++ G +L EL+
Sbjct: 192 VGVDMWAVGCILAELL 207
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 70/215 (32%), Positives = 99/215 (46%), Gaps = 34/215 (15%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAE--IRTLGRVQHPNLVTLI-GY 865
IG G +GA YK + VAVK S F Q F E I + ++H N+ I G
Sbjct: 21 IGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 866 HVSEA----EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH----- 916
A E L+ Y P G+L K++ T +W ++A V R LAYLH
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 917 -DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA-RLLGT------SETHATTDVAGTFG 968
D P + HRD+ N+L+ N+ +SDFGL+ RL G E +A GT
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 969 YVAPEY---AMTCRVSDKA----DVYSFGVVLLEL 996
Y+APE A+ R + A D+Y+ G++ E+
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 207 FGVLMWEIYS 216
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG--------VVVAVKRLSVGRFQGVQQFAAEIRTLGRV 854
F + +G+G +G + I G + V K V + + + E + L +
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 855 -QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVAR 910
Q P LVTL +E ++ LI +Y+ GG L + R R T H++ + ++
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE-----HEVQIYVGEIVL 170
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
AL +LH +++RDIK NILLD+N + L+DFGL++ ET D GT Y+
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 971 APEYAMTCRVS-DKA-DVYSFGVVLLELIS 998
AP+ DKA D +S GV++ EL++
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLT 257
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 82 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 137
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 197
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 198 FGVLMWEIYS 207
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 75 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 130
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 190
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 191 FGVLMWEIYS 200
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 76 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 131
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 192 FGVLMWEIYS 201
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 146
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 207 FGVLMWEIYS 216
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 71 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 126
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 186
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 187 FGVLMWEIYS 196
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + + EI L + P + G +
Sbjct: 15 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ + ++++I YL GG+ ++ P ++ + + I ++ + L YLH E + +HR
Sbjct: 75 LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE---KKIHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADI 187
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 188 WSLGITAIEL 197
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 32/224 (14%)
Query: 797 VRATAG------FNVQNCIGSGGFGATYKAEIIPG------VVVAVKRLSVGRF----QG 840
VR G F V+ +GSG +G + G V+ + GR+ +
Sbjct: 27 VRKKEGKIGESYFKVRK-LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 841 VQQFAAEIRT----LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTV 896
+++F EI L + HPN++ L + +L+ + GG L F Q R
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIINRHKF 143
Query: 897 EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNN---LNAYLSDFGLARLLG 953
+ I + + YLH ++HRDIKP NILL+N LN + DFGL+
Sbjct: 144 DECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF- 199
Query: 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
S+ + D GT Y+APE + + ++K DV+S GV++ L+
Sbjct: 200 -SKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILL 241
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 10/194 (5%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNLVTLIGY 865
IG G +G +K G +VA+K+ V + A EIR L +++HPNLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ + L++ Y L + DR +R V ++ I +A+ + H +H
Sbjct: 71 FRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIH 125
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKA 984
RD+KP NIL+ + L DFG ARLL T + D T Y +PE + +
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 985 DVYSFGVVLLELIS 998
DV++ G V EL+S
Sbjct: 185 DVWAIGCVFAELLS 198
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 804 NVQNCIGSGGFGATYKAEI-IPGV---VVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPN 858
++ IG+G FG + + PG VA+K L G + ++F +E +G+ +HPN
Sbjct: 19 KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLH 916
++ L G + + ++ ++ G L+ F++ +++++ + + +A + YL
Sbjct: 79 IIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLA 135
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGT--FGYVAP 972
+ +HRD+ NIL+++NL +SDFGL+R L +S+ T+ + G + AP
Sbjct: 136 EMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E + + +D +S+G+V+ E++S
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMS 218
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 50/190 (26%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G Y A ++ G VA++++++ + + EI + ++PN+V + ++
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ YL GG+L + + ++ + + + +AL +LH +V+HR+
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRN 142
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK NILL + + L+DFG + T E + + GT ++APE K D++
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 988 SFGVVLLELI 997
S G++ +E+I
Sbjct: 202 SLGIMAIEMI 211
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 29/212 (13%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE + P ++VAVK L + F E L +QH ++V
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQ------------DRPRRTVEWSMLHKIALDVAR 910
G V + +++ Y+ G+L KF++ + P + MLH IA +A
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLH-IAQQIAA 139
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG----T 966
+ YL + +HRD+ N L+ NL + DFG++R + +++ + V G
Sbjct: 140 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLP 193
Query: 967 FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE M + + ++DV+S GVVL E+ +
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 77.0 bits (188), Expect = 5e-14, Method: Composition-based stats.
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 809 IGSGGFGATYKAEI---IPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG+ + + VA+K L G + ++ E + + ++ +P +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+EA M L+ GG L KF+ + R + S + ++ V+ + YL ++ +
Sbjct: 78 VCQAEALM-LVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRVSD 982
HRD+ N+LL N A +SDFGL++ LG +++ T AG + + APE + S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 983 KADVYSFGVVLLELIS 998
++DV+S+GV + E +S
Sbjct: 193 RSDVWSYGVTMWEALS 208
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + + +L G +L K + +T S H + R L Y+H
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHSA-- 163
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 164 -NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 77.0 bits (188), Expect = 5e-14, Method: Composition-based stats.
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 5/190 (2%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
+G+G FG + VA+K + G +F E + + + H LV L G
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +F+I Y+ G L ++++ R + L ++ DV A+ YL + + LHRD+
Sbjct: 76 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDL 131
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N L+++ +SDFGL+R + E ++ + PE M + S K+D+++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIWA 191
Query: 989 FGVVLLELIS 998
FGV++ E+ S
Sbjct: 192 FGVLMWEIYS 201
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 77.0 bits (188), Expect = 5e-14, Method: Composition-based stats.
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 806 QNCIGSGGFGATYKAEIIPGVV---VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
Q+ IG G FG KA I + A+KR+ + FA E+ L ++ HPN++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKF--------------IQDRPRRTVEWSMLHKIAL 906
L+G ++L Y P GNL F I + T+ L A
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
DVAR + YL + + +HRD+ NIL+ N A ++DFGL+R E + V T
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKT 189
Query: 967 FG-----YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G ++A E + +DV+S+GV+L E++S
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 77.0 bits (188), Expect = 5e-14, Method: Composition-based stats.
Identities = 65/217 (29%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 806 QNCIGSGGFGATYKAEIIPGVV---VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
Q+ IG G FG KA I + A+KR+ + FA E+ L ++ HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKF--------------IQDRPRRTVEWSMLHKIAL 906
L+G ++L Y P GNL F I + T+ L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
DVAR + YL + + +HRD+ NIL+ N A ++DFGL+R E + V T
Sbjct: 150 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKT 199
Query: 967 FG-----YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G ++A E + +DV+S+GV+L E++S
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 801 AGFNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR-VQ 855
+ F+ IG G FG A +KAE + V +++ ++ + + + +E L + V+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYL 915
HP LV L + +++ + +Y+ GG L +Q R R +E A ++A AL YL
Sbjct: 98 HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLE-PRARFYAAEIASALGYL 155
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H +++RD+KP NILLD+ + L+DFGL + T+ GT Y+APE
Sbjct: 156 HSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 976 MTCRVSDKADVYSFGVVLLELI 997
D + G VL E++
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEML 233
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 804 NVQNCIGSGGFGATYKAEI-IPGV---VVAVKRLSVGRFQ-GVQQFAAEIRTLGRVQHPN 858
++ IG+G FG + + PG VA+K L G + ++F +E +G+ +HPN
Sbjct: 17 KIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL--DVARALAYLH 916
++ L G + + ++ ++ G L+ F++ +++++ + + +A + YL
Sbjct: 77 IIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLA 133
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL--GTSETHATTDVAGT--FGYVAP 972
+ +HRD+ NIL+++NL +SDFGL+R L +S+ T+ + G + AP
Sbjct: 134 EMSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E + + +D +S+G+V+ E++S
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMS 216
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 77.0 bits (188), Expect = 6e-14, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + + EI L + P + G +
Sbjct: 35 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ + ++++I YL GG+ ++ P ++ + + I ++ + L YLH E + +HR
Sbjct: 95 LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE---KKIHR 148
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 149 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADI 207
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 208 WSLGITAIEL 217
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 11/196 (5%)
Query: 809 IGSGGFGATYKAEI---IPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLVTLIG 864
+G G FG+ + + VA+K L G + ++ E + + ++ +P +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+EA + L+ GG L KF+ + R + S + ++ V+ + YL ++ +
Sbjct: 404 VCQAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF--GYVAPEYAMTCRVSD 982
HR++ N+LL N A +SDFGL++ LG +++ T AG + + APE + S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 983 KADVYSFGVVLLELIS 998
++DV+S+GV + E +S
Sbjct: 519 RSDVWSYGVTMWEALS 534
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 76.6 bits (187), Expect = 8e-14, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV----VVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G GG+G ++ + G + A+K L V + AE L V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALA 913
+HP +V LI + +++LI YL GG L F+Q +R +E + +A +++ AL
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH + +++RD+KP NI+L++ + L+DFGL + + T GT Y+APE
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAPE 191
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
M + D +S G ++ ++++
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLT 216
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 76.3 bits (186), Expect = 8e-14, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV----VVAVKRLS----VGRFQGVQQFAAEIRTLGRV 854
F + +G GG+G ++ + G + A+K L V + AE L V
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALA 913
+HP +V LI + +++LI YL GG L F+Q +R +E + +A +++ AL
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLA-EISMALG 135
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH + +++RD+KP NI+L++ + L+DFGL + + T GT Y+APE
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEYMAPE 191
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
M + D +S G ++ ++++
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLT 216
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 76.3 bits (186), Expect = 1e-13, Method: Composition-based stats.
Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG YK +P + VA+K L + G V+ F E + + HP+LV
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 104
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G +S + L+ +P G L +++ + + + +L + +A+ + YL +
Sbjct: 105 LLGVCLSPT-IQLVTQLMPHGCLLEYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRV 980
R++HRD+ N+L+ + + ++DFGLARLL E D ++A E +
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 981 SDKADVYSFGVVLLELIS 998
+ ++DV+S+GV + EL++
Sbjct: 220 THQSDVWSYGVTIWELMT 237
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 76.3 bits (186), Expect = 1e-13, Method: Composition-based stats.
Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG YK +P + VA+K L + G V+ F E + + HP+LV
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 81
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G +S + L+ +P G L +++ + + + +L + +A+ + YL +
Sbjct: 82 LLGVCLSPT-IQLVTQLMPHGCLLEYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRV 980
R++HRD+ N+L+ + + ++DFGLARLL E D ++A E +
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 981 SDKADVYSFGVVLLELIS 998
+ ++DV+S+GV + EL++
Sbjct: 197 THQSDVWSYGVTIWELMT 214
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 76.3 bits (186), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 21/228 (9%)
Query: 775 GLVRKEVVICNNIGVQLTYENVVRA--TAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKR 832
GL +K V C + Q +E ++ +G+G FG + A VAVK
Sbjct: 154 GLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKT 213
Query: 833 LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRP 892
+ G V+ F AE + +QH LV L V++ +++I ++ G+L F++
Sbjct: 214 MKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDE 271
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
L + +A +A++ +HRD++ +NIL+ +L ++DFGLAR
Sbjct: 272 GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR-- 326
Query: 953 GTSETHATTDVAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
V F + APE + K+DV+SFG++L+E+++
Sbjct: 327 ----------VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 796 VVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS-VGRFQGVQQFAAEIRTLGR 853
V ++ F +++ +G G +G A P G +VA+K++ + + EI+ L
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML-----HKIALDV 908
+H N++T+ +++ + F +N + +++ +Q R + ML
Sbjct: 66 FKHENIITI--FNIQRPDSFENFNEV--YIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG---------TSETHA 959
RA+ LH V+HRD+KPSN+L+++N + + DFGLAR++ T +
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 960 TTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLEL 996
T+ T Y APE +T + S DV+S G +L EL
Sbjct: 179 MTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 24/218 (11%)
Query: 796 VVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS-VGRFQGVQQFAAEIRTLGR 853
V ++ F +++ +G G +G A P G +VA+K++ + + EI+ L
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML-----HKIALDV 908
+H N++T+ +++ + F +N + +++ +Q R + ML
Sbjct: 66 FKHENIITI--FNIQRPDSFENFNEV--YIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG---------TSETHA 959
RA+ LH V+HRD+KPSN+L+++N + + DFGLAR++ T +
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 960 TTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLEL 996
T+ T Y APE +T + S DV+S G +L EL
Sbjct: 179 MTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 75.5 bits (184), Expect = 2e-13, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + + EI L + P + G +
Sbjct: 15 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ + ++++I YL GG+ ++ P ++ + + I ++ + L YLH E + +HR
Sbjct: 75 LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE---KKIHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ V F ++APE KAD+
Sbjct: 129 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQSAYDSKADI 187
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 188 WSLGITAIEL 197
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 75.1 bits (183), Expect = 2e-13, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + + EI L + P + G +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ + ++++I YL GG+ ++ P ++ + + I ++ + L YLH E + +HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE---KKIHR 143
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ V F ++APE KAD+
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVIKQSAYDSKADI 202
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 203 WSLGITAIEL 212
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 75.1 bits (183), Expect = 2e-13, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 806 QNCIGSGGFGATYKAEIIPGVV---VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
Q+ IG G FG KA I + A+KR+ + FA E+ L ++ HPN++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKF--------------IQDRPRRTVEWSMLHKIAL 906
L+G ++L Y P GNL F I + T+ L A
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT 966
DVAR + YL + + +HR++ NIL+ N A ++DFGL+R E + V T
Sbjct: 147 DVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR---GQEVY----VKKT 196
Query: 967 FG-----YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G ++A E + +DV+S+GV+L E++S
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 75.1 bits (183), Expect = 2e-13, Method: Composition-based stats.
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRVQHPN 858
F + +G G FG Y A E +VA+K L + + GV+ Q EI + HPN
Sbjct: 25 FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ L Y ++LI Y P G L K +Q T + I ++A AL Y H +
Sbjct: 85 ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEELADALMYCHGK 142
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEY 974
+V+HRDIKP N+LL ++DFG + HA + + GT Y+ PE
Sbjct: 143 ---KVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKTMCGTLDYLPPEM 192
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
++K D++ GV+ EL+
Sbjct: 193 IEGRMHNEKVDLWCIGVLCYELL 215
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
IG G FG + + +VAVK ++ +F E R L + HPN+V LIG
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ ++++ + GG+ F++ R ++L + D A + YL +C +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG-DAAAGMEYLESKC---CIHR 237
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVSDKAD 985
D+ N L+ +SDFG++R A+ + + APE R S ++D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 986 VYSFGVVLLELIS 998
V+SFG++L E S
Sbjct: 298 VWSFGILLWETFS 310
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 16/198 (8%)
Query: 807 NCIGSGGFGATY--KAEIIPGVVVAVK---RLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+ +G G FG K E+ G VAVK R + V + EI+ L +HP+++
Sbjct: 22 DTLGVGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L + +++F++ Y+ GG L +I R + S ++ + + Y H V
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES--RRLFQQILSGVDYCHRHMV- 137
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV- 980
+HRD+KP N+LLD ++NA ++DFGL+ ++ E + G+ Y APE ++ R+
Sbjct: 138 --VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPE-VISGRLY 192
Query: 981 -SDKADVYSFGVVLLELI 997
+ D++S GV+L L+
Sbjct: 193 AGPEVDIWSSGVILYALL 210
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHP 857
F + +G G FG + AE + A+K+ V V+ E R L +HP
Sbjct: 20 FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
L + ++ +F + YL GG+L IQ + + + + A ++ L +LH
Sbjct: 80 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHS 137
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--LLGTSETHATTDVAGTFGYVAPEYA 975
+ +++RD+K NILLD + + ++DFG+ + +LG ++T+ + GT Y+APE
Sbjct: 138 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---EFCGTPDYIAPEIL 191
Query: 976 MTCRVSDKADVYSFGVVLLELI 997
+ + + D +SFGV+L E++
Sbjct: 192 LGQKYNHSVDWWSFGVLLYEML 213
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 90/193 (46%), Gaps = 7/193 (3%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLVTLIGYH 866
IG G FG + + +VAVK ++ +F E R L + HPN+V LIG
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ ++++ + GG+ F++ R ++L + D A + YL +C +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG-DAAAGMEYLESKC---CIHR 237
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVSDKAD 985
D+ N L+ +SDFG++R A+ + + APE R S ++D
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 986 VYSFGVVLLELIS 998
V+SFG++L E S
Sbjct: 298 VWSFGILLWETFS 310
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 56/190 (29%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A E G VAVK++ + + Q + E+ + H N+V + ++
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V RAL+YLH++ V+HRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIATVCLSVLRALSYLHNQ---GVIHRD 166
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 988 SFGVVLLELI 997
S G++++E+I
Sbjct: 226 SLGIMVIEMI 235
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 74.7 bits (182), Expect = 3e-13, Method: Composition-based stats.
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VA+K + + +Q+ E+R + + HPN+
Sbjct: 14 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLHD 917
V L +E ++LI Y GG + ++ R + S +I A+ Y H
Sbjct: 74 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQ 129
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ R++HRD+K N+LLD ++N ++DFG + T G+ Y APE
Sbjct: 130 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQG 184
Query: 978 CRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPFD 212
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 74.7 bits (182), Expect = 3e-13, Method: Composition-based stats.
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 14/196 (7%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLV 860
F + +G+G F AE G + AVK + +G + EI L +++H N+V
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
L + S ++L+ + GG L ++ ++ + S L + LD A+ YLH
Sbjct: 84 ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD---AVYYLHRM- 139
Query: 920 VPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KP N+L D +SDFGL+++ G + +T GT GYVAPE
Sbjct: 140 --GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGTPGYVAPEVLA 195
Query: 977 TCRVSDKADVYSFGVV 992
S D +S GV+
Sbjct: 196 QKPYSKAVDCWSIGVI 211
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 74.7 bits (182), Expect = 3e-13, Method: Composition-based stats.
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNL 859
+ +Q IG G F A ++ G VAVK + + +Q+ E+R + + HPN+
Sbjct: 17 YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ R M K A + A+ Y
Sbjct: 77 VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYC 130
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + ++HRD+K N+LLD ++N ++DFG + T G+ Y APE
Sbjct: 131 HQK---YIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELF 185
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 74.3 bits (181), Expect = 3e-13, Method: Composition-based stats.
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSV-----GRFQGVQQFAAEIRTLG 852
AT+ + IG G +G YKA + G VA+K + V G + A +R L
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 853 RVQHPNLVTLIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
+HPN+V L+ + E ++ L++ ++ +L ++ P + + +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
R L +LH C+ +HRD+KP NIL+ + L+DFGLAR+ S A V T
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALAPVVVTL 175
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008
Y APE + + D++S G + E+ K P FC
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFC 212
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 74.3 bits (181), Expect = 4e-13, Method: Composition-based stats.
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----P 892
+F E + + HP +V + Y EAE +++ Y+ G L + P
Sbjct: 75 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 132
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+R +E + D +AL + H ++HRD+KP+NI++ + DFG+AR +
Sbjct: 133 KRAIE------VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 183
Query: 953 GTSETHATTDVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
S T A GT Y++PE A V ++DVYS G VL E+++
Sbjct: 184 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 796 VVRATAGFNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS-VGRFQGVQQFAAEIRTLGR 853
V ++ F +++ +G G +G A P G +VA+K++ + + EI+ L
Sbjct: 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSML-----HKIALDV 908
+H N++T+ +++ + F +N + +++ +Q R + ML
Sbjct: 66 FKHENIITI--FNIQRPDSFENFNEV--YIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG---------TSETHA 959
RA+ LH V+HRD+KPSN+L+++N + + DFGLAR++ T +
Sbjct: 122 LRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 960 TTDVAGTFGYVAPEYAMT-CRVSDKADVYSFGVVLLEL 996
+ T Y APE +T + S DV+S G +L EL
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 73.9 bits (180), Expect = 4e-13, Method: Composition-based stats.
Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 26/225 (11%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR---------FQGVQQFAAEI 848
AT+ + IG G +G YKA + G VA+K + V V++ A +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-L 65
Query: 849 RTLGRVQHPNLVTLIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK 903
R L +HPN+V L+ + E ++ L++ ++ +L ++ P + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKD 124
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ R L +LH C+ +HRD+KP NIL+ + L+DFGLAR+ S A T V
Sbjct: 125 LMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALTPV 179
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008
T Y APE + + D++S G + E+ K P FC
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFC 220
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 73.9 bits (180), Expect = 5e-13, Method: Composition-based stats.
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----P 892
+F E + + HP +V + Y EAE +++ Y+ G L + P
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+R +E + D +AL + H ++HRD+KP+NIL+ + DFG+AR +
Sbjct: 116 KRAIE------VIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAI 166
Query: 953 GTS--ETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
S T V GT Y++PE A V ++DVYS G VL E+++
Sbjct: 167 ADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.9 bits (180), Expect = 5e-13, Method: Composition-based stats.
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSV-----GRFQGVQQFAAEIRTLG 852
AT+ + IG G +G YKA + G VA+K + V G + A +R L
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 853 RVQHPNLVTLIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
+HPN+V L+ + E ++ L++ ++ +L ++ P + + +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
R L +LH C+ +HRD+KP NIL+ + L+DFGLAR+ S A V T
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALDPVVVTL 175
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008
Y APE + + D++S G + E+ K P FC
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFC 212
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 73.6 bits (179), Expect = 6e-13, Method: Composition-based stats.
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----P 892
+F E + + HP +V + Y EAE +++ Y+ G L + P
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+R +E + D +AL + H ++HRD+KP+NI++ + DFG+AR +
Sbjct: 116 KRAIE------VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 953 GTSETHATTDVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
S T A GT Y++PE A V ++DVYS G VL E+++
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 73.2 bits (178), Expect = 7e-13, Method: Composition-based stats.
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----P 892
+F E + + HP +V + Y EAE +++ Y+ G L + P
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+R +E + D +AL + H ++HRD+KP+NI++ + DFG+AR +
Sbjct: 116 KRAIE------VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 953 GTSETHATTDVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
S T A GT Y++PE A V ++DVYS G VL E+++
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 73.2 bits (178), Expect = 7e-13, Method: Composition-based stats.
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 21/221 (9%)
Query: 799 ATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSV-----GRFQGVQQFAAEIRTLG 852
AT+ + IG G +G YKA + G VA+K + V G + A +R L
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 853 RVQHPNLVTLIGYHVS-----EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
+HPN+V L+ + E ++ L++ ++ +L ++ P + + +
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
R L +LH C+ +HRD+KP NIL+ + L+DFGLAR+ S A V T
Sbjct: 121 FLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALFPVVVTL 175
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFC 1008
Y APE + + D++S G + E+ K P FC
Sbjct: 176 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFC 212
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 73.2 bits (178), Expect = 7e-13, Method: Composition-based stats.
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----P 892
+F E + + HP +V + Y EAE +++ Y+ G L + P
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+R +E + D +AL + H ++HRD+KP+NI++ + DFG+AR +
Sbjct: 116 KRAIE------VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 953 GTSETHATTDVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
S T A GT Y++PE A V ++DVYS G VL E+++
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 73.2 bits (178), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 99 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 150
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 151 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNR 233
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 73.2 bits (178), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 144
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 73.2 bits (178), Expect = 8e-13, Method: Composition-based stats.
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKFIQDR----P 892
+F E + + HP +V + Y EAE +++ Y+ G L + P
Sbjct: 58 RFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+R +E + D +AL + H ++HRD+KP+NI++ + DFG+AR +
Sbjct: 116 KRAIE------VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 166
Query: 953 GTSETHATTDVA--GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
S T A GT Y++PE A V ++DVYS G VL E+++
Sbjct: 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 72.8 bits (177), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 807 NCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
C+G G +G ++ + G VAVK S R + EI ++H N++ I
Sbjct: 14 ECVGKGRYGEVWRG-LWHGESVAVKIFS-SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 867 V----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV-- 920
+ S +++LI +Y G+L F+Q R+T+E + ++A+ A LA+LH E
Sbjct: 72 MTSRNSSTQLWLITHYHEHGSLYDFLQ---RQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 921 ---PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH---ATTDVAGTFGYVAPEY 974
P + HRD K N+L+ +NL ++D GLA + + GT Y+APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEV 188
Query: 975 -----AMTCRVSDK-ADVYSFGVVLLEL 996
C S K D+++FG+VL E+
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEI 216
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 37/222 (16%)
Query: 809 IGSGGFGATYKAEIIPGVV-------VAVKRLSVGRFQGVQ-QFAAEIRTLGRVQHPNLV 860
IG G FG ++A PG++ VAVK L +Q F E + +PN+V
Sbjct: 55 IGEGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK----------------- 903
L+G M L++ Y+ G+L +F++ TV S+ H
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV-CSLSHSDLSTRARVSSPGPPPLS 172
Query: 904 ------IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
IA VA +AYL + + +HRD+ N L+ N+ ++DFGL+R + +++
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 958 H-ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ A + A ++ PE R + ++DV+++GVVL E+ S
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 72.8 bits (177), Expect = 1e-12, Method: Composition-based stats.
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++TL+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + ++ H N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHSA-- 163
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 164 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/193 (26%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 809 IGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG G G AT ++ G +VAVK++ + + Q + E+ + QH N+V +
Sbjct: 159 IGEGSTGIVCIATVRSS---GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 865 YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
++ E++++ +L GG L + + + + L V +AL+ LH + V+
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHAQG---VI 269
Query: 925 HRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKA 984
HRDIK +ILL ++ LSDFG + + E + GT ++APE +
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 985 DVYSFGVVLLELI 997
D++S G++++E++
Sbjct: 329 DIWSLGIMVIEMV 341
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
+ Q +G G FG + I G AVK +S V + + E++ L ++ HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHD 917
++ L + + +L+ GG L I R R V+ + +I V + Y+H
Sbjct: 88 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHK 144
Query: 918 ECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+++HRD+KP N+LL+ + N + DFGL+ S+ D GT Y+APE
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE- 198
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
+ +K DV+S GV+L L+S
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLS 222
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + ++ H N+V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 72.8 bits (177), Expect = 1e-12, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV----VVAVKRLSVGRFQGVQQFAAEIR--TLGRVQH 856
F + +G G FG + + I G + A+K L + + ++ L V H
Sbjct: 27 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P +V L +E +++LI ++L GG+L + T E + ++A AL +LH
Sbjct: 87 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDHLH 144
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP NILLD + L+DFGL++ E A + GT Y+APE
Sbjct: 145 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVN 200
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ AD +SFGV++ E+++
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLT 222
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 72.8 bits (177), Expect = 1e-12, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV----VVAVKRLSVGRFQGVQQFAAEIR--TLGRVQH 856
F + +G G FG + + I G + A+K L + + ++ L V H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P +V L +E +++LI ++L GG+L + T E + ++A AL +LH
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP NILLD + L+DFGL++ E A + GT Y+APE
Sbjct: 144 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVN 199
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ AD +SFGV++ E+++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLT 221
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 72.8 bits (177), Expect = 1e-12, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV----VVAVKRLSVGRFQGVQQFAAEIR--TLGRVQH 856
F + +G G FG + + I G + A+K L + + ++ L V H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P +V L +E +++LI ++L GG+L + T E + ++A AL +LH
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP NILLD + L+DFGL++ E A + GT Y+APE
Sbjct: 144 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVN 199
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ AD +SFGV++ E+++
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLT 221
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 147
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 97 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 148
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 149 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 72.8 bits (177), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F T A E+ A+K L + + V E + R+ HP
Sbjct: 32 FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
+ Q +G G FG + I G AVK +S V + + E++ L ++ HPN
Sbjct: 51 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHD 917
++ L + + +L+ GG L I R R V+ + +I V + Y+H
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHK 167
Query: 918 ECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+++HRD+KP N+LL+ + N + DFGL+ S+ D GT Y+APE
Sbjct: 168 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE- 221
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
+ +K DV+S GV+L L+S
Sbjct: 222 VLHGTYDEKCDVWSTGVILYILLS 245
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
+ Q +G G FG + I G AVK +S V + + E++ L ++ HPN
Sbjct: 52 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARALAYLHD 917
++ L + + +L+ GG L I R R V+ + +I V + Y+H
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHK 168
Query: 918 ECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
+++HRD+KP N+LL+ + N + DFGL+ S+ D GT Y+APE
Sbjct: 169 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KMKDKIGTAYYIAPE- 222
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
+ +K DV+S GV+L L+S
Sbjct: 223 VLHGTYDEKCDVWSTGVILYILLS 246
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 56/202 (27%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHP 857
F + +G G FG + AE + A+K+ V V+ E R L +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
L + ++ +F + YL GG+L IQ + + + + A ++ L +LH
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFLHS 136
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--LLGTSETHATTDVAGTFGYVAPEYA 975
+ +++RD+K NILLD + + ++DFG+ + +LG ++T+ GT Y+APE
Sbjct: 137 K---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNX---FCGTPDYIAPEIL 190
Query: 976 MTCRVSDKADVYSFGVVLLELI 997
+ + + D +SFGV+L E++
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEML 212
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122)
Length = 677
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLV 860
+ ++ +G+GGFG + G VA+K+ + +++ EI+ + ++ HPN+V
Sbjct: 17 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 861 TLIGYHVSEAEMFLIYNYLP--------GGNLEKFI---------QDRPRRTVEWSMLHK 903
+ V + L N LP GG+L K++ ++ P RT
Sbjct: 77 S--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-------- 126
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHAT 960
+ D++ AL YLH+ R++HRD+KP NI+L L + D G A+ L E
Sbjct: 127 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--C 181
Query: 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
T+ GT Y+APE + + D +SFG + E I+ + P++
Sbjct: 182 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 228
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 37/227 (16%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLV 860
+ ++ +G+GGFG + G VA+K+ + +++ EI+ + ++ HPN+V
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 861 TLIGYHVSEAEMFLIYNYLP--------GGNLEKFI---------QDRPRRTVEWSMLHK 903
+ V + L N LP GG+L K++ ++ P RT
Sbjct: 76 S--AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT-------- 125
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHAT 960
+ D++ AL YLH+ R++HRD+KP NI+L L + D G A+ L E
Sbjct: 126 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--C 180
Query: 961 TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
T+ GT Y+APE + + D +SFG + E I+ + P++
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNW 227
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 15/208 (7%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQ--GVQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VA+K + + +Q+ E+R + + HPN+
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLHD 917
V L +E ++LI Y GG + ++ R + S +I A+ Y H
Sbjct: 77 VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV----SAVQYCHQ 132
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ R++HRD+K N+LLD ++N ++DFG + G Y APE
Sbjct: 133 K---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQG 187
Query: 978 CRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFD 215
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG--- 864
IGSGGFG +KA+ I G +KR+ ++ E++ L ++ H N+V G
Sbjct: 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 865 ---YHVSEAE----------MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARA 911
Y + +F+ + G LE++I+ R ++ + ++ + +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ Y+H + ++++RD+KPSNI L + + DFGL L + GT Y++
Sbjct: 135 VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK--GTLRYMS 189
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELI 997
PE + + D+Y+ G++L EL+
Sbjct: 190 PEQISSQDYGKEVDLYALGLILAELL 215
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 9/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
IG G FG +K + VVA+K + + + + EI L + + G +
Sbjct: 31 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ +++++I YL GG+ ++ P + + + K ++ + L YLH E + +HR
Sbjct: 91 LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE---KKIHR 144
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADV 986
DIK +N+LL + L+DFG+A L ++ T V F ++APE KAD+
Sbjct: 145 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKADI 203
Query: 987 YSFGVVLLEL 996
+S G+ +EL
Sbjct: 204 WSLGITAIEL 213
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 147 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 72.0 bits (175), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition By
Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition By
Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A Taxol-
Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A Taxol-
Induced Checkpoint Sensitivity Screen
Length = 284
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRVQHPN 858
F++ +G G FG Y A E ++A+K L + + GV+ Q EI ++HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ + Y ++L+ + P G L K +Q R + S ++A AL Y H+
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHER 133
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEY 974
+V+HRDIKP N+L+ ++DFG + HA + + GT Y+ PE
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEM 183
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALD-PS 1006
+K D++ GV+ E + D PS
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRVQHPN 858
F++ +G G FG Y A E ++A+K L + + GV+ Q EI ++HPN
Sbjct: 17 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ + Y ++L+ + P G L K +Q R + S ++A AL Y H+
Sbjct: 77 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHER 134
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEY 974
+V+HRDIKP N+L+ ++DFG + HA + + GT Y+ PE
Sbjct: 135 ---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEM 184
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALD-PS 1006
+K D++ GV+ E + D PS
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 217
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 978 CRVSDKADVYSFGVVLLELIS 998
S +D+++ G ++ +L++
Sbjct: 209 KSASKSSDLWALGCIIYQLVA 229
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation
At Position 52
Length = 364
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA++++S Q Q+ EI+ L R +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGV-----VVAVKRLSVGRFQGVQQFAAEIRTLGRVQH 856
++V+ +G G F + G+ ++ K+LS FQ +++ E R ++QH
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQH 87
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
PN+V L E+ +L+++ + GG L + I R + E H I + ++AY H
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCIQ-QILESIAYCH 145
Query: 917 DECVPRVLHRDIKPSNILLDNNLN---AYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++HR++KP N+LL + L+DFGLA + +++ A AGT GY++PE
Sbjct: 146 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPE 200
Query: 974 YAMTCRVSDKADVYSFGVVLLELI 997
S D+++ GV+L L+
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILL 224
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 21/213 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQ--GVQ-QFAAEIRTLGRVQHPN 858
F++ +G G FG Y A E ++A+K L + + GV+ Q EI ++HPN
Sbjct: 16 FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ + Y ++L+ + P G L K +Q R + S ++A AL Y H+
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA--TFMEELADALHYCHER 133
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT----DVAGTFGYVAPEY 974
+V+HRDIKP N+L+ ++DFG + HA + + GT Y+ PE
Sbjct: 134 ---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEM 183
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALD-PS 1006
+K D++ GV+ E + D PS
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 103/197 (52%), Gaps = 14/197 (7%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRL-SVGRFQGVQQFAAEIR-TLGRVQHPNLVTLIGY 865
+G G +G K +P G ++AVKR+ + Q ++ ++ ++ V P VT G
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
E ++++ + +L+KF + +T+ +L KIA+ + +AL +LH + V
Sbjct: 119 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 175
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA----MTCR 979
+HRD+KPSN+L++ + DFG++ L ++ A T AG Y+APE
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTIDAGCKPYMAPERINPELNQKG 233
Query: 980 VSDKADVYSFGVVLLEL 996
S K+D++S G+ ++EL
Sbjct: 234 YSVKSDIWSLGITMIEL 250
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 30/214 (14%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE + P ++VAVK L + F E L +QH ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQ-----------DRPRRT---VEWSMLHKIALDV 908
G + +++ Y+ G+L KF++ +PR+ + S + IA +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG--- 965
A + YL + +HRD+ N L+ NL + DFG++R + +++ + V G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR---VGGHTM 196
Query: 966 -TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE M + + ++DV+SFGV+L E+ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTL 851
++V+ +G G F G + A+II K+LS FQ +++ E R
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-----NTKKLSARDFQKLER---EARIC 59
Query: 852 GRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARA 911
++QHPN+V L E+ +L+++ + GG L + I R + E H I + +
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCIQ-QILES 117
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFG 968
+AY H ++HR++KP N+LL + L+DFGLA + +++ A AGT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y++PE S D+++ GV+L L+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILL 201
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTL 851
++V+ +G G F G + A+II K+LS FQ +++ E R
Sbjct: 7 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-----NTKKLSARDFQKLER---EARIC 58
Query: 852 GRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARA 911
++QHPN+V L E+ +L+++ + GG L + I R + E H I + +
Sbjct: 59 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCIQ-QILES 116
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFG 968
+AY H ++HR++KP N+LL + L+DFGLA + +++ A AGT G
Sbjct: 117 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 171
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y++PE S D+++ GV+L L+
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILL 200
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTL 851
++V+ +G G F G + A+II K+LS FQ +++ E R
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-----NTKKLSARDFQKLER---EARIC 59
Query: 852 GRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARA 911
++QHPN+V L E+ +L+++ + GG L + I R + E H I + +
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS-EADASHCIQ-QILES 117
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFG 968
+AY H ++HR++KP N+LL + L+DFGLA + +++ A AGT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPG 172
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y++PE S D+++ GV+L L+
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILL 201
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 84 LGICLT-STVQLIMQLMPFGXLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 138
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 199 HQSDVWSYGVTVWELMT 215
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+AR + + + A ++ P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ + + I L +L K ++ + + + + R L Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLK---CQHLSNDHICYFLYQILRGLKYIHS---AN 148
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTCRV 980
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE + +
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 981 SDKA-DVYSFGVVLLELISDK 1000
K+ D++S G +L E++S++
Sbjct: 209 YTKSIDIWSVGCILAEMLSNR 229
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGICLT-STVQLITQLMPFGXLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIPG-----VVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V P + L
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + L+ +P G L +++ R +L+ + +A+ ++YL D R
Sbjct: 85 LGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLN-WCMQIAKGMSYLED---VR 139
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + + ++DFGLARLL ET D ++A E + R +
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 54/215 (25%), Positives = 100/215 (46%), Gaps = 13/215 (6%)
Query: 798 RATAGFNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR 853
R + ++ +G G FG AT+ + + R + + + EI L
Sbjct: 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
++HP+++ L + ++ ++ Y GG L +I ++ R T + + + A+
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEG--RRFFQQIICAIE 122
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
Y H +++HRD+KP N+LLD+NLN ++DFGL+ ++ T+ G+ Y APE
Sbjct: 123 YCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 974 YAM-TCRVSDKADVYSFGVVLLELISDKKALDPSF 1007
+ DV+S G+VL ++ + D F
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 12/194 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
F +GSG F + + + G + A+K + EI L +++H N+VT
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L + S +L+ + GG L I +R T + + L + V A+ YLH+
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL--VIQQVLSAVKYLHEN--- 125
Query: 922 RVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
++HRD+KP N+L + N ++DFGL+++ + + GT GYVAPE
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYVAPEVLAQK 182
Query: 979 RVSDKADVYSFGVV 992
S D +S GV+
Sbjct: 183 PYSKAVDCWSIGVI 196
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV-AGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSM--------------LHKI 904
++ L+G + +++I Y GNL +++Q R +E+S L
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + TT+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA-TTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 209 KSAXKSSDLWALGCIIYQLVA 229
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL +++Q R P + L
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 85 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 139
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 86 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 201 HQSDVWSYGVTVWELMT 217
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 87 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 141
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 202 HQSDVWSYGVTVWELMT 218
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 24 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 84 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 138
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 199 HQSDVWSYGVTVWELMT 215
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 53/219 (24%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG--- 864
IGSGGFG +KA+ I G ++R+ ++ E++ L ++ H N+V G
Sbjct: 20 IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWD 75
Query: 865 ---YHVSEAE-----------------------MFLIYNYLPGGNLEKFIQDRPRRTVEW 898
Y ++ +F+ + G LE++I+ R ++
Sbjct: 76 GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
+ ++ + + + Y+H + +++HRD+KPSNI L + + DFGL L
Sbjct: 136 VLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 192
Query: 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
T GT Y++PE + + D+Y+ G++L EL+
Sbjct: 193 --TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAVK + + +Q+ E+R + + HPN+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ R M K A + A+ Y
Sbjct: 76 VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYC 129
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + + +HRD+K N+LLD ++N ++DFG + T G+ Y APE
Sbjct: 130 HQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELF 184
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAVK + + +Q+ E+R + + HPN+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ R M K A + A+ Y
Sbjct: 76 VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYC 129
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + + +HRD+K N+LLD ++N ++DFG + T G+ Y APE
Sbjct: 130 HQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELF 184
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 806 QNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
Q +G G FG + I G AVK +S V + + E++ L ++ HPN++
Sbjct: 37 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT-VEWSMLHKIALDVARALAYLHDECV 920
L + + +L+ GG L I R R + V+ + +I V + Y+H
Sbjct: 97 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMHKN-- 151
Query: 921 PRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++HRD+KP N+LL++ + N + DFGL+ S+ D GT Y+APE +
Sbjct: 152 -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTAYYIAPE-VLH 207
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+K DV+S GV+L L+S
Sbjct: 208 GTYDEKCDVWSTGVILYILLS 228
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G +VAVK++ + + Q + E+ + QH N+V + ++
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL+ LH + V+HRD
Sbjct: 88 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIAAVCLAVLQALSVLHAQ---GVIHRD 141
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 201 SLGIMVIEMV 210
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 9 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 69 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 127 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 184 KSACKSSDLWALGCIIYQLVA 204
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 11 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 71 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 129 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 186 KSACKSSDLWALGCIIYQLVA 206
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 12 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 72 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 130 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 187 KSACKSSDLWALGCIIYQLVA 207
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 16 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 76 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 134 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 191 KSACKSSDLWALGCIIYQLVA 211
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 128 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 185 KSACKSSDLWALGCIIYQLVA 205
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 37 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 97 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 155 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 212 KSACKSSDLWALGCIIYQLVA 232
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 91 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 149 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 206 KSACKSSDLWALGCIIYQLVA 226
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 91 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 149 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 206 KSACKSSDLWALGCIIYQLVA 226
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 150 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 207 KSACKSSDLWALGCIIYQLVA 227
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G +VAVK++ + + Q + E+ + QH N+V + ++
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL+ LH + V+HRD
Sbjct: 92 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIAAVCLAVLQALSVLHAQ---GVIHRD 145
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 205 SLGIMVIEMV 214
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 95 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 153 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 210 KSACKSSDLWALGCIIYQLVA 230
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 152 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 209 KSACKSSDLWALGCIIYQLVA 229
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 95 FVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 153 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 210 KSACKSSDLWALGCIIYQLVA 230
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 29/226 (12%)
Query: 798 RATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRVQ 855
R F C+G GGFG ++A+ + A+KR+ + R ++ E++ L +++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 856 HPNLVTLIGYHVSE------------AEMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLH 902
HP +V + + +++ NL+ ++ R E S+
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT-- 960
I L +A A+ +LH + ++HRD+KPSNI + + DFGL + E T
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 961 ---------TDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
T GT Y++PE S K D++S G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G +VAVK++ + + Q + E+ + QH N+V + ++
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL+ LH + V+HRD
Sbjct: 97 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIAAVCLAVLQALSVLHAQ---GVIHRD 150
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 151 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 210 SLGIMVIEMV 219
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII------PGVV--VAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE I P V VAVK L S + + +E+ + + +H N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL +++Q R P + L
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
A VAR + YL + + +HRD+ N+L+ + ++DFGLAR + + + TT+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV+L E+ +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 85 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 139
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 48 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 108 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 162
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 223 HQSDVWSYGVTVWELMT 239
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 29 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 89 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 143
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 204 HQSDVWSYGVTVWELMT 220
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 33 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 93 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 147
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 208 HQSDVWSYGVTVWELMT 224
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 86 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 201 HQSDVWSYGVTVWELMT 217
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 90 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 144
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 205 HQSDVWSYGVTVWELMT 221
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 77 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 131
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 192 HQSDVWSYGVTVWELMT 208
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 86 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 201 HQSDVWSYGVTVWELMT 217
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 26 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 86 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 140
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 201 HQSDVWSYGVTVWELMT 217
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
+ Q +G G FG + I G AVK +S V + + E++ L ++ HPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ L + + +L+ GG L F + R+ +I V + Y H
Sbjct: 88 IXKLYEFFEDKGYFYLVGEVYTGGEL--FDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 919 CVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
+++HRD+KP N+LL+ + N + DFGL+ S+ D GT Y+APE
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--KXKDKIGTAYYIAPE-V 199
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ +K DV+S GV+L L+S
Sbjct: 200 LHGTYDEKCDVWSTGVILYILLS 222
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G +VAVK++ + + Q + E+ + QH N+V + ++
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL+ LH + V+HRD
Sbjct: 99 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIAAVCLAVLQALSVLHAQ---GVIHRD 152
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 153 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 212 SLGIMVIEMV 221
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 146
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H + T Y APE +
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 147
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H + T Y APE +
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 70.5 bits (171), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 803 FNVQNCIGSGGFGA------TYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH 856
+ + +G G FG T + + ++ K L+ QG + EI L ++H
Sbjct: 16 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRH 73
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P+++ L S+ E+ ++ Y G L +I R + + + + + + A+ Y H
Sbjct: 74 PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA--RRFFQQIISAVEYCH 130
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY-A 975
+++HRD+KP N+LLD +LN ++DFGL+ ++ T+ G+ Y APE +
Sbjct: 131 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIS 185
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
+ DV+S GV+L ++ + D
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 214
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 70.1 bits (170), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 12/213 (5%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAE 847
V++ +++V+ +++ +G+G FG ++ E G A K + + E
Sbjct: 42 VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 98
Query: 848 IRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
I+T+ ++HP LV L + EM +IY ++ GG L + + D + E + +
Sbjct: 99 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-Q 157
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTSETHATTDVAG 965
V + L ++H+ +H D+KP NI+ + L DFGL L ++ T G
Sbjct: 158 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TG 212
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T + APE A V D++S GV+ L+S
Sbjct: 213 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 245
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPN 858
F +G G F A E+ A+K L + + V E + R+ HP
Sbjct: 39 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
V L + +++ +Y G L K+I R + + + ++ AL YLH +
Sbjct: 99 FVKLYFCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD-VAGTFGYVAPEYAMT 977
++HRD+KP NILL+ +++ ++DFG A++L A + GT YV+PE
Sbjct: 157 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+D+++ G ++ +L++
Sbjct: 214 KSACKSSDLWALGCIIYQLVA 234
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE-THATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 70.1 bits (170), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 803 FNVQNCIGSGGFGA------TYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH 856
+ + +G G FG T + + ++ K L+ QG + EI L ++H
Sbjct: 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRH 72
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P+++ L S+ E+ ++ Y G L +I R + + + + + + A+ Y H
Sbjct: 73 PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA--RRFFQQIISAVEYCH 129
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY-A 975
+++HRD+KP N+LLD +LN ++DFGL+ ++ T+ G+ Y APE +
Sbjct: 130 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIS 184
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
+ DV+S GV+L ++ + D
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 213
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE-THATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 70.1 bits (170), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 12/213 (5%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAE 847
V++ +++V+ +++ +G+G FG ++ E G A K + + E
Sbjct: 148 VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 204
Query: 848 IRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
I+T+ ++HP LV L + EM +IY ++ GG L + + D + E + +
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-Q 263
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTSETHATTDVAG 965
V + L ++H+ +H D+KP NI+ + L DFGL L ++ T G
Sbjct: 264 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TG 318
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T + APE A V D++S GV+ L+S
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 825 GVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAE--MFLIYNYLPG 881
G +VAVK L G ++ + EI L + H ++V G + E + L+ Y+P
Sbjct: 37 GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941
G+L ++ PR V + L A + +AYLH + +HR + N+LLDN+
Sbjct: 97 GSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLV 150
Query: 942 YLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ DFGLA+ + G D + APE C+ +DV+SFGV L EL++
Sbjct: 151 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 11/179 (6%)
Query: 825 GVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRVQHPNLVTLIGYHVSEAE--MFLIYNYLPG 881
G +VAVK L G ++ + EI L + H ++V G + E + L+ Y+P
Sbjct: 38 GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941
G+L ++ PR V + L A + +AYLH + +HR + N+LLDN+
Sbjct: 98 GSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHAQ---HYIHRALAARNVLLDNDRLV 151
Query: 942 YLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ DFGLA+ + G D + APE C+ +DV+SFGV L EL++
Sbjct: 152 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 70.1 bits (170), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-----GVVVAVKRLSVGRF-QGVQQFAAEIRTLGRVQH 856
F +GSG FG YK IP + VA+ L + ++ E + V +
Sbjct: 51 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P++ L+G ++ + + LI +P G L ++++ + + L + +A+ + YL
Sbjct: 111 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 168
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYA 975
D R++HRD+ N+L+ + ++DFGLA+LLG E + ++A E
Sbjct: 169 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 225
Query: 976 MTCRVSDKADVYSFGVVLLELIS 998
+ + ++DV+S+GV + EL++
Sbjct: 226 LHRIYTHQSDVWSYGVTVWELMT 248
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 70.1 bits (170), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 809 IGSGGFGATYKAEI--IPG----VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ ++ +P + VAVK L V Q F E + + H N+V
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD-RPRRTVEWSM----LHKIALDVARALAYLH 916
IG + F++ + GG+L+ F+++ RPR + S+ L +A D+A YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 917 DECVPRVLHRDIKPSNILLD---NNLNAYLSDFGLARLLGTSETHATTDVAG-TFGYVAP 972
+ +HRDI N LL A + DFG+A+ + + + A ++ P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 973 EYAMTCRVSDKADVYSFGVVLLELIS 998
E M + K D +SFGV+L E+ S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 70.1 bits (170), Expect = 7e-12, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 70.1 bits (170), Expect = 7e-12, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 143 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e
Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e
Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e
Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e
Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e
Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e
Double Mutant
Length = 327
Score = 70.1 bits (170), Expect = 7e-12, Method: Composition-based stats.
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAV+ + + +Q+ E+R + + HPN+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ R M K A + A+ Y
Sbjct: 76 VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYC 129
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + + +HRD+K N+LLD ++N ++DFG + + + + G+ Y APE
Sbjct: 130 HQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPELF 184
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 70.1 bits (170), Expect = 7e-12, Method: Composition-based stats.
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGVQQFAAEIR--TLGRVQH 856
F + +G G FG + + G + A+K L + + ++ L V H
Sbjct: 30 FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P +V L +E +++LI ++L GG+L + T E + ++A L +LH
Sbjct: 90 PFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALGLDHLH 147
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP NILLD + L+DFGL++ E A + GT Y+APE
Sbjct: 148 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS-FCGTVEYMAPEVVN 203
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
S AD +S+GV++ E+++
Sbjct: 204 RQGHSHSADWWSYGVLMFEMLT 225
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 70.1 bits (170), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L S + +E++ + + QH N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--------RTVEWSMLHKIALDVARAL 912
L+G + +I Y G+L F++ + R +E L + VA+ +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYVA 971
A+L + +HRD+ N+LL N A + DFGLAR ++ S + ++A
Sbjct: 166 AFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELIS 998
PE C + ++DV+S+G++L E+ S
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS 249
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 70.1 bits (170), Expect = 7e-12, Method: Composition-based stats.
Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A + G +VAVK++ + + Q + E+ + QH N+V + ++
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + R E + + L V +AL+ LH + V+HRD
Sbjct: 142 VGDELWVVMEFLEGGALTDIVT-HTRMNEE--QIAAVCLAVLQALSVLHAQ---GVIHRD 195
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL ++ LSDFG + + E + GT ++APE + D++
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 255 SLGIMVIEMV 264
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 70.1 bits (170), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L +H N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 144
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 69.7 bits (169), Expect = 7e-12, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 91 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 142
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 143 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 847 EIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
E+ L +V HPN++ L + + FL+++ + G L ++ ++ T+ KI
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 130
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ + LH ++HRD+KP NILLD+++N L+DFG + L E +V G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 185
Query: 966 TFGYVAPEYAMTCRVSD-------KADVYSFGVVLLELIS 998
T Y+APE + C ++D + D++S GV++ L++
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 847 EIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
E+ L +V HPN++ L + + FL+++ + G L ++ ++ T+ KI
Sbjct: 60 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 117
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ + LH ++HRD+KP NILLD+++N L+DFG + L E +V G
Sbjct: 118 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 172
Query: 966 TFGYVAPEYAMTCRVSD-------KADVYSFGVVLLELIS 998
T Y+APE + C ++D + D++S GV++ L++
Sbjct: 173 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 211
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 28/215 (13%)
Query: 809 IGSGGFGATYKAEII--------PGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRV-QHPN 858
+G G FG AE + V VAVK L + + +E+ + + +H N
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR--------------PRRTVEWSMLHKI 904
++ L+G + +++I Y GNL ++++ R P + + L
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH-ATTDV 963
+AR + YL + + +HRD+ N+L+ N ++DFGLAR + + + TT+
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + ++DV+SFGV++ E+ +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAV+ + + +Q+ E+R + + HPN+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ R M K A + A+ Y
Sbjct: 76 VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYC 129
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + + +HRD+K N+LLD ++N ++DFG + T G+ Y APE
Sbjct: 130 HQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELF 184
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 69.7 bits (169), Expect = 9e-12, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 20 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A + YL D R
Sbjct: 80 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAEGMNYLEDR---R 134
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 195 HQSDVWSYGVTVWELMT 211
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 140
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 88 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 139
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 140 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-VQQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L R +H N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 140
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 803 FNVQNCIGSGGFGA------TYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH 856
+ + +G G FG T + + ++ K L+ QG + EI L ++H
Sbjct: 6 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRH 63
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P+++ L S+ E+ ++ Y G L +I R + + + + + + A+ Y H
Sbjct: 64 PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA--RRFFQQIISAVEYCH 120
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY-A 975
+++HRD+KP N+LLD +LN ++DFGL+ ++ T+ G+ Y APE +
Sbjct: 121 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIS 175
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
+ DV+S GV+L ++ + D
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 204
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 803 FNVQNCIGSGGFGA------TYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQH 856
+ + +G G FG T + + ++ K L+ QG + EI L ++H
Sbjct: 10 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRH 67
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P+++ L S+ E+ ++ Y G L +I R + + + + + + A+ Y H
Sbjct: 68 PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEA--RRFFQQIISAVEYCH 124
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY-A 975
+++HRD+KP N+LLD +LN ++DFGL+ ++ T+ G+ Y APE +
Sbjct: 125 RH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIS 179
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALD 1004
+ DV+S GV+L ++ + D
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPFD 208
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 70/232 (30%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRL----SVGRFQGV-------QQFAAEIRTL 851
+ VQ I SG +GA G+ VA+KR+ S GR + ++ EIR L
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 852 GRVQHPNLVTL--IGYHVSEAEMFLIY--NYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
HPN++ L I H E M +Y L +L + I D+ R + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ-RIVISPQHIQYFMYH 142
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ L LH+ V +HRD+ P NILL +N + + DF LAR T++ + T V +
Sbjct: 143 ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVTHRW 198
Query: 968 GYVAPEYAMTCRVSDK-ADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA 1018
Y APE M + K D++S G V+ E+ + K S +F N N +
Sbjct: 199 -YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS--TFYNQLNKIV 247
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 70/232 (30%), Positives = 105/232 (45%), Gaps = 24/232 (10%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRL----SVGRFQGV-------QQFAAEIRTL 851
+ VQ I SG +GA G+ VA+KR+ S GR + ++ EIR L
Sbjct: 24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 852 GRVQHPNLVTL--IGYHVSEAEMFLIY--NYLPGGNLEKFIQDRPRRTVEWSMLHKIALD 907
HPN++ L I H E M +Y L +L + I D+ R + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ-RIVISPQHIQYFMYH 142
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
+ L LH+ V +HRD+ P NILL +N + + DF LAR T++ + T V +
Sbjct: 143 ILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVTHRW 198
Query: 968 GYVAPEYAMTCRVSDK-ADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVA 1018
Y APE M + K D++S G V+ E+ + K S +F N N +
Sbjct: 199 -YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS--TFYNQLNKIV 247
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L S + +E++ + + QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--------RTVEWSMLHKIALDVARAL 912
L+G + +I Y G+L F++ + R +E L + VA+ +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYVA 971
A+L + +HRD+ N+LL N A + DFGLAR ++ S + ++A
Sbjct: 174 AFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 230
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELIS 998
PE C + ++DV+S+G++L E+ S
Sbjct: 231 PESIFDCVYTVQSDVWSYGILLWEIFS 257
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 17/191 (8%)
Query: 813 GFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872
G G Y A+ I ++ R V R ++ E+ L ++HPN++TL ++ ++
Sbjct: 28 GTGKEYAAKFIKKRRLSSSRRGVSR----EEIEREVNILREIRHPNIITLHDIFENKTDV 83
Query: 873 FLIYNYLPGGNLEKFIQDRPRRTV-EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
LI + GG L F+ ++ T E + K LD + YLH + R+ H D+KP
Sbjct: 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK---RIAHFDLKPE 137
Query: 932 NI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
NI LLD N+ L DFG+A + ++ GT +VAPE + +AD++
Sbjct: 138 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMW 195
Query: 988 SFGVVLLELIS 998
S GV+ L+S
Sbjct: 196 SIGVITYILLS 206
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 58/191 (30%), Positives = 93/191 (48%), Gaps = 17/191 (8%)
Query: 813 GFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872
G G Y A+ I ++ R V R ++ E+ L ++HPN++TL ++ ++
Sbjct: 35 GTGKEYAAKFIKKRRLSSSRRGVSR----EEIEREVNILREIRHPNIITLHDIFENKTDV 90
Query: 873 FLIYNYLPGGNLEKFIQDRPRRTV-EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
LI + GG L F+ ++ T E + K LD + YLH + R+ H D+KP
Sbjct: 91 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK---RIAHFDLKPE 144
Query: 932 NI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
NI LLD N+ L DFG+A + ++ GT +VAPE + +AD++
Sbjct: 145 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMW 202
Query: 988 SFGVVLLELIS 998
S GV+ L+S
Sbjct: 203 SIGVITYILLS 213
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + V VA+K++S Q Q+ EI+ L +H N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH--KIALDVARALAYLHDECV 920
+ + + I L +L K + +T S H + R L Y+H
Sbjct: 93 RAPTIEQMKDVYIVQDLMETDLYKLL-----KTQHLSNDHICYFLYQILRGLKYIHS--- 144
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTC 978
VLHRD+KPSN+LL+ + + DFGLAR+ H T+ T Y APE +
Sbjct: 145 ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 979 RVSDKA-DVYSFGVVLLELISDK 1000
+ K+ D++S G +L E++S++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 16/160 (10%)
Query: 847 EIRTLGRVQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
E+ L +V HPN++ L + + FL+++ + G L ++ ++ T+ KI
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 130
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
+ + LH ++HRD+KP NILLD+++N L+DFG + L E V G
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRSVCG 185
Query: 966 TFGYVAPEYAMTCRVSD-------KADVYSFGVVLLELIS 998
T Y+APE + C ++D + D++S GV++ L++
Sbjct: 186 TPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 56/216 (25%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 795 NVVRATAG-FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLG 852
+ +R AG F + +G+G +G YK + G + A+K + V + ++ EI L
Sbjct: 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLK 75
Query: 853 RV-QHPNLVTLIGYHVS------EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIA 905
+ H N+ T G + + +++L+ + G++ I++ T++ + I
Sbjct: 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG 965
++ R L++LH +V+HRDIK N+LL N L DFG++ L + T + G
Sbjct: 136 REILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-G 191
Query: 966 TFGYVAPEYAMTCRVSD-----KADVYSFGVVLLEL 996
T ++APE D K+D++S G+ +E+
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAVK + + +Q+ E+R + + HPN+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ R M K A + A+ Y
Sbjct: 76 VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGR------MKEKEARAKFRQIVSAVQYC 129
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + + +HRD+K N+LLD ++N ++DFG + + + G Y APE
Sbjct: 130 HQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELF 184
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase Erk1
Length = 382
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV-QQFAAEIRTLGRVQHPNLV----TL 862
IG G +G A + + VA+K++S Q Q+ EI+ L R +H N++ L
Sbjct: 51 IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+ I L +L K ++ + + + + R L Y+H
Sbjct: 111 RASTLEAMRDVYIVQDLMETDLYKLLKSQ---QLSNDHICYFLYQILRGLKYIHS---AN 164
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHA--TTDVAGTFGYVAPEYAMTCRV 980
VLHRD+KPSN+L++ + + DFGLAR+ H T+ T Y APE + +
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 981 SDKA-DVYSFGVVLLELISDK 1000
K+ D++S G +L E++S++
Sbjct: 225 YTKSIDIWSVGCILAEMLSNR 245
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 807 NCIGSGGFGATYKAEI-IPGVVVA---VKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGFG + ++ G + A + + + + +G Q E + L +V +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI----QDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ ++ L+ + GG++ I +D P ++ + + L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQR 308
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+++RD+KP N+LLD++ N +SD GLA L +T T AGT G++APE +
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
D ++ GV L E+I+ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 68.9 bits (167), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 807 NCIGSGGFGATYKAEI-IPGVVVA---VKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGFG + ++ G + A + + + + +G Q E + L +V +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI----QDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ ++ L+ + GG++ I +D P ++ + + L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQR 308
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+++RD+KP N+LLD++ N +SD GLA L +T T AGT G++APE +
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
D ++ GV L E+I+ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 807 NCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPNLVTL 862
+G GGFG + ++ G + A K+L+ R + G Q E + L +V +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI----QDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ ++ L+ + GG++ I +D P ++ + + L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQR 308
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+++RD+KP N+LLD++ N +SD GLA L +T T AGT G++APE +
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
D ++ GV L E+I+ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY
Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY
Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY
Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY
Mimicking Host Substrates
Length = 319
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 19/210 (9%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAVK + + +Q+ E+R + + HPN+
Sbjct: 9 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL----DVARALAYL 915
V L +E ++L+ Y GG + ++ M K A + A+ Y
Sbjct: 69 VKLFEVIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H + + +HRD+K N+LLD ++N ++DFG + T G+ Y APE
Sbjct: 123 HQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELF 177
Query: 976 MTCRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 38/245 (15%)
Query: 769 NSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVV 828
N + DP V K + G Q R A N + IG+G FG ++A+++ V
Sbjct: 16 NPLDDPNKVIKVLASDGKTGEQ-------REIAYTNCK-VIGNGSFGVVFQAKLVESDEV 67
Query: 829 AVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS----EAEMFL--IYNYLP- 880
A+K+ L RF+ E++ + V+HPN+V L + S + E+FL + Y+P
Sbjct: 68 AIKKVLQDKRFKN-----RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 881 -----GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935
+ K Q P ++ M + R+LAY+H + HRDIKP N+LL
Sbjct: 123 TVYRASRHYAKLKQTMPMLLIKLYMYQ-----LLRSLAYIHSIGI---CHRDIKPQNLLL 174
Query: 936 DNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVL 993
D L DFG A++L E + + + + Y APE + D++S G V+
Sbjct: 175 DPPSGVLKLIDFGSAKILIAGEPNVSX-ICSRY-YRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 994 LELIS 998
EL+
Sbjct: 233 AELMQ 237
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled Receptor
Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled Receptor
Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 807 NCIGSGGFGATYKAEI-IPGVVVA---VKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGFG + ++ G + A + + + + +G Q E + L +V +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI----QDRPRRTVEWSMLHKIALDVARALAYLHDE 918
++ ++ L+ + GG++ I +D P ++ + + L +LH
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY--TAQIVSGLEHLHQR 308
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
+++RD+KP N+LLD++ N +SD GLA L +T T AGT G++APE +
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLGE 364
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
D ++ GV L E+I+ +
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIP-GVVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQ-HP 857
F +G G FG A + G + AVK L + + V+ E R L + HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
L L + +F + ++ GG+L IQ + RR E + A ++ AL +LHD
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDE-ARARFYAAEIISALMFLHD 142
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ + ++RD+K N+LLD+ + L+DFG+ + G T GT Y+APE
Sbjct: 143 KGI---IYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPEILQE 198
Query: 978 CRVSDKADVYSFGVVLLELI 997
D ++ GV+L E++
Sbjct: 199 MLYGPAVDWWAMGVLLYEML 218
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 11/179 (6%)
Query: 825 GVVVAVKRLSV-GRFQGVQQFAAEIRTLGRVQHPNLVTLIG--YHVSEAEMFLIYNYLPG 881
G +VAVK L Q + EI L + H +++ G A + L+ Y+P
Sbjct: 60 GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941
G+L ++ PR ++ + L A + +AYLH + +HRD+ N+LLDN+
Sbjct: 120 GSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLV 173
Query: 942 YLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ DFGLA+ + G D + APE + +DV+SFGV L EL++
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 808 CIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
C+G G +G ++ G VAVK S R + E+ ++H N++ I +
Sbjct: 44 CVGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDM 101
Query: 868 ----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV--- 920
S +++LI +Y G+L ++Q TV S L +I L +A LA+LH E
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV--SCL-RIVLSIASGLAHLHIEIFGTQ 158
Query: 921 --PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV-----AGTFGYVAPE 973
P + HRD+K NIL+ N ++D GLA + S++ DV GT Y+APE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--HSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 974 Y-----AMTCRVS-DKADVYSFGVVLLEL 996
+ C S + D+++FG+VL E+
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 58/191 (30%), Positives = 92/191 (48%), Gaps = 17/191 (8%)
Query: 813 GFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEM 872
G G Y A+ I + R V R ++ E+ L ++HPN++TL ++ ++
Sbjct: 49 GTGKEYAAKFIKKRRLXSSRRGVSR----EEIEREVNILREIRHPNIITLHDIFENKTDV 104
Query: 873 FLIYNYLPGGNLEKFIQDRPRRTV-EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
LI + GG L F+ ++ T E + K LD + YLH + R+ H D+KP
Sbjct: 105 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSK---RIAHFDLKPE 158
Query: 932 NI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
NI LLD N+ L DFG+A + ++ GT +VAPE + +AD++
Sbjct: 159 NIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMW 216
Query: 988 SFGVVLLELIS 998
S GV+ L+S
Sbjct: 217 SIGVITYILLS 227
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+ SG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 30 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 90 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 144
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 205 HQSDVWSYGVTVWELMT 221
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 85 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 139
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFG A+LLG E + ++A E + +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 85 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 139
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFG A+LLG E + ++A E + +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 27 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 87 LGICLT-STVQLIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 141
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFG A+LLG E + ++A E + +
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 202 HQSDVWSYGVTVWELMT 218
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 36/279 (12%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQH-PNLVTLIGY 865
IG G +G+ K P G ++AVKR+ S + +Q ++ + R P +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 866 HVSEAEMFLIYNYLPGG--NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
E + ++ + K++ + +L KI L +AL +L + ++
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE----YAMTCR 979
+HRDIKPSNILLD + N L DFG++ L ++ A T AG Y+APE A
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASML-----LLQGRPCEFFT 1034
++DV+S G+ L EL + + F W S+ +++G P +
Sbjct: 206 YDVRSDVWSLGITLYELATGR-------------FPYPKWNSVFDQLTQVVKGDPPQLSN 252
Query: 1035 AGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQ 1073
+ + P +N +C + S RP +++ +
Sbjct: 253 SEEREFSP-----SFINFVNLCLTKDESKRPKYKELLKH 286
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 68.2 bits (165), Expect = 3e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+ SG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 30 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 90 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 144
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 205 HQSDVWSYGVTVWELMT 221
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 68.2 bits (165), Expect = 3e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+ SG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 23 LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFGLA+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 25 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 85 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 139
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFG A+LLG E + ++A E + +
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 30 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 90 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 144
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFG A+LLG E + ++A E + +
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 205 HQSDVWSYGVTVWELMT 221
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 12/197 (6%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+GSG FG YK IP + VA+K L + ++ E + V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
+G ++ + + LI +P G L ++++ + + L + +A+ + YL D R
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVS 981
++HRD+ N+L+ + ++DFG A+LLG E + ++A E + +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 982 DKADVYSFGVVLLELIS 998
++DV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 808 CIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
C+G G +G ++ G VAVK S R + E+ ++H N++ I +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 868 ----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV--- 920
S +++LI +Y G+L ++Q TV S L +I L +A LA+LH E
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV--SCL-RIVLSIASGLAHLHIEIFGTQ 129
Query: 921 --PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV-----AGTFGYVAPE 973
P + HRD+K NIL+ N ++D GLA + S++ DV GT Y+APE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--HSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 974 Y-----AMTCRVS-DKADVYSFGVVLLEL 996
+ C S + D+++FG+VL E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 69/251 (27%), Positives = 112/251 (44%), Gaps = 49/251 (19%)
Query: 769 NSIADPGLVRKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGAT----YKAEIIP 824
N D L R E ++ G+Q+ E+ ++V IG G FG +KA
Sbjct: 50 NKNIDNFLNRYEKIVKKIRGLQMKAED-------YDVVKVIGRGAFGEVQLVRHKAS--- 99
Query: 825 GVVVAVKRLSVGRFQGVQQ-----FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879
V A+K LS +F+ +++ F E + P +V L + ++++ Y+
Sbjct: 100 QKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYM 157
Query: 880 PGGNLEKFIQ--DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDN 937
PGG+L + D P + W+ + +V AL +H + +HRD+KP N+LLD
Sbjct: 158 PGGDLVNLMSNYDVPEK---WAKFY--TAEVVLALDAIHSMGL---IHRDVKPDNMLLDK 209
Query: 938 NLNAYLSDFGLA-RLLGTSETHATTDVAGTFGYVAPE----------YAMTCRVSDKADV 986
+ + L+DFG ++ T H T V GT Y++PE Y C D
Sbjct: 210 HGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGGDGYYGREC------DW 262
Query: 987 YSFGVVLLELI 997
+S GV L E++
Sbjct: 263 WSVGVFLFEML 273
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 15/201 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLVTL 862
IG G F + G AVK + V +F + E ++HP++V L
Sbjct: 32 IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
+ + S+ +++++ ++ G +L I R +S + + AL Y HD
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 921 PRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
++HRD+KP N+LL +N+ L DFG+A LG S A V GT ++APE
Sbjct: 150 -NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207
Query: 978 CRVSDKADVYSFGVVLLELIS 998
DV+ GV+L L+S
Sbjct: 208 EPYGKPVDVWGCGVILFILLS 228
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 808 CIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
C+G G +G ++ G VAVK S R + E+ ++H N++ I +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFS-SRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 868 ----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV--- 920
S +++LI +Y G+L ++Q TV S L +I L +A LA+LH E
Sbjct: 73 TSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV--SCL-RIVLSIASGLAHLHIEIFGTQ 129
Query: 921 --PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV-----AGTFGYVAPE 973
P + HRD+K NIL+ N ++D GLA + S++ DV GT Y+APE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--HSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 974 Y-----AMTCRVS-DKADVYSFGVVLLEL 996
+ C S + D+++FG+VL E+
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L S + +E++ + + QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR------------RTVEWSMLHKIALDV 908
L+G + +I Y G+L F++ + R T+ L + V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTF 967
A+ +A+L + +HRD+ N+LL N A + DFGLAR ++ S +
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE C + ++DV+S+G++L E+ S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 67.4 bits (163), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L S + +E++ + + QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS---------------MLHKIA 905
L+G + +I Y G+L F++ + +E+S +LH +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH-FS 172
Query: 906 LDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVA 964
VA+ +A+L + +HRD+ N+LL N A + DFGLAR ++ S +
Sbjct: 173 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 965 GTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE C + ++DV+S+G++L E+ S
Sbjct: 230 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 67.4 bits (163), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNL 859
+N+ +G G FG K + I AVK + + + + E+ L ++ HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ L + +++ GG L I R R + + +I V + Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--RIIKQVFSGITYMHKH- 140
Query: 920 VPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KP NILL + + + + DFGL+ + D GT Y+APE +
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE-VL 195
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+K DV+S GV+L L+S
Sbjct: 196 RGTYDEKCDVWSAGVILYILLS 217
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 67.4 bits (163), Expect = 5e-11, Method: Composition-based stats.
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 809 IGSGGFGATY-------KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y K E I V K+ ++F +E + + HP++V
Sbjct: 32 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECV 920
LIG + E ++I P G L +++ R + +++ L +L + +A+AYL CV
Sbjct: 90 LIGI-IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINCV 147
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
HRDI NIL+ + L DFGL+R + + + + +++PE R
Sbjct: 148 ----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 981 SDKADVYSFGVVLLELIS 998
+ +DV+ F V + E++S
Sbjct: 204 TTASDVWMFAVCMWEILS 221
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 67.4 bits (163), Expect = 5e-11, Method: Composition-based stats.
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 809 IGSGGFGATY-------KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y K E I V K+ ++F +E + + HP++V
Sbjct: 16 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECV 920
LIG + E ++I P G L +++ R + +++ L +L + +A+AYL CV
Sbjct: 74 LIGI-IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINCV 131
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
HRDI NIL+ + L DFGL+R + + + + +++PE R
Sbjct: 132 ----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 981 SDKADVYSFGVVLLELIS 998
+ +DV+ F V + E++S
Sbjct: 188 TTASDVWMFAVCMWEILS 205
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 67.4 bits (163), Expect = 5e-11, Method: Composition-based stats.
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 809 IGSGGFGATY-------KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y K E I V K+ ++F +E + + HP++V
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT--LDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD-ECV 920
LIG + E ++I P G L +++ R + +++ L +L + +A+AYL CV
Sbjct: 78 LIGI-IEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINCV 135
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
HRDI NIL+ + L DFGL+R + + + + +++PE R
Sbjct: 136 ----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 981 SDKADVYSFGVVLLELIS 998
+ +DV+ F V + E++S
Sbjct: 192 TTASDVWMFAVCMWEILS 209
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 803 FNVQNCIGSGGFGAT-----YKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QH 856
F++ IG G + K + I + V K L V + + E + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKEL-VNDDEDIDWVQTEKHVFEQASNH 112
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YLH
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 170
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ + ++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 171 ERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILR 226
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFD 254
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 803 FNVQNCIGSGGFGATY-----KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QH 856
F++ IG G + K + I + V K L V + + E + H
Sbjct: 7 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNH 65
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YLH
Sbjct: 66 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 123
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ + ++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 124 ERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILR 179
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 180 GEDYGFSVDWWALGVLMFEMMAGRSPFD 207
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 67.0 bits (162), Expect = 5e-11, Method: Composition-based stats.
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE ++P ++VAVK L Q F E L +QH ++V
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI-------------QDRPRRTVEWSMLHKIALDVA 909
G + +++ Y+ G+L +F+ +D + L +A VA
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---- 965
+ YL +HRD+ N L+ L + DFG++R + +++ + V G
Sbjct: 146 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTML 199
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE + + + ++DV+SFGVVL E+ +
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 67.0 bits (162), Expect = 5e-11, Method: Composition-based stats.
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE ++P ++VAVK L Q F E L +QH ++V
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI-------------QDRPRRTVEWSMLHKIALDVA 909
G + +++ Y+ G+L +F+ +D + L +A VA
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---- 965
+ YL +HRD+ N L+ L + DFG++R + +++ + V G
Sbjct: 140 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTML 193
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE + + + ++DV+SFGVVL E+ +
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 67.0 bits (162), Expect = 5e-11, Method: Composition-based stats.
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 809 IGSGGFGATYKAE---IIP---GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G FG + AE ++P ++VAVK L Q F E L +QH ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFI-------------QDRPRRTVEWSMLHKIALDVA 909
G + +++ Y+ G+L +F+ +D + L +A VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 910 RALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---- 965
+ YL +HRD+ N L+ L + DFG++R + +++ + V G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR---VGGRTML 222
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++ PE + + + ++DV+SFGVVL E+ +
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 803 FNVQNCIGSGGFGATY-----KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QH 856
F++ IG G + K + I + V K L V + + E + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNH 69
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YLH
Sbjct: 70 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 127
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ + ++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 128 ERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILR 183
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSPFD 211
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 803 FNVQNCIGSGGFGATY-----KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QH 856
F++ IG G + K + I + V K L V + + E + H
Sbjct: 22 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNH 80
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P LV L +E+ +F + Y+ GG+L +Q + + E + + + +++ AL YLH
Sbjct: 81 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--SAEISLALNYLH 138
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ + ++RD+K N+LLD+ + L+D+G+ + G T+ GT Y+APE
Sbjct: 139 ERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILR 194
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALD 1004
D ++ GV++ E+++ + D
Sbjct: 195 GEDYGFSVDWWALGVLMFEMMAGRSPFD 222
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL---SVGRFQGVQQFAAEIRTLGRVQHPNLV 860
+G G FG P G VAVK L S G + EI L + H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 86
Query: 861 TLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
G + + LI +LP G+L++++ + + + K A+ + + + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT--DVAGTFGYVAPEYAM 976
+ +HRD+ N+L+++ + DFGL + + T + T D + APE M
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ +DV+SFGV L EL++
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 67.0 bits (162), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 809 IGSGGFGATYKAEIIP-----GVVVAVKRL---SVGRFQGVQQFAAEIRTLGRVQHPNLV 860
+G G FG P G VAVK L S G + EI L + H N+V
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 74
Query: 861 TLIGYHVSEAE--MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
G + + LI +LP G+L++++ + + + K A+ + + + YL
Sbjct: 75 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT--DVAGTFGYVAPEYAM 976
+ +HRD+ N+L+++ + DFGL + + T + T D + APE M
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ +DV+SFGV L EL++
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 8 LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 66 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 122
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-----GTFGYV 970
P + HRD+K NIL+ N ++D GLA + T D+A GT Y+
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYM 180
Query: 971 APEY------AMTCRVSDKADVYSFGVVLLEL 996
APE +AD+Y+ G+V E+
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 212
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-----GTFGYV 970
P + HRD+K NIL+ N ++D GLA + T D+A GT Y+
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYM 179
Query: 971 APEY------AMTCRVSDKADVYSFGVVLLEL 996
APE +AD+Y+ G+V E+
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 211
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 33 LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 91 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 147
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-----GTFGYV 970
P + HRD+K NIL+ N ++D GLA + T D+A GT Y+
Sbjct: 148 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYM 205
Query: 971 APEY------AMTCRVSDKADVYSFGVVLLEL 996
APE +AD+Y+ G+V E+
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 237
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 13 LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 71 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 127
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-----GTFGYV 970
P + HRD+K NIL+ N ++D GLA + T D+A GT Y+
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYM 185
Query: 971 APEY------AMTCRVSDKADVYSFGVVLLEL 996
APE +AD+Y+ G+V E+
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 217
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 10 LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 68 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 124
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-----GTFGYV 970
P + HRD+K NIL+ N ++D GLA + T D+A GT Y+
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYM 182
Query: 971 APEY------AMTCRVSDKADVYSFGVVLLEL 996
APE +AD+Y+ G+V E+
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 214
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L S + +E++ + + QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR------------RTVEWSMLHKIALDV 908
L+G + +I Y G+L F++ + R T L + V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTF 967
A+ +A+L + +HRD+ N+LL N A + DFGLAR ++ S +
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE C + ++DV+S+G++L E+ S
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 66.6 bits (161), Expect = 6e-11, Method: Composition-based stats.
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 805 VQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+Q IG G FG ++ + G VAVK S R + AEI ++H N++ I
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 865 YHVSE----AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ +++L+ +Y G+L ++ R TV + K+AL A LA+LH E V
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 921 -----PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVA-----GTFGYV 970
P + HRD+K NIL+ N ++D GLA + T D+A GT Y+
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYM 218
Query: 971 APEY------AMTCRVSDKADVYSFGVVLLEL 996
APE +AD+Y+ G+V E+
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEI 250
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 66.6 bits (161), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRF-QGVQQFA-AEIRTLGRVQHPNLVTLIGY 865
IG G +G +KA+ +VA+KR+ + +GV A EI L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
S+ ++ L++ + +L+K+ D ++ ++ + + L + H VLH
Sbjct: 70 LHSDKKLTLVFEFC-DQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
RD+KP N+L++ N L+DFGLAR G + +V T Y P+ ++ S
Sbjct: 125 RDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + EL + + L P
Sbjct: 184 DMWSAGCIFAELANAARPLFP 204
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 8/190 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG G G A E G VAVK + + + Q + E+ + QH N+V + ++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
E++++ +L GG L + + + + + V +ALAYLH + V+HRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRD 166
Query: 928 IKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVY 987
IK +ILL + LSDFG + + + + GT ++APE + + D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 988 SFGVVLLELI 997
S G++++E++
Sbjct: 226 SLGIMVIEMV 235
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 15/208 (7%)
Query: 803 FNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGRVQHPNL 859
+ + IG G F A I+ G VAVK + + +Q+ E+R + HPN+
Sbjct: 16 YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFI--QDRPRRTVEWSMLHKIALDVARALAYLHD 917
V L +E ++L+ Y GG + ++ R + + +I A+ Y H
Sbjct: 76 VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIV----SAVQYCHQ 131
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ + +HRD+K N+LLD + N ++DFG + + + G Y APE
Sbjct: 132 KFI---VHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQG 186
Query: 978 CRVSD-KADVYSFGVVLLELISDKKALD 1004
+ + DV+S GV+L L+S D
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFD 214
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 66.2 bits (160), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVV--AVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV 860
+ ++N IG G +G K + G + A K++ + V +F EI + + HPN++
Sbjct: 28 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
L +++L+ GG L E+ + R R + + + K DV A+AY H
Sbjct: 87 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK---DVLSAVAYCHK-- 141
Query: 920 VPRVLHRDIKPSNILL-----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
V HRD+KP N L D+ L L DFGLA + T GT YV+P+
Sbjct: 142 -LNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTK--VGTPYYVSPQ- 195
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
+ + D +S GV++ L+
Sbjct: 196 VLEGLYGPECDEWSAGVMMYVLL 218
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 66.2 bits (160), Expect = 1e-10, Method: Composition-based stats.
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 24/202 (11%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRL-SVGRFQGVQQFAAEIR-TLGRVQHPNLVTLIGY 865
+G G +G K +P G ++AVKR+ + Q ++ ++ ++ V P VT G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
E ++++ L +L+KF + +T+ +L KIA+ + +AL +LH + V
Sbjct: 75 LFREGDVWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV--- 980
+HRD+KPSN+L++ + DFG++ L + D AG Y+APE R+
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID-AGCKPYMAPE-----RINPE 184
Query: 981 ------SDKADVYSFGVVLLEL 996
S K+D++S G+ ++EL
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 825 GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--MFLIYNYLPG 881
G +VAVK L Q + EI L + H +++ G + E + L+ Y+P
Sbjct: 43 GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941
G+L ++ PR ++ + L A + +AYLH + +HR++ N+LLDN+
Sbjct: 103 GSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLV 156
Query: 942 YLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ DFGLA+ + G D + APE + +DV+SFGV L EL++
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPAFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF-LIYNYLPGGNLEKFIQDRPRRTVEWSML 901
+ AE + ++ +P +V +IG + EAE + L+ G L K++Q R V+ +
Sbjct: 416 ELLAEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNI 471
Query: 902 HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 472 IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528
Query: 962 DVAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMF-LIYNYLPGGNLEKFIQDRPRRTVEWSML 901
+ AE + ++ +P +V +IG + EAE + L+ G L K++Q R V+ +
Sbjct: 417 ELLAEANVMQQLDNPYIVRMIG--ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNI 472
Query: 902 HKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT 961
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 473 IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 529
Query: 962 DVAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 530 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRL-SVGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L S + +E++ + + QH N+V
Sbjct: 39 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR---------------------RTVEWS 899
L+G + +I Y G+L F++ + R +E
Sbjct: 99 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETH 958
L + VA+ +A+L + +HRD+ N+LL N A + DFGLAR ++ S
Sbjct: 159 DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ ++APE C + ++DV+S+G++L E+ S
Sbjct: 216 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 54/193 (27%), Positives = 86/193 (44%), Gaps = 9/193 (4%)
Query: 809 IGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG +K E G+ +A K + + ++ EI + ++ H NL+ L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
S+ ++ L+ Y+ GG L I D E + + + + ++H +LH D
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK-QICEGIRHMHQ---MYILHLD 212
Query: 928 IKPSNILLDNNLNAYLS--DFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKAD 985
+KP NIL N + DFGLAR E GT ++APE VS D
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN--FGTPEFLAPEVVNYDFVSFPTD 270
Query: 986 VYSFGVVLLELIS 998
++S GV+ L+S
Sbjct: 271 MWSVGVIAYMLLS 283
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 65.5 bits (158), Expect = 2e-10, Method: Composition-based stats.
Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 11/179 (6%)
Query: 825 GVVVAVKRLSVG-RFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--MFLIYNYLPG 881
G +VAVK L Q + EI L + H +++ G + E + L+ Y+P
Sbjct: 43 GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 882 GNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNA 941
G+L ++ PR ++ + L A + +AYLH + +HR++ N+LLDN+
Sbjct: 103 GSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLV 156
Query: 942 YLSDFGLARLL--GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ DFGLA+ + G D + APE + +DV+SFGV L EL++
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 54/242 (22%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRF-----QGVQQFAAEIRTLGRVQH 856
++++ IG G +G A E + A+K ++ + + V++ E+R + ++ H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNL----EKFIQDRP-------------------- 892
PN+ L + E + L+ GG+L FI D
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 893 ----------RRTVEWSMLHKIALDVAR----ALAYLHDECVPRVLHRDIKPSNILLDNN 938
R ++++ K+ ++ R AL YLH++ + HRDIKP N L N
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI---CHRDIKPENFLFSTN 204
Query: 939 --LNAYLSDFGLAR---LLGTSETHATTDVAGTFGYVAPEYAMTCRVS--DKADVYSFGV 991
L DFGL++ L E + T AGT +VAPE T S K D +S GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264
Query: 992 VL 993
+L
Sbjct: 265 LL 266
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNL 859
+N+ +G G FG K + I AVK + + + + E+ L ++ HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ L + +++ GG L I R R + + +I V + Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--RIIKQVFSGITYMHKH- 140
Query: 920 VPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KP NILL++ + + + DFGL+ + D GT Y+APE +
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE-VL 195
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+K DV+S GV+L L+S
Sbjct: 196 RGTYDEKCDVWSAGVILYILLS 217
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNL 859
+N+ +G G FG K + I AVK + + + + E+ L ++ HPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ L + +++ GG L I R R + + +I V + Y+H
Sbjct: 84 MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--RIIKQVFSGITYMHKH- 140
Query: 920 VPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KP NILL++ + + + DFGL+ + D GT Y+APE +
Sbjct: 141 --NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYYIAPE-VL 195
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+K DV+S GV+L L+S
Sbjct: 196 RGTYDEKCDVWSAGVILYILLS 217
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 13/216 (6%)
Query: 788 GVQLTYENVVRATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGV--QQF 844
GV L EN+ + + + +G G F + +++ G A K ++ + Q+
Sbjct: 10 GVDLGTENLYFQSM-YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL 68
Query: 845 AAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKI 904
E R ++HPN+V L E +LI++ + GG L + I R + E H I
Sbjct: 69 EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCI 127
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATT 961
+ A+ + H V+HRD+KP N+LL + L L+DFGLA + E A
Sbjct: 128 Q-QILEAVLHCHQM---GVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWF 182
Query: 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
AGT GY++PE D+++ GV+L L+
Sbjct: 183 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 218
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 73
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 131
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 132 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 186
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLS 211
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 73
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 131
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 132 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 186
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLS 211
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 15/188 (7%)
Query: 815 GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFL 874
G Y A+ I R V R + E+ L +QHPN++TL + ++ ++ L
Sbjct: 36 GLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91
Query: 875 IYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNI- 933
I + GG L F+ ++ T E + + + + YLH ++ H D+KP NI
Sbjct: 92 ILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHSL---QIAHFDLKPENIM 146
Query: 934 LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFG 990
LLD N+ + DFGLA + ++ GT +VAPE + +AD++S G
Sbjct: 147 LLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIG 204
Query: 991 VVLLELIS 998
V+ L+S
Sbjct: 205 VITYILLS 212
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From The
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From The
Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRF-QGVQQFA-AEIRTLGRVQHPNLVTLIGY 865
IG G +G +KA+ +VA+KR+ + +GV A EI L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
S+ ++ L++ + +L+K+ D ++ ++ + + L + H VLH
Sbjct: 70 LHSDKKLTLVFEFC-DQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLH 124
Query: 926 RDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
RD+KP N+L++ N L++FGLAR G + +V T Y P+ ++ S
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 183
Query: 985 DVYSFGVVLLELISDKKALDP 1005
D++S G + EL + + L P
Sbjct: 184 DMWSAGCIFAELANAGRPLFP 204
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVK----RLSVGRFQGV--QQFAAEIRTLGRVQ 855
+++ +GSG F K E G+ A K R S +GV ++ E+ L +V
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAY 914
HPN++TL + + ++ LI + GG L F+ Q E + K LD + Y
Sbjct: 74 HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 915 LHDECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LH ++ H D+KP NI LLD N+ + L DFGLA + + ++ GT +V
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +AD++S GV+ L+S
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---XQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 64.3 bits (155), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPN 858
F +G GGFG ++ G + A K+L R + G E + L +V
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V+L + ++ + L+ + GG+L+ I + + A ++ L LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R+++RD+KP NILLD++ + +SD GLA + E GT GY+APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 979 RVSDKADVYSFGVVLLELIS 998
R + D ++ G +L E+I+
Sbjct: 361 RYTFSPDWWALGCLLYEMIA 380
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 64.3 bits (155), Expect = 4e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 64.3 bits (155), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 35/237 (14%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAE 847
VQ + N ++ T G+ V+ IG G + + + AVK + + + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----E 65
Query: 848 IRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPGGNL------EKFIQDRPRRTVEWSM 900
I L R QHPN++TL + ++++ + GG L +KF +R V ++
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT- 124
Query: 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNIL-LDNNLN---AYLSDFGLARLLGTSE 956
+ + + YLH + V +HRD+KPSNIL +D + N + DFG A+ L +E
Sbjct: 125 -------ITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAE 173
Query: 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG 1013
T +VAPE D++S GV+L +++ + F NG
Sbjct: 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT-------GYTPFANG 223
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 64.3 bits (155), Expect = 4e-10, Method: Composition-based stats.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---XQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 64.3 bits (155), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
IGSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 149 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 200
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind
E804
Length = 324
Score = 64.3 bits (155), Expect = 4e-10, Method: Composition-based stats.
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 15/198 (7%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQGVQQFAA-EIRTLGRVQHPNLVTLIGYH 866
+G G + YK + + +VA+K + + +G A E+ L ++H N+VTL
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL---DVARALAYLHDECVPRV 923
+E + L++ YL +L++++ D +H + L + R LAY H + +V
Sbjct: 70 HTEKSLTLVFEYL-DKDLKQYLDD----CGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSD 982
LHRD+KP N+L++ L+DFGLAR +V T Y P+ + + S
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 983 KADVYSFGVVLLELISDK 1000
+ D++ G + E+ + +
Sbjct: 181 QIDMWGVGCIFYEMATGR 198
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 9/200 (4%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRLSVGRFQ---GVQQFAAEIRTLGRVQHPN 858
F +G GGFG ++ G + A K+L R + G E + L +V
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+V+L + ++ + L+ + GG+L+ I + + A ++ L LH E
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTC 978
R+++RD+KP NILLD++ + +SD GLA + E GT GY+APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 360
Query: 979 RVSDKADVYSFGVVLLELIS 998
R + D ++ G +L E+I+
Sbjct: 361 RYTFSPDWWALGCLLYEMIA 380
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 26/205 (12%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
+GSG F G Y A+ I R V R + E+ L +QHP
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR----EDIEREVSILKEIQHP 74
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N++TL + ++ ++ LI + GG L F+ ++ T E + + + + YLH
Sbjct: 75 NVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGVYYLHS 132
Query: 918 ECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
++ H D+KP NI LLD N+ + DFGLA + ++ GT +VAPE
Sbjct: 133 L---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPE 187
Query: 974 YAMTCRVSDKADVYSFGVVLLELIS 998
+ +AD++S GV+ L+S
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLS 212
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 52 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 108
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 109 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 165
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 166 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 64 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 120
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 121 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 63.9 bits (154), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IG+G FG Y+A++ G +VA+K++ QG E++ + ++ H N+V L +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 866 HVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDE 918
S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 919 CVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM- 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 142 GI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIFG 196
Query: 977 TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 74 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 130
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 131 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 74 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 130
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 131 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 187
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 188 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 54 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 110
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 205
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 58 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 114
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 171
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 72 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 128
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E +
Sbjct: 129 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 185
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 186 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 86 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 63.9 bits (154), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ----MELDHERMSYLLYQMLXGIKHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 144 SAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 1037 L 1037
L
Sbjct: 252 L 252
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 63.9 bits (154), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLS-KPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 207
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 80 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 134
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT 213
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 63.9 bits (154), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 809 IGSGGFGATY----KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G K + + +++ SV + E+ L + HPN++ L
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN-SKLLEEVAVLKLLDHPNIMKLYD 103
Query: 865 YHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ + +L+ GG L ++ I V+ +++ K V + YLH +
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK---QVLSGVTYLHKH---NI 157
Query: 924 LHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+HRD+KP N+LL++ L DFGL+ + + + GT Y+APE + +
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYYIAPE-VLRKKY 214
Query: 981 SDKADVYSFGVVLLELIS 998
+K DV+S GV+L L++
Sbjct: 215 DEKCDVWSIGVILFILLA 232
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 63.9 bits (154), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPEIML 202
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 63.9 bits (154), Expect = 5e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 76 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 131 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFT 209
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPEIML 202
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 63.5 bits (153), Expect = 5e-10, Method: Composition-based stats.
Identities = 56/199 (28%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 809 IGSGGFGATYKAEI-IPGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQH-PNLVTLIGY 865
+GSG G +K G V+AVK++ G + ++ ++ + + P +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
++ ++F+ + G + ++ R + + +L K+ + + +AL YL ++ V+H
Sbjct: 93 FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIH 148
Query: 926 RDIKPSNILLDNNLNAYLSDFGLA-RLLGTSETHATTDVAGTFGYVAPEY-----AMTCR 979
RD+KPSNILLD L DFG++ RL+ + A AG Y+APE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 980 VSDKADVYSFGVVLLELIS 998
+ADV+S G+ L+EL +
Sbjct: 206 YDIRADVWSLGISLVELAT 224
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In
Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++AG T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating
Mutant
Length = 367
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTADEMTGYVATRWYRAPEIML 202
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++AG T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 63.5 bits (153), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 207
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 100
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 155
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 156 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 207
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 208 NWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With
An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex With
An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNL 859
+ + IG+G +G A + G VA+K++ + ++ E++ L +H N+
Sbjct: 57 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 860 VTL---IGYHVSEAEMFLIYNYLP--GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+ + + V E +Y L +L + I T+E + + R L Y
Sbjct: 117 IAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE--HVRYFLYQLLRGLKY 174
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS---ETHATTDVAGTFGYVA 971
+H +V+HRD+KPSN+L++ N + DFG+AR L TS + T+ T Y A
Sbjct: 175 MHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 972 PEYAMTCRVSDKA-DVYSFGVVLLELISDKK 1001
PE ++ +A D++S G + E+++ ++
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 80 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 134
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 135 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFT 213
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 155 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 206
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 146 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 197
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 TC-RVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 9/200 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLV 860
+++ +G G +G A + VAVK + + R + EI + H N+V
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G+ +L Y GG L F + P + + + + YLH +
Sbjct: 69 KFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCR 979
HRDIKP N+LLD N +SDFGLA + + + GT YVAPE
Sbjct: 127 ---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 980 V-SDKADVYSFGVVLLELIS 998
++ DV+S G+VL +++
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA 203
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 809 IGSGGFGATYKAEI-IPG---VVVAVKRLS---VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG + E P V VAVK L + + + + F E+ + + H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRT---VEWSMLHKIALDVARALAYLHDE 918
L G V M ++ P G+L DR R+ L + A+ VA + YL +
Sbjct: 86 LYGV-VLTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT--FGYVAPEYAM 976
R +HRD+ N+LL + DFGL R L ++ H F + APE
Sbjct: 141 ---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
T S +D + FGV L E+ +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFT 219
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 146 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 197
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 21/202 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT-C 978
++HRD+KPSN+ ++ + + DFGLAR ++ T VA T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGXVA-TRWYRAPEIMLNWM 198
Query: 979 RVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide Substituted
Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 64/240 (26%), Positives = 107/240 (44%), Gaps = 35/240 (14%)
Query: 786 NIGVQLTYENVVRATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQF 844
++G + Y + + G+ V+ IG G + + + AVK + + +
Sbjct: 12 DLGTENLYFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK----RDP 67
Query: 845 AAEIRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPGGNL------EKFIQDRPRRTVE 897
+ EI L R QHPN++TL + ++L+ + GG L +KF +R V
Sbjct: 68 SEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV- 126
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL-LDNNLNA---YLSDFGLARLLG 953
LH I + + YLH + V +HRD+KPSNIL +D + N + DFG A+ L
Sbjct: 127 ---LHTIG----KTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQL- 175
Query: 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG 1013
+E T +VAPE + D++S G++L +++ + F NG
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA-------GYTPFANG 228
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 9/200 (4%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLV 860
+++ +G G +G A + VAVK + + R + EI + H N+V
Sbjct: 8 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
G+ +L Y GG L F + P + + + + YLH +
Sbjct: 68 KFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCR 979
HRDIKP N+LLD N +SDFGLA + + + GT YVAPE
Sbjct: 126 ---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 980 V-SDKADVYSFGVVLLELIS 998
++ DV+S G+VL +++
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA 202
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino Quinoline
Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 797 VRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ 855
+R + F +G G FG KA + A+K++ + + +E+ L +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLN 60
Query: 856 HP-------------NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWS 899
H N V + ++ +F+ Y G L I +R W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--------- 950
+ +I AL+Y+H + ++HRD+KP NI +D + N + DFGLA+
Sbjct: 121 LFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 951 ------LLGTSETHATTDVAGTFGYVAPEYA-MTCRVSDKADVYSFGVVLLELI 997
L G+S+ T GT YVA E T ++K D+YS G++ E+I
Sbjct: 174 KLDSQNLPGSSDN--LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 50 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 215
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 146 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 197
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 167 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPEIML 218
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydropyrido-
Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 95 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 201
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 149 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 200
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 87
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 88 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 142
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 143 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 194
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 195 NWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 111
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 166
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 167 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 218
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 150
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 151 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 202
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 162
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 163 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 214
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 63.5 bits (153), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAG----------FNVQNCIGSGGFGA 816
SC + P V + G ++T V AT G + IG+G FG
Sbjct: 13 SCKPVQQPSAFGSMKVSRDKDGSKVT---TVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 69
Query: 817 TYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--- 871
Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L + S E
Sbjct: 70 VYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKD 124
Query: 872 ---MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ L+ +Y+P R ++T+ + + R+LAY+H + HRD
Sbjct: 125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 181
Query: 928 IKPSNILLDNNLNA-YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
IKP N+LLD + L DFG A+ L E + + + + Y APE + D
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-YRAPELIFGATDYTSSID 239
Query: 986 VYSFGVVLLELI 997
V+S G VL EL+
Sbjct: 240 VWSAGCVLAELL 251
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 63.5 bits (153), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 149 -ADIIHRDLKPSNLAVNEDXELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 200
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2-
Carboxamide Inhibitor
Length = 371
Score = 63.5 bits (153), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 99
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 154
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 155 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 206
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 207 NWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 63.5 bits (153), Expect = 7e-10, Method: Composition-based stats.
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F IG+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG++ + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 63.5 bits (153), Expect = 7e-10, Method: Composition-based stats.
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F IG+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG++ + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVV--AVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLV 860
+ ++N IG G +G K + G + A K++ + V +F EI + + HPN++
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
L +++L+ GG L E+ + R R + + + K DV A+AY H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK---DVLSAVAYCHKL- 125
Query: 920 VPRVLHRDIKPSNILL-----DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
V HRD+KP N L D+ L L DFGLA + T GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTK--VGTPYYVSPQ- 178
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
+ + D +S GV++ L+
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLL 201
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 86
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 87 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 141
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 142 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 193
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 86 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 140
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 141 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 192
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 93
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 94 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 148
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 149 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 200
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 201 NWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule
Inhibitor
Length = 349
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 85
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 86 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 140
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 141 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 192
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 193 NWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 797 VRATAGFNVQNCIGSGGFGATYK-AEIIPG-----VVVAVKRLSVGRFQGVQQFAAEIRT 850
R T + + +G G F + +++ G +++ K+LS Q +++ E R
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARI 63
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
++HPN+V L E +LI++ + GG L + I R + E H I +
Sbjct: 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS-EADASHCIQ-QILE 121
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLN---AYLSDFGLARLLGTSETHATTDVAGTF 967
A+ + H V+HR++KP N+LL + L L+DFGLA + E A AGT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTP 177
Query: 968 GYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
GY++PE D+++ GV+L L+
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILL 207
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 809 IGSGGFGATYKAEIIPG-------VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG +K IP V + V GR Q Q + +G + H ++V
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 79
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G + + L+ YLP G+L ++ R + +L + +A+ + YL +
Sbjct: 80 LLGL-CPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH--- 134
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRV 980
++HR++ N+LL + ++DFG+A LL + A T ++A E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 981 SDKADVYSFGVVLLELIS 998
+ ++DV+S+GV + EL++
Sbjct: 195 THQSDVWSYGVTVWELMT 212
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAG----------FNVQNCIGSGGFGA 816
SC + P V + G ++T V AT G + IG+G FG
Sbjct: 17 SCKPVQQPSAFGSMKVSRDKDGSKVT---TVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 73
Query: 817 TYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--- 871
Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L + S E
Sbjct: 74 VYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKD 128
Query: 872 ---MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ L+ +Y+P R ++T+ + + R+LAY+H + HRD
Sbjct: 129 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 185
Query: 928 IKPSNILLDNNLNA-YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
IKP N+LLD + L DFG A+ L E + + + + Y APE + D
Sbjct: 186 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIFGATDYTSSID 243
Query: 986 VYSFGVVLLELI 997
V+S G VL EL+
Sbjct: 244 VWSAGCVLAELL 255
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 191
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++AG T Y APE +
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWYRAPEIML 191
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 809 IGSGGFGATYKAEIIPGVV-VAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y + V +A+K + + Q EI ++H N+V +G
Sbjct: 16 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ + +PGG+L ++ + P + E ++ + L YLHD +++H
Sbjct: 76 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILEGLKYLHDN---QIVH 131
Query: 926 RDIKPSNILLDNNLNAY-LSDFGLA-RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
RDIK N+L++ +SDFG + RL G + T GT Y+APE + DK
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPE------IIDK 183
Query: 984 --------ADVYSFGVVLLELISDKKALDPSFCSFG 1011
AD++S G ++E+ + K P F G
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGK----PPFYELG 215
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAG----------FNVQNCIGSGGFGA 816
SC + P V + G ++T V AT G + IG+G FG
Sbjct: 15 SCKPVQQPSAFGSMKVSRDKDGSKVT---TVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 71
Query: 817 TYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--- 871
Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L + S E
Sbjct: 72 VYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKD 126
Query: 872 ---MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ L+ +Y+P R ++T+ + + R+LAY+H + HRD
Sbjct: 127 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 183
Query: 928 IKPSNILLDNNLNA-YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
IKP N+LLD + L DFG A+ L E + + + + Y APE + D
Sbjct: 184 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIFGATDYTSSID 241
Query: 986 VYSFGVVLLELI 997
V+S G VL EL+
Sbjct: 242 VWSAGCVLAELL 253
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase
5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase
5
Length = 295
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 809 IGSGGFGATYKAEIIPGVV-VAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G +G Y + V +A+K + + Q EI ++H N+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDR--PRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ + +PGG+L ++ + P + E ++ + L YLHD +++H
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILEGLKYLHDN---QIVH 145
Query: 926 RDIKPSNILLDNNLNAY-LSDFGLA-RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
RDIK N+L++ +SDFG + RL G + T GT Y+APE + DK
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPE------IIDK 197
Query: 984 --------ADVYSFGVVLLELISDKKALDPSFCSFG 1011
AD++S G ++E+ + K P F G
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK----PPFYELG 229
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 63.2 bits (152), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 90
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 91 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 145
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 146 -ADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 197
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 198 NWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 63.2 bits (152), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 95 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 150 -ADIIHRDLKPSNLAVNEDSELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 201
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine Based
Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 95 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 201
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 62.8 bits (151), Expect = 9e-10, Method: Composition-based stats.
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRL-SVGRFQGVQQFAAEIRTLGR-VQHPNLVTLIGY 865
+G G +G K +P G + AVKR+ + Q ++ ++ R V P VT G
Sbjct: 42 LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQD--RPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
E ++++ L +L+KF + +T+ +L KIA+ + +AL +LH + V
Sbjct: 102 LFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 158
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV--- 980
+HRD+KPSN+L++ DFG++ L + D AG Y APE R+
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKDID-AGCKPYXAPE-----RINPE 211
Query: 981 ------SDKADVYSFGVVLLEL 996
S K+D++S G+ +EL
Sbjct: 212 LNQKGYSVKSDIWSLGITXIEL 233
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAG----------FNVQNCIGSGGFGA 816
SC + P V + G ++T V AT G + IG+G FG
Sbjct: 13 SCKPVQQPSAFGSMKVSRDKDGSKVT---TVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 69
Query: 817 TYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--- 871
Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L + S E
Sbjct: 70 VYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKD 124
Query: 872 ---MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ L+ +Y+P R ++T+ + + R+LAY+H + HRD
Sbjct: 125 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 181
Query: 928 IKPSNILLDNNLNA-YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
IKP N+LLD + L DFG A+ L E + + + + Y APE + D
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIFGATDYTSSID 239
Query: 986 VYSFGVVLLELI 997
V+S G VL EL+
Sbjct: 240 VWSAGCVLAELL 251
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 80
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 141 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIF 195
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELL 217
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 62.8 bits (151), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAG----------FNVQNCIGSGGFGA 816
SC + P V + G ++T V AT G + IG+G FG
Sbjct: 58 SCKPVQQPSAFGSMKVSRDKDGSKVT---TVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 114
Query: 817 TYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--- 871
Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L + S E
Sbjct: 115 VYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKD 169
Query: 872 ---MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ L+ +Y+P R ++T+ + + R+LAY+H + HRD
Sbjct: 170 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 226
Query: 928 IKPSNILLDNNLNA-YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
IKP N+LLD + L DFG A+ L E + + + + Y APE + D
Sbjct: 227 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIFGATDYTSSID 284
Query: 986 VYSFGVVLLELI 997
V+S G VL EL+
Sbjct: 285 VWSAGCVLAELL 296
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 62.8 bits (151), Expect = 9e-10, Method: Composition-based stats.
Identities = 52/198 (26%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 809 IGSGGFGATYKAEIIPG-------VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+GSG FG +K IP V + V GR Q Q + +G + H ++V
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 97
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L+G + + L+ YLP G+L ++ R + +L + +A+ + YL +
Sbjct: 98 LLGL-CPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH--- 152
Query: 922 RVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRV 980
++HR++ N+LL + ++DFG+A LL + A T ++A E +
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 981 SDKADVYSFGVVLLELIS 998
+ ++DV+S+GV + EL++
Sbjct: 213 THQSDVWSYGVTVWELMT 230
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 70/252 (27%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 767 SCNSIADPGLVRKEVVICNNIGVQLTYENVVRATAG----------FNVQNCIGSGGFGA 816
SC + P V + G ++T V AT G + IG+G FG
Sbjct: 7 SCKPVQQPSAFGSMKVSRDKDGSKVT---TVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 63
Query: 817 TYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAE--- 871
Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L + S E
Sbjct: 64 VYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSSGEKKD 118
Query: 872 ---MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ L+ +Y+P R ++T+ + + R+LAY+H + HRD
Sbjct: 119 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRD 175
Query: 928 IKPSNILLDNNLNA-YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM-TCRVSDKAD 985
IKP N+LLD + L DFG A+ L E + + + + Y APE + D
Sbjct: 176 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIFGATDYTSSID 233
Query: 986 VYSFGVVLLELI 997
V+S G VL EL+
Sbjct: 234 VWSAGCVLAELL 245
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 80
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 81 FFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 141 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIF 195
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELL 217
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 31/229 (13%)
Query: 783 ICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATY---KAEIIPGVVVAVKRLSVGRFQ 839
C V+L N+ F+V IG GGFG Y KA+ G + A+K L R +
Sbjct: 174 FCQWKNVEL---NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIK 228
Query: 840 GVQQFAAEIRTLGRVQHPNLVTL----------IGYHVSEAEMFLIYNYLPGGNLEKFIQ 889
Q E L +LV+ +H + F++ + + GG+L +
Sbjct: 229 MKQ---GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLS 284
Query: 890 DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949
+ + A ++ L ++H+ V ++RD+KP+NILLD + + +SD GLA
Sbjct: 285 QHG--VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA 339
Query: 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD-KADVYSFGVVLLELI 997
+ HA+ GT GY+APE D AD +S G +L +L+
Sbjct: 340 CDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 783 ICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATY---KAEIIPGVVVAVKRLSVGRF- 838
C V+L N+ F+V IG GGFG Y KA+ G + A+K L R
Sbjct: 174 FCQWKNVEL---NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIK 228
Query: 839 --QGVQQFAAEIRTLGRVQH---PNLVTL-IGYHVSEAEMFLIYNYLPGGNLEKFIQDRP 892
QG E L V P +V + +H + F++ + + GG+L +
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG 287
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+ + A ++ L ++H+ V ++RD+KP+NILLD + + +SD GLA
Sbjct: 288 --VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSD-KADVYSFGVVLLELI 997
+ HA+ GT GY+APE D AD +S G +L +L+
Sbjct: 343 SKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 783 ICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATY---KAEIIPGVVVAVKRLSVGRF- 838
C V+L N+ F+V IG GGFG Y KA+ G + A+K L R
Sbjct: 174 FCQWKNVEL---NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIK 228
Query: 839 --QGVQQFAAEIRTLGRVQH---PNLVTL-IGYHVSEAEMFLIYNYLPGGNLEKFIQDRP 892
QG E L V P +V + +H + F++ + + GG+L +
Sbjct: 229 MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHG 287
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+ + A ++ L ++H+ V ++RD+KP+NILLD + + +SD GLA
Sbjct: 288 --VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSD-KADVYSFGVVLLELI 997
+ HA+ GT GY+APE D AD +S G +L +L+
Sbjct: 343 SKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 38 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 92
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 93 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 153 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-YRAPELIF 207
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELL 229
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 62.8 bits (151), Expect = 1e-09, Method: Composition-based stats.
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
+ AE + ++ +P +V +IG +E+ M L+ G L K++Q R V+ +
Sbjct: 58 ELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQN--RHVKDKNII 114
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
++ V+ + YL + +HRD+ N+LL A +SDFGL++ L E
Sbjct: 115 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQ 171
Query: 963 VAGTF--GYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
G + + APE + S K+DV+SFGV++ E S
Sbjct: 172 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 45 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 99
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 159
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 160 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-YRAPELIF 214
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 215 GATDYTSSIDVWSAGCVLAELL 236
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 80
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 141 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIF 195
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELL 217
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 34 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 88
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 89 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 148
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 149 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-YRAPELIF 203
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 204 GATDYTSSIDVWSAGCVLAELL 225
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IG+G FG Y+A++ G +VA+K++ QG E++ + ++ H N+V L +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 866 HVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDE 918
S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 919 CVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM- 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 142 GI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAPELIFG 196
Query: 977 TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 27 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 81
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 82 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 141
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 142 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIF 196
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 197 GATDYTSSIDVWSAGCVLAELL 218
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IG+G FG Y+A++ G +VA+K++ QG E++ + ++ H N+V L +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYF 81
Query: 866 HVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHDE 918
S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 919 CVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM- 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 142 GI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAPELIFG 196
Query: 977 TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELL 217
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 31/229 (13%)
Query: 783 ICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATY---KAEIIPGVVVAVKRLSVGRFQ 839
C V+L N+ F+V IG GGFG Y KA+ G + A+K L R +
Sbjct: 173 FCQWKNVEL---NIHLTMNDFSVHRIIGRGGFGEVYGCRKADT--GKMYAMKCLDKKRIK 227
Query: 840 GVQQFAAEIRTLGRVQHPNLVTL----------IGYHVSEAEMFLIYNYLPGGNLEKFIQ 889
Q E L +LV+ +H + F++ + + GG+L +
Sbjct: 228 MKQ---GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLS 283
Query: 890 DRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949
+ + A ++ L ++H+ V ++RD+KP+NILLD + + +SD GLA
Sbjct: 284 QHG--VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLA 338
Query: 950 RLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD-KADVYSFGVVLLELI 997
+ HA+ GT GY+APE D AD +S G +L +L+
Sbjct: 339 CDFSKKKPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 38 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 92
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 93 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 152
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 153 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX-ICSRY-YRAPELIF 207
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELL 229
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ----MELDHERMSYLLYQMLXGIKHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 144 SAGI---IHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 1037 L 1037
L
Sbjct: 252 L 252
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 30 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 84
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 85 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 145 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YRAPELIF 199
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 200 GATDYTSSIDVWSAGCVLAELL 221
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 803 FNVQNCIGSGGFGATYKAEI-IPGVVVAVKRL--SVGRFQGVQQFAAEIRTLGRVQHPNL 859
+ + IG+G +G A + G VA+K++ + ++ E++ L +H N+
Sbjct: 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 860 VTL---IGYHVSEAEMFLIYNYLP--GGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+ + + V E +Y L +L + I T+E + + R L Y
Sbjct: 116 IAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE--HVRYFLYQLLRGLKY 173
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTS---ETHATTDVAGTFGYVA 971
+H +V+HRD+KPSN+L++ N + DFG+AR L TS + T+ T Y A
Sbjct: 174 MHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 972 PEYAMTCRVSDKA-DVYSFGVVLLELISDKK 1001
PE ++ +A D++S G + E+++ ++
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 62/224 (27%), Positives = 100/224 (44%), Gaps = 35/224 (15%)
Query: 802 GFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV-QHPNL 859
G+ V+ IG G + + + AVK + + + + EI L R QHPN+
Sbjct: 28 GYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK----RDPSEEIEILLRYGQHPNI 83
Query: 860 VTLIGYHVSEAEMFLIYNYLPGGNL------EKFIQDRPRRTVEWSMLHKIALDVARALA 913
+TL + ++L+ + GG L +KF +R V LH I + +
Sbjct: 84 ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV----LHTIG----KTVE 135
Query: 914 YLHDECVPRVLHRDIKPSNIL-LDNNLNA---YLSDFGLARLLGTSETHATTDVAGTFGY 969
YLH + V +HRD+KPSNIL +D + N + DFG A+ L +E T +
Sbjct: 136 YLHSQGV---VHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCYTANF 191
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG 1013
VAPE + D++S G++L +++ + F NG
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLA-------GYTPFANG 228
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSV-GRFQGVQQFA-AEIRTLGRVQHPNLVTLIGY 865
+G G +G YKA + + VA+KR+ + +GV A E+ L +QH N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
+ LI+ Y +L+K++ P V ++ + + + H R LH
Sbjct: 102 IHHNHRLHLIFEY-AENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLH 155
Query: 926 RDIKPSNILL---DNNLNAYLS--DFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR- 979
RD+KP N+LL D + L DFGLAR G T ++ T Y PE + R
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRH 214
Query: 980 VSDKADVYSFGVVLLELI 997
S D++S + E++
Sbjct: 215 YSTSVDIWSIACIWAEML 232
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 39 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 93
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 94 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 153
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 154 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIF 208
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 209 GATDYTSSIDVWSAGCVLAELL 230
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 30/201 (14%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIAL 906
EI L R+ HPN++ L + E+ L+ + GG L I ++ + + A
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYS------ERDAA 151
Query: 907 DVAR----ALAYLHDECVPRVLHRDIKPSNILLDN---NLNAYLSDFGLARLLGTSETHA 959
D + A+AYLH+ ++HRD+KP N+L + ++DFGL++++
Sbjct: 152 DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 960 TTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAW 1019
T V GT GY APE C + D++S G++ L+ +P + G+ F
Sbjct: 209 T--VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC---GFEPFYDERGDQF----- 258
Query: 1020 ASMLLLQGRPCE-FFTAGLWD 1039
+ + CE +F + WD
Sbjct: 259 ---MFRRILNCEYYFISPWWD 276
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With A
Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQ---KLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGL R H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDSELKILDFGLCR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 80
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + Y APE
Sbjct: 141 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAPELIF 195
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELL 217
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ + ++ G+ +AVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 117
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 172
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 173 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 224
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 225 NWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F IG+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 807 NCIGSGGFGATYKAEII-PGVVVAVKR-LSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
IG+G FG Y+A++ G +VA+K+ L RF+ E++ + ++ H N+V L
Sbjct: 31 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----RELQIMRKLDHCNIVRLRY 85
Query: 865 YHVSEAE------MFLIYNYLPGGNLEKFIQ-DRPRRTVEWSMLHKIALDVARALAYLHD 917
+ S E + L+ +Y+P R ++T+ + + R+LAY+H
Sbjct: 86 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 145
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ HRDIKP N+LLD + L DFG A+ L E + + + + Y APE
Sbjct: 146 FGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRY-YRAPELIF 200
Query: 977 -TCRVSDKADVYSFGVVLLELI 997
+ DV+S G VL EL+
Sbjct: 201 GATDYTSSIDVWSAGCVLAELL 222
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 16 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 75
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 76 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 131
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA-RLLGTSETHATTD 962
A + YLH +++RD+KP N+L+D ++DFG A R+ G + T
Sbjct: 132 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 183
Query: 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
+ GT Y+APE ++ + D ++ GV++ E+
Sbjct: 184 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 217
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 22/214 (10%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 31 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 90
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 146
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA-RLLGTSETHATTD 962
A + YLH +++RD+KP N+L+D ++DFG A R+ G + T
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----- 198
Query: 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
+ GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 17/217 (7%)
Query: 788 GVQLTYENV-VRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKR-LSVGRFQGVQQF 844
GV L EN+ ++ + +G G +G K G +VA+K+ L + V++
Sbjct: 11 GVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI 70
Query: 845 AA-EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPG---GNLEKFIQDRPRRTVEWSM 900
A EI+ L +++H NLV L+ + +L++ ++ +LE F +++ +
Sbjct: 71 AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQV 125
Query: 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960
+ K + + + H ++HRDIKP NIL+ + L DFG AR L +
Sbjct: 126 VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVY 181
Query: 961 TDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLEL 996
D T Y APE + + DV++ G ++ E+
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 107
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 162
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 163 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 214
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 215 NWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + D+GLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDYGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking
Partner
Length = 380
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 215
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 99 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 153
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 154 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 205
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 206 NWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 108
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 163
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 164 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEIML 215
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking
Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking
Site On Its Activator Mkk3b
Length = 360
Score = 61.6 bits (148), Expect = 2e-09, Method: Composition-based stats.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 61.6 bits (148), Expect = 2e-09, Method: Composition-based stats.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 191
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 61.6 bits (148), Expect = 3e-09, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 31 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 90
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 146
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 61.6 bits (148), Expect = 3e-09, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 61.6 bits (148), Expect = 3e-09, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 61.6 bits (148), Expect = 3e-09, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 61.6 bits (148), Expect = 3e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 95 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 149
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 150 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 201
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F +G G FG V+ VK + GR+ ++ E+
Sbjct: 153 FEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 202
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 203 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI 260
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH E V++RD+K N++LD + + ++DFGL + G + GT
Sbjct: 261 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 317
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 318 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 346
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F +G G FG V+ VK + GR+ ++ E+
Sbjct: 150 FEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI 257
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH E V++RD+K N++LD + + ++DFGL + G + GT
Sbjct: 258 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPE 314
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 35/237 (14%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAE 847
VQ + N ++ T G+ V+ IG G + + AVK + + + E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE----E 65
Query: 848 IRTLGRV-QHPNLVTLIGYHVSEAEMFLIYNYLPGGNL------EKFIQDRPRRTVEWSM 900
I L R QHPN++TL + ++++ GG L +KF +R V ++
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT- 124
Query: 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNIL-LDNNLNA---YLSDFGLARLLGTSE 956
+ + + YLH + V+HRD+KPSNIL +D + N + DFG A+ L +E
Sbjct: 125 -------ITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAE 173
Query: 957 THATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNG 1013
T +VAPE D++S GV+L ++ + F NG
Sbjct: 174 NGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLT-------GYTPFANG 223
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 64 FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+PGG + + RR +S H A + YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 232
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ + D ++ GV++ E+ +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAA 254
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 43/158 (27%), Positives = 83/158 (52%), Gaps = 12/158 (7%)
Query: 841 VQQFAAEIRTLGRVQHPNLVTLIGY--HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEW 898
++Q EI L ++ HPN+V L+ +E +++++ + G + + +P +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139
Query: 899 SMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETH 958
+ D+ + + YLH + +++HRDIKPSN+L+ + + ++DFG++ S+
Sbjct: 140 RFYFQ---DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA- 192
Query: 959 ATTDVAGTFGYVAPEYAMTCR--VSDKA-DVYSFGVVL 993
++ GT ++APE R S KA DV++ GV L
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/227 (22%), Positives = 106/227 (46%), Gaps = 21/227 (9%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATY----KAEIIPGVVVAVK--RLSVGRFQGVQ 842
+Q E+VV + +G G FG+ K E + VAVK +L + ++
Sbjct: 22 LQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE 81
Query: 843 QFAAEIRTLGRVQHPNLVTLIGYHVSEAEM-----FLIYNYLPGGNLEKFI-----QDRP 892
+F +E + HPN++ L+G + + +I ++ G+L ++ + P
Sbjct: 82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 893 RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+ + L K +D+A + YL + LHRD+ N +L +++ ++DFGL++ +
Sbjct: 142 KH-IPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKI 197
Query: 953 GTSETHATTDVAGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ + + +A ++A E + K+DV++FGV + E+ +
Sbjct: 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 56/195 (28%), Positives = 86/195 (44%), Gaps = 14/195 (7%)
Query: 809 IGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYH 866
+G G F K AVK +S R + Q EI L + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ FL+ L GG L F + + ++ + I + A++++HD V+HR
Sbjct: 76 HDQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHR 130
Query: 927 DIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK 983
D+KP N+L ++NL + DFG ARL + T Y APE +
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189
Query: 984 ADVYSFGVVLLELIS 998
D++S GV+L ++S
Sbjct: 190 CDLWSLGVILYTMLS 204
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 60.8 bits (146), Expect = 3e-09, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFGLA+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 60.8 bits (146), Expect = 4e-09, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFGLA+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 60.8 bits (146), Expect = 4e-09, Method: Composition-based stats.
Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 844 FAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKF-----IQDRPRRT-VE 897
F E++ + +++ +T G + E+++IY Y+ ++ KF + D+ +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
++ I V + +Y+H+E + HRD+KPSNIL+D N LSDFG + + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 958 HATTDVAGTFGYVAPEY--AMTCRVSDKADVYSFGVVL 993
+ GT+ ++ PE+ + K D++S G+ L
Sbjct: 208 KGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 181
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 182 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 236
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEFMKK 289
Query: 1037 L 1037
L
Sbjct: 290 L 290
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 26/227 (11%)
Query: 788 GVQLTYENV--------VRATAGFNVQNCIGSGGFGATYK------AEIIPGVVVAVKRL 833
GV L EN+ R T + + +G G F + + ++ K+L
Sbjct: 10 GVDLGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL 69
Query: 834 SVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR 893
S Q +++ E R ++HPN+V L E +L+++ + GG L + I R
Sbjct: 70 SARDHQKLER---EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY 126
Query: 894 RTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLAR 950
+ E H I + ++ ++H ++HRD+KP N+LL + L+DFGLA
Sbjct: 127 YS-EADASHCIH-QILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA- 180
Query: 951 LLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
+ E A AGT GY++PE D+++ GV+L L+
Sbjct: 181 IEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILL 227
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A 1-O-Tolyl-1,2,
3-Triazole-4-Carboxamide
Length = 348
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + R L Y+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CAKLTDDHVQFLIYQILRGLKYIHS-- 139
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR H ++ G T Y APE +
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATRWYRAPEIML 191
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 9/199 (4%)
Query: 803 FNVQNCIGSGGFGATYK-AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+++ +GSG FG ++ E G V K ++ EI + ++ HP L+
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
L + EM LI +L GG L I + E +++ + L ++H+
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR-QACEGLKHMHEHS-- 169
Query: 922 RVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++H DIKP NI+ + + + DFGLA L E T F APE
Sbjct: 170 -IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA--APEIVDREP 226
Query: 980 VSDKADVYSFGVVLLELIS 998
V D+++ GV+ L+S
Sbjct: 227 VGFYTDMWAIGVLGYVLLS 245
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFA 845
+EN + TA F +G+G FG +K + + + V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFA 845
+EN + TA F +G+G FG +K + + + V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFA 845
+EN + TA F +G+G FG +K + + + V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 17/202 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 64 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + AT + GT Y+APE +
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPEIIL 232
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ + D ++ GV++ E+ +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAA 254
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 73 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 127
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 187
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 188 DVWSCGIVLTAMLAGELPWDQPS 210
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1
Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human Chk1
Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint Kinase
1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint Kinase
1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 75 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 129
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPV 189
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 190 DVWSCGIVLTAMLAGELPWDQPS 212
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A 1-Aryl-3,4-
Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of Jnk
Length = 364
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 144 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 1037 L 1037
L
Sbjct: 252 L 252
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK----RLSVGRFQGV--QQFAAEIRTLGRVQ 855
+++ +GSG F K E G+ A K R S +GV ++ E+ L +V
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAY 914
H N++TL + + ++ LI + GG L F+ Q E + K LD + Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 915 LHDECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LH + ++ H D+KP NI LLD N+ + L DFGLA + + ++ GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +AD++S GV+ L+S
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment Of
Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment Of
Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 90 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 144
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 199
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 1037 L 1037
L
Sbjct: 253 L 253
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK----RLSVGRFQGV--QQFAAEIRTLGRVQ 855
+++ +GSG F K E G+ A K R S +GV ++ E+ L +V
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAY 914
H N++TL + + ++ LI + GG L F+ Q E + K LD + Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 915 LHDECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LH + ++ H D+KP NI LLD N+ + L DFGLA + + ++ GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +AD++S GV+ L+S
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK----RLSVGRFQGV--QQFAAEIRTLGRVQ 855
+++ +GSG F K E G+ A K R S +GV ++ E+ L +V
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAY 914
H N++TL + + ++ LI + GG L F+ Q E + K LD + Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 915 LHDECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LH + ++ H D+KP NI LLD N+ + L DFGLA + + ++ GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +AD++S GV+ L+S
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK----RLSVGRFQGV--QQFAAEIRTLGRVQ 855
+++ +GSG F K E G+ A K R S +GV ++ E+ L +V
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAY 914
H N++TL + + ++ LI + GG L F+ Q E + K LD + Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 915 LHDECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LH + ++ H D+KP NI LLD N+ + L DFGLA + + ++ GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +AD++S GV+ L+S
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVK----RLSVGRFQGV--QQFAAEIRTLGRVQ 855
+++ +GSG F K E G+ A K R S +GV ++ E+ L +V
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFI-QDRPRRTVEWSMLHKIALDVARALAY 914
H N++TL + + ++ LI + GG L F+ Q E + K LD + Y
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---GVNY 130
Query: 915 LHDECVPRVLHRDIKPSNI-LLDNNL---NAYLSDFGLARLLGTSETHATTDVAGTFGYV 970
LH + ++ H D+KP NI LLD N+ + L DFGLA + + ++ GT +V
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +AD++S GV+ L+S
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLS 213
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp
Length = 423
Score = 60.5 bits (145), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 126
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 127 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 181
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 182 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 236
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 1037 L 1037
L
Sbjct: 290 L 290
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 60.5 bits (145), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQH 856
+ + IG G F + G AVK + V +F + E ++H
Sbjct: 28 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAY 914
P++V L+ + S+ +++++ ++ G +L I R +S + + AL Y
Sbjct: 88 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 915 LHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
HD ++HRD+KP +LL +N+ L FG+A LG S A V GT ++A
Sbjct: 148 CHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMA 203
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELIS 998
PE DV+ GV+L L+S
Sbjct: 204 PEVVKREPYGKPVDVWGCGVILFILLS 230
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 60.5 bits (145), Expect = 6e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 60.5 bits (145), Expect = 6e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 60.1 bits (144), Expect = 6e-09, Method: Composition-based stats.
Identities = 58/203 (28%), Positives = 87/203 (42%), Gaps = 10/203 (4%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGR-FQGVQQFAAEIRTLGRVQHPNLVTLIGYH 866
+G G +G A + VAVK + + R + EI + H N+V G+
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+L Y GG L F + P + + + + YLH + HR
Sbjct: 74 REGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHR 128
Query: 927 DIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAPEYAMTCRV-SDKA 984
DIKP N+LLD N +SDFGLA + + + GT YVAPE ++
Sbjct: 129 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPV 188
Query: 985 DVYSFGVVLLELISDKKALD-PS 1006
DV+S G+VL +++ + D PS
Sbjct: 189 DVWSCGIVLTAMLAGELPWDQPS 211
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + FGLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILGFGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole
Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 31 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 87
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 88 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 142
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 143 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 197
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 198 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 1037 L 1037
L
Sbjct: 251 L 251
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 29/204 (14%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAY 914
+ + E + I L NL + IQ D R + +L+++ + + +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY---LLYQMLV----GIKH 141
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH + +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 142 LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 196
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
+ + D++S GV++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIK 220
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 89
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 90 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 144
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 199
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 200 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 1037 L 1037
L
Sbjct: 253 L 253
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 60.1 bits (144), Expect = 6e-09, Method: Composition-based stats.
Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 43/234 (18%)
Query: 797 VRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ 855
+R + F +G G FG KA + A+K++ + + +E+ L +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLN 60
Query: 856 HP-------------NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWS 899
H N V + ++ +F+ Y L I +R W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--------- 950
+ +I AL+Y+H + ++HRD+KP NI +D + N + DFGLA+
Sbjct: 121 LFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 951 ------LLGTSETHATTDVAGTFGYVAPEYA-MTCRVSDKADVYSFGVVLLELI 997
L G+S+ T GT YVA E T ++K D+YS G++ E+I
Sbjct: 174 KLDSQNLPGSSDN--LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 25/202 (12%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IGSG G A + I VA+K+LS FQ ++ E+ + V H N++ L+
Sbjct: 32 IGSGAQGIVVAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 865 Y-----HVSEAEMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYLH 916
+ E + I L NL + IQ D R + +L+++ + + +LH
Sbjct: 91 VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY---LLYQMLV----GIKHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 144 SAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ D++S GV++ E+I
Sbjct: 199 GMGYKENVDIWSVGVIMGEMIK 220
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 60.1 bits (144), Expect = 6e-09, Method: Composition-based stats.
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 14/184 (7%)
Query: 825 GVVVAVKRLSVGRFQG-----VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYL 879
G AVK + V +F + E ++HP++V L+ + S+ +++++ ++
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 880 PGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL-- 935
G +L I R +S + + AL Y HD ++HRD+KP +LL
Sbjct: 109 DGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLAS 165
Query: 936 -DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLL 994
+N+ L FG+A LG S A V GT ++APE DV+ GV+L
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 995 ELIS 998
L+S
Sbjct: 225 ILLS 228
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 60.1 bits (144), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 88
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 143
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 144 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 198
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K F I W ++ G PC F
Sbjct: 199 GMGYKENVDIWSVGCIMGEMVRHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 1037 L 1037
L
Sbjct: 252 L 252
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 60.1 bits (144), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGAT---YKAEIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTL 862
+GSG +G+ Y A + V AVK+LS FQ + ++ E+R L ++H N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQKV--AVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 863 IGYHVSE------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ +E++L+ L G +L ++ + + + + + R L Y+H
Sbjct: 93 LDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKSQ---ALSDEHVQFLVYQLLRGLKYIH 148
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSN+ ++ + + DFGLAR T T Y APE +
Sbjct: 149 SAGI---IHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEIML 201
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL+ K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
562
Length = 301
Score = 60.1 bits (144), Expect = 7e-09, Method: Composition-based stats.
Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF Y+ E+ G VV K + + Q ++ + EI + +P++V
Sbjct: 34 LGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGF 91
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G+ + ++++ +L + + R+ V + + YLH+ R
Sbjct: 92 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 146
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
V+HRD+K N+ L+++++ + DFGLA + + D+ GT Y+APE S
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 983 KADVYSFGVVLLELISDKKALDPS 1006
+ D++S G +L L+ K + S
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETS 229
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 60.1 bits (144), Expect = 7e-09, Method: Composition-based stats.
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALA 913
+ + +++L+ L NL + IQ D R + +L+++ +
Sbjct: 89 LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQMELDHERMSY---LLYQMLC----GIK 140
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 141 HLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 195
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEF 248
Query: 1034 TAGL 1037
L
Sbjct: 249 MKKL 252
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With Compound
094
Length = 317
Score = 60.1 bits (144), Expect = 7e-09, Method: Composition-based stats.
Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF Y+ E+ G VV K + + Q ++ + EI + +P++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGF 107
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G+ + ++++ +L + + R+ V + + YLH+ R
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
V+HRD+K N+ L+++++ + DFGLA + + D+ GT Y+APE S
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 983 KADVYSFGVVLLELISDKKALDPS 1006
+ D++S G +L L+ K + S
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 60.1 bits (144), Expect = 7e-09, Method: Composition-based stats.
Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 32/241 (13%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ + +++L+ L NL + IQ ++ + + + + +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVME-LMDANLXQVIQ----MELDHERMSYLLYQMLXGIKHLH 136
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVIL 191
Query: 977 TCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAG 1036
+ D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEFMKK 244
Query: 1037 L 1037
L
Sbjct: 245 L 245
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 59.7 bits (143), Expect = 8e-09, Method: Composition-based stats.
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 59.7 bits (143), Expect = 8e-09, Method: Composition-based stats.
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + D GLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDAGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 59.7 bits (143), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 40/216 (18%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQ-----FAAEIRTLGRVQHP 857
+ V IG G FG V +L + +F+ +++ F E + P
Sbjct: 76 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL-LSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHK----IALDVARA 911
+V L + ++++ Y+PGG+L + D P + W+ + +ALD +
Sbjct: 135 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALDAIHS 191
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ ++H RD+KP N+LLD + + L+DFG + GT Y++
Sbjct: 192 MGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 972 PE----------YAMTCRVSDKADVYSFGVVLLELI 997
PE Y C D +S GV L E++
Sbjct: 243 PEVLKSQGGDGYYGREC------DWWSVGVFLYEML 272
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y PGG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 59.7 bits (143), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + D GLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDGGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR + H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 59.7 bits (143), Expect = 9e-09, Method: Composition-based stats.
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR + H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 59.7 bits (143), Expect = 1e-08, Method: Composition-based stats.
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 31 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 90
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+PGG + + RR + H
Sbjct: 91 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RRIGRFXEPHARF 146
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 199
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 47/296 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ L + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS-----------------MLHK 903
L+G +I Y G+L F++ R R + S L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ VA+ +A+L + +HRD+ NILL + + DFGLAR + +
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 964 AGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
A ++APE C + ++DV+S+G+ L EL S + P
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---------------- 250
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL-KQI 1077
+ + + + G P EM ++ C RP+ +Q+ Q + KQI
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G+ VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + D GLAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDRGLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase
11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 809 IGSGGFGAT---YKAEIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTL 862
+GSG +G+ Y A + V AVK+LS FQ + ++ E+R L ++H N++ L
Sbjct: 28 VGSGAYGSVCSAYDARLRQKV--AVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 863 IGYHVSE------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ +E++L+ L G +L ++ + + + + + R L Y+H
Sbjct: 85 LDVFTPATSIEDFSEVYLVTT-LMGADLNNIVK---CQALSDEHVQFLVYQLLRGLKYIH 140
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DFGLAR T T Y APE +
Sbjct: 141 S---AGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRAPEIML 193
Query: 977 T-CRVSDKADVYSFGVVLLELISDKKALDP 1005
+ D++S G ++ EL+ KAL P
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQG-KALFP 222
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 48/220 (21%)
Query: 803 FNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGVQQ-----FAAEIRTLGR 853
+ V IG G FG + +++ V A+K LS +F+ +++ F E +
Sbjct: 71 YEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAF 125
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHK----IALD 907
P +V L + ++++ Y+PGG+L + D P + W+ + +ALD
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALD 182
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
++ ++H RD+KP N+LLD + + L+DFG + GT
Sbjct: 183 AIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 968 GYVAPE----------YAMTCRVSDKADVYSFGVVLLELI 997
Y++PE Y C D +S GV L E++
Sbjct: 234 DYISPEVLKSQGGDGYYGREC------DWWSVGVFLYEML 267
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 47/296 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ L + H N+V
Sbjct: 47 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS-----------------MLHK 903
L+G +I Y G+L F++ R R + S L
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ VA+ +A+L + +HRD+ NILL + + DFGLAR + +
Sbjct: 166 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 222
Query: 964 AGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
A ++APE C + ++DV+S+G+ L EL S + P
Sbjct: 223 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---------------- 266
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL-KQI 1077
+ + + + G P EM ++ C RP+ +Q+ Q + KQI
Sbjct: 267 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 322
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 47/296 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ L + H N+V
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS-----------------MLHK 903
L+G +I Y G+L F++ R R + S L
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ VA+ +A+L + +HRD+ NILL + + DFGLAR + +
Sbjct: 173 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGN 229
Query: 964 AGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
A ++APE C + ++DV+S+G+ L EL S + P
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---------------- 273
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL-KQI 1077
+ + + + G P EM ++ C RP+ +Q+ Q + KQI
Sbjct: 274 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 329
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R L V P LV L + ++++ Y+PGG + + RR
Sbjct: 72 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RR 127
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+S H A + YLH +++RD+KP N+L+D ++DFG A+ +
Sbjct: 128 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 185 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R L V P LV L + ++++ Y+PGG + + RR
Sbjct: 80 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RR 135
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+S H A + YLH +++RD+KP N+L+D ++DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 193 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R L V P LV L + ++++ Y+PGG + + RR
Sbjct: 80 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RR 135
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+S H A + YLH +++RD+KP N+L+D ++DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 193 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R L V P LV L + ++++ Y+PGG + + RR
Sbjct: 80 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RR 135
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+S H A + YLH +++RD+KP N+L+D ++DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 193 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 48/220 (21%)
Query: 803 FNVQNCIGSGGFGATYKAEII----PGVVVAVKRLSVGRFQGVQQ-----FAAEIRTLGR 853
+ V IG G FG + +++ V A+K LS +F+ +++ F E +
Sbjct: 76 YEVVKVIGRGAFG---EVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAF 130
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ--DRPRRTVEWSMLHK----IALD 907
P +V L + ++++ Y+PGG+L + D P + W+ + +ALD
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTAEVVLALD 187
Query: 908 VARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTF 967
++ ++H RD+KP N+LLD + + L+DFG + GT
Sbjct: 188 AIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 238
Query: 968 GYVAPE----------YAMTCRVSDKADVYSFGVVLLELI 997
Y++PE Y C D +S GV L E++
Sbjct: 239 DYISPEVLKSQGGDGYYGREC------DWWSVGVFLYEML 272
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 47/156 (30%), Positives = 70/156 (44%), Gaps = 8/156 (5%)
Query: 854 VQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALA 913
+ H N+V G+ +L Y GG L F + P + + + +
Sbjct: 61 LNHENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLG-TSETHATTDVAGTFGYVAP 972
YLH + HRDIKP N+LLD N +SDFGLA + + + GT YVAP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 973 EYAMTCRV-SDKADVYSFGVVLLELISDKKALD-PS 1006
E ++ DV+S G+VL +++ + D PS
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 10 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 59
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 60 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 117
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 118 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 173
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 174 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 202
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 7 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 7 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 170
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 12 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 62 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 119
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 120 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 175
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 204
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 7 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 7 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 30/209 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F+ +G G FG V+ V+ + GR+ ++ E+
Sbjct: 7 FDYLKLLGKGTFGK----------VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 57 RVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEI 114
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH V++RDIK N++LD + + ++DFGL + G S+ GT
Sbjct: 115 VSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPE 170
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 47/296 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ L + H N+V
Sbjct: 49 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS-----------------MLHK 903
L+G +I Y G+L F++ R R + S L
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ VA+ +A+L + +HRD+ NILL + + DFGLAR + +
Sbjct: 168 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 224
Query: 964 AGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
A ++APE C + ++DV+S+G+ L EL S + P
Sbjct: 225 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---------------- 268
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL-KQI 1077
+ + + + G P EM ++ C RP+ +Q+ Q + KQI
Sbjct: 269 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 324
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 31/233 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV 854
N+ +G G FG +A+ G+ VAVK L G + +E++ L +
Sbjct: 29 LNLGKPLGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 855 -QHPNLVTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--------- 903
H N+V L+G + +I + GNL +++ + V + L+K
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 904 -IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT- 961
+ VA+ + +L + +HRD+ NILL + DFGLAR + +
Sbjct: 148 CYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
D ++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 257
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 25/217 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV 854
N+ +G G FG +A+ G+ VAVK L G + +E++ L +
Sbjct: 29 LNLGKPLGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHI 87
Query: 855 -QHPNLVTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--------- 903
H N+V L+G + +I + GNL +++ + V + L+K
Sbjct: 88 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 904 -IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT- 961
+ VA+ + +L + +HRD+ NILL + DFGLAR + +
Sbjct: 148 XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 962 DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
D ++APE + ++DV+SFGV+L E+ S
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 31/235 (13%)
Query: 786 NIGVQLTYENVVRATAGFNVQNC-IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQF 844
+ V+L+ E R F + C +G G +G YKA+ G L G+
Sbjct: 6 DFKVKLSSERE-RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS 64
Query: 845 AA-EIRTLGRVQHPNLVTLIGYHVSEAE--MFLIYNYLPGG--NLEKFIQ---------D 890
A EI L ++HPN+++L +S A+ ++L+++Y ++ KF +
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQ 124
Query: 891 RPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILL----DNNLNAYLSDF 946
PR V+ S+L++I LD + YLH V LHRD+KP+NIL+ ++D
Sbjct: 125 LPRGMVK-SLLYQI-LD---GIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADM 176
Query: 947 GLARLLGTS-ETHATTD-VAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLELIS 998
G ARL + + A D V TF Y APE + R KA D+++ G + EL++
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 69/296 (23%), Positives = 115/296 (38%), Gaps = 47/296 (15%)
Query: 809 IGSGGFGATYKAEII------PGVVVAVKRLS-VGRFQGVQQFAAEIRTLGRV-QHPNLV 860
+G+G FG +A + VAVK L + +E++ L + H N+V
Sbjct: 54 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS-----------------MLHK 903
L+G +I Y G+L F++ R R + S L
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
+ VA+ +A+L + +HRD+ NILL + + DFGLAR + +
Sbjct: 173 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 229
Query: 964 AGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASM 1022
A ++APE C + ++DV+S+G+ L EL S + P
Sbjct: 230 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG---------------- 273
Query: 1023 LLLQGRPCEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQL-KQI 1077
+ + + + G P EM ++ C RP+ +Q+ Q + KQI
Sbjct: 274 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 329
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G+ A + G VA+K+LS FQ ++ E+ L +QH N++ L+
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHENVIGLLD 90
Query: 865 YHVSEAEMFLIYN-YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ + Y+ YL ++ +Q + + + + L Y+H V
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGV 147
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMT-CR 979
+HRD+KP N+ ++ + + DFGLAR HA ++ G T Y APE ++
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 980 VSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ E+++ K
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 42/156 (26%), Positives = 74/156 (47%), Gaps = 13/156 (8%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR----PRRTVEWSMLH 902
E RT GR+Q P++V + + + ++++ + G +L ++ + P R V +++
Sbjct: 84 EARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAV--AIVR 141
Query: 903 KIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTD 962
+I + L HRD+KP NIL+ + AYL DFG+A + +
Sbjct: 142 QIG-------SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN 194
Query: 963 VAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
GT Y APE + +AD+Y+ VL E ++
Sbjct: 195 TVGTLYYXAPERFSESHATYRADIYALTCVLYECLT 230
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F +G G FG V+ VK + GR+ ++ E+
Sbjct: 12 FEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 61
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 62 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI 119
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH E V++RD+K N++LD + + ++DFGL + G + GT
Sbjct: 120 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 176
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 177 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 205
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F +G G FG V+ VK + GR+ ++ E+
Sbjct: 10 FEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 59
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 60 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI 117
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH E V++RD+K N++LD + + ++DFGL + G + GT
Sbjct: 118 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 174
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 175 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 203
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/209 (24%), Positives = 81/209 (38%), Gaps = 29/209 (13%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEI-------------- 848
F +G G FG V+ VK + GR+ ++ E+
Sbjct: 11 FEYLKLLGKGTFGK----------VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 60
Query: 849 RTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDV 908
R L +HP L L + + + Y GG L F R ++
Sbjct: 61 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEI 118
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG 968
AL YLH E V++RD+K N++LD + + ++DFGL + G + GT
Sbjct: 119 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKXFCGTPE 175
Query: 969 YVAPEYAMTCRVSDKADVYSFGVVLLELI 997
Y+APE D + GVV+ E++
Sbjct: 176 YLAPEVLEDNDYGRAVDWWGLGVVMYEMM 204
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr-
3451
Length = 353
Score = 58.9 bits (141), Expect = 2e-08, Method: Composition-based stats.
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISL 88
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALA 913
+ + +++L+ L NL + IQ D R + +L+++ +
Sbjct: 89 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQMELDHERMSY---LLYQMLC----GIK 140
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 141 HLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 195
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEF 248
Query: 1034 TAGL 1037
L
Sbjct: 249 MKKL 252
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 58.9 bits (141), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 29/206 (14%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +GA A + G VA+K+L FQ ++ E+R L ++H N++ L+
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 865 YHVSE------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDE 918
+ + +L+ ++ G +L K ++ + + + + + L Y+H
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIH-- 145
Query: 919 CVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYA 975
++HRD+KP N+ ++ + + DFGLAR A +++ G T Y APE
Sbjct: 146 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXGXVVTRWYRAPEVI 197
Query: 976 MT-CRVSDKADVYSFGVVLLELISDK 1000
+ R + D++S G ++ E+I+ K
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 20/201 (9%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G+ A + G VA+K+LS FQ ++ E+ L +QH N++ L+
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-FQSEIFAKRAYRELLLLKHMQHENVIGLLD 108
Query: 865 YHVSEAEMFLIYN-YLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ + Y+ YL ++ +Q + + + + L Y+H V
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGV--- 165
Query: 924 LHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAMT-CR 979
+HRD+KP N+ ++ + + DFGLAR HA ++ G T Y APE ++
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 980 VSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ E+++ K
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGAT---YKAEIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTL 862
+GSG +G+ Y A + V AVK+LS FQ + ++ E+R L ++H N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQKV--AVKKLSRP-FQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 863 IGYHVSE------AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
+ +E++L+ L G +L ++ + + + + + R L Y+H
Sbjct: 93 LDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKCQ---ALSDEHVQFLVYQLLRGLKYIH 148
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+ +HRD+KPSN+ ++ + + DFGLAR T T Y APE +
Sbjct: 149 SAGI---IHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRAPEIML 201
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL+ K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 809 IGSGGFGATYKAEIIP------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G F + IP ++ K+LS Q +++ E R ++HPN+V L
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIVRL 68
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
E +L+++ + GG L + I R + E H I + ++ + H +
Sbjct: 69 HDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCIQ-QILESVNHCH---LNG 123
Query: 923 VLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++HRD+KP N+LL + L+DFGLA + + A AGT GY++PE
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 980 VSDKADVYSFGVVLLELI 997
D+++ GV+L L+
Sbjct: 183 YGKPVDMWACGVILYILL 200
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 809 IGSGGFGATYKAEIIP------GVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G G F + IP ++ K+LS Q +++ E R ++HPN+V L
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIVRL 68
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
E +L+++ + GG L + I R + E H I + ++ + H +
Sbjct: 69 HDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCIQ-QILESVNHCH---LNG 123
Query: 923 VLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++HRD+KP N+LL + L+DFGLA + + A AGT GY++PE
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 980 VSDKADVYSFGVVLLELI 997
D+++ GV+L L+
Sbjct: 183 YGKPVDMWACGVILYILL 200
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 37 IGSGAQGIVCAAYDA--ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGL 93
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 94 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 149
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 150 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 204
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E++ K F I W ++ G PC F L
Sbjct: 205 MGYKENVDLWSVGCIMGEMVCHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 257
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T +AGT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 33 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 89
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 145
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 146 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 200
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E+I F +I W ++ G PC F L
Sbjct: 201 MGYKENVDIWSVGCIMGEMIK-------GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The
Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The
Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E+I F +I W ++ G PC F L
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK-------GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 46/225 (20%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-------HPNLV 860
+G G +G +K+ + G VVAVK++ F Q RT + H N+V
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI----FDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 861 TLIGYHVSE--AEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
L+ ++ +++L+++Y+ +L I R +HK + + + + YLH
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMET-DLHAVI-----RANILEPVHKQYVVYQLIKVIKYLH 126
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARL------------LGTSETHAT---- 960
+ LHRD+KPSNILL+ + ++DFGL+R L +E
Sbjct: 127 SGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 961 ----TDVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELISDK 1000
TD T Y APE + + + + D++S G +L E++ K
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF Y+ E+ G VV K + + Q ++ + EI + +P++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGF 107
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G+ + ++++ +L + + R+ V + + YLH+ R
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
V+HRD+K N+ L+++++ + DFGLA + T + GT Y+APE S
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVLCKKGHSF 221
Query: 983 KADVYSFGVVLLELISDKKALDPS 1006
+ D++S G +L L+ K + S
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T +V + Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPEVVTRY-YRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E+I F +I W ++ G PC F L
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK-------GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 17/197 (8%)
Query: 809 IGSGGFGATY----KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G K + +K+ SV E+ L ++ HPN++ L
Sbjct: 12 LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 865 YHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ + +L+ GG L ++ I + V+ +++ K V YLH +
Sbjct: 72 FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHKH---NI 125
Query: 924 LHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+HRD+KP N+LL++ L DFGL+ + GT Y+APE + +
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKERLGTAYYIAPE-VLRKKY 182
Query: 981 SDKADVYSFGVVLLELI 997
+K DV+S GV+L L+
Sbjct: 183 DEKCDVWSCGVILYILL 199
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 25/210 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQ-----FAAEIRTLGRVQHP 857
F + IG G FG ++ V ++ + +++ +++ F E L
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKI-LNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNL----EKFIQDRPRRTVEWSMLHK-IALDVARAL 912
+ TL + ++L+ +Y GG+L KF P + + IA+D L
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
Y+H RDIKP NIL+D N + L+DFG L T ++ GT Y++P
Sbjct: 195 HYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 973 EYAMTC-----RVSDKADVYSFGVVLLELI 997
E R + D +S GV + E++
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEML 275
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 58.2 bits (139), Expect = 3e-08, Method: Composition-based stats.
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y+ GG + + RR +S H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+L+D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 31 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 90
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P L L + ++++ Y PGG + + RR +S H
Sbjct: 91 NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARF 146
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFG A+ + T +
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXL 199
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 31 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 90
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P L L + ++++ Y PGG + + RR +S H
Sbjct: 91 NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFSEPHARF 146
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFG A+ + T +
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXL 199
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 52/205 (25%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV---QQFAAEIRTLGRVQHPNLVTLI- 863
+GSG +G+ A + G VAVK+LS FQ + ++ E+R L ++H N++ L+
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 88
Query: 864 ----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDEC 919
+ E + +L G +L ++ + + + + + R L Y+H
Sbjct: 89 VFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHS-- 143
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAG---TFGYVAPEYAM 976
++HRD+KPSN+ ++ + + DF LAR H ++ G T Y APE +
Sbjct: 144 -ADIIHRDLKPSNLAVNEDCELKILDFYLAR-------HTDDEMTGYVATRWYRAPEIML 195
Query: 977 T-CRVSDKADVYSFGVVLLELISDK 1000
+ D++S G ++ EL++ +
Sbjct: 196 NWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 29/204 (14%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAY 914
+ + E + I L NL + IQ D R + +L+++ + + +
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY---LLYQMLV----GIKH 141
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH + +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 142 LHSAGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 196
Query: 975 AMTCRVSDKADVYSFGVVLLELIS 998
+ + D++S G ++ E+I
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIK 220
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS V T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E++ K F I W ++ G PC F L
Sbjct: 200 MGYKENVDIWSVGCIMGEMVCHK-------ILFPGRDYIDQWNKVIEQLGTPCPAFMKKL 252
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALA 913
+ + +++L+ L NL + IQ D R + +L+++ +
Sbjct: 83 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQMELDHERMSY---LLYQMLC----GIK 134
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 135 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 189
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEF 242
Query: 1034 TAGL 1037
L
Sbjct: 243 MKKL 246
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 82
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALA 913
+ + +++L+ L NL + IQ D R + +L+++ +
Sbjct: 83 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQMELDHERMSY---LLYQMLC----GIK 134
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 135 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 189
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEF 242
Query: 1034 TAGL 1037
L
Sbjct: 243 MKKL 246
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 69/244 (28%), Positives = 112/244 (45%), Gaps = 38/244 (15%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A + V A+K+LS FQ ++ E+ + V H N+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNV--AIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 863 IGYHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALA 913
+ + +++L+ L NL + IQ D R + +L+++ +
Sbjct: 82 LNVFTPQKTLEEFQDVYLVME-LMDANLCQVIQMELDHERMSY---LLYQMLC----GIK 133
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
+LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 134 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 188
Query: 974 YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFF 1033
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVR-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEF 241
Query: 1034 TAGL 1037
L
Sbjct: 242 MKKL 245
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 59/245 (24%), Positives = 108/245 (44%), Gaps = 43/245 (17%)
Query: 778 RKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR 837
RK +V+ +G + + VV+ATA F+++ G G+ VAVK L
Sbjct: 22 RKNLVLGKTLG-EGEFGKVVKATA-FHLK---GRAGY-----------TTVAVKMLKENA 65
Query: 838 FQG-VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ------- 889
++ +E L +V HP+++ L G + + LI Y G+L F++
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 890 --------------DRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934
D P R + L A +++ + YL + +++HRD+ NIL
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL 182
Query: 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVSDKADVYSFGVVL 993
+ +SDFGL+R + +++ ++A E + ++DV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 994 LELIS 998
E+++
Sbjct: 243 WEIVT 247
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 57.8 bits (138), Expect = 4e-08, Method: Composition-based stats.
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 30 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 89
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P LV L + ++++ Y PGG + + RR + H
Sbjct: 90 NEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFXEPHARF 145
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFG A+ + T +
Sbjct: 146 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXL 198
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 231
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R L V P LV L + ++++ Y PGG + + RR
Sbjct: 80 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RR 135
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+S H A + YLH +++RD+KP N+++D ++DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRV 192
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 193 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R L V P LV L + ++++ Y+PGG + + RR
Sbjct: 72 VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL----RR 127
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+ H A + YLH +++RD+KP N+L+D ++DFG A+ +
Sbjct: 128 IGRFXEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 185 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 224
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In
Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16 In
Complex With Staurosporine
Length = 317
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 39/292 (13%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G GGF E + G A+KR+ Q ++ E HPN++ L+ Y +
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 868 SEA----EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYLHDECV 920
E E +L+ + G L I+ D+ E +L + L + R L +H +
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIHAKGY 155
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFG-----LARLLGTSETHATTDVAG---TFGYVAP 972
HRD+KP+NILL + L D G + G+ + D A T Y AP
Sbjct: 156 A---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 973 E---YAMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRP 1029
E C + ++ DV+S G VL ++ + D F + VA A L
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF----QKGDSVALAVQNQLSIPQ 268
Query: 1030 CEFFTAGLWDCGPHDDLIEMLNLAIMCTGESLSSRPSMRQVAQQLKQIQPPA 1081
++ LW ++LN ++M RP + + QL+ +QPPA
Sbjct: 269 SPRHSSALW---------QLLN-SMMTVDP--HQRPHIPLLLSQLEALQPPA 308
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 57.4 bits (137), Expect = 5e-08, Method: Composition-based stats.
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSM-LHKI 904
EI L ++ HP ++ + + +E + +++ + GG L +K + ++ + + +++
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATT 961
L A+ YLH+ ++HRD+KP N+LL + L +DFG +++LG ET
Sbjct: 124 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 962 DVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELIS 998
+ GT Y+APE + T + D +S GV+L +S
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 57.4 bits (137), Expect = 5e-08, Method: Composition-based stats.
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSM-LHKI 904
EI L ++ HP ++ + + +E + +++ + GG L +K + ++ + + +++
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATT 961
L A+ YLH+ ++HRD+KP N+LL + L +DFG +++LG ET
Sbjct: 124 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 962 DVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELIS 998
+ GT Y+APE + T + D +S GV+L +S
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 57.4 bits (137), Expect = 5e-08, Method: Composition-based stats.
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSM-LHKI 904
EI L ++ HP ++ + + +E + +++ + GG L +K + ++ + + +++
Sbjct: 64 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATT 961
L A+ YLH+ ++HRD+KP N+LL + L +DFG +++LG ET
Sbjct: 123 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 173
Query: 962 DVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELIS 998
+ GT Y+APE + T + D +S GV+L +S
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 213
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 57.4 bits (137), Expect = 5e-08, Method: Composition-based stats.
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSM-LHKI 904
EI L ++ HP ++ + + +E + +++ + GG L +K + ++ + + +++
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATT 961
L A+ YLH+ ++HRD+KP N+LL + L +DFG +++LG ET
Sbjct: 124 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 962 DVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELIS 998
+ GT Y+APE + T + D +S GV+L +S
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 57.4 bits (137), Expect = 5e-08, Method: Composition-based stats.
Identities = 44/160 (27%), Positives = 83/160 (51%), Gaps = 18/160 (11%)
Query: 847 EIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSM-LHKI 904
EI L ++ HP ++ + + +E + +++ + GG L +K + ++ + + +++
Sbjct: 71 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATT 961
L A+ YLH+ ++HRD+KP N+LL + L +DFG +++LG ET
Sbjct: 130 LL----AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 180
Query: 962 DVAGTFGYVAPEYAM---TCRVSDKADVYSFGVVLLELIS 998
+ GT Y+APE + T + D +S GV+L +S
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 220
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 57.0 bits (136), Expect = 5e-08, Method: Composition-based stats.
Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 17/197 (8%)
Query: 809 IGSGGFGATY----KAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIG 864
+GSG +G K + +K+ SV E+ L ++ HPN++ L
Sbjct: 29 LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 865 YHVSEAEMFLIYNYLPGGNL-EKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRV 923
+ + +L+ GG L ++ I + V+ +++ K V YLH +
Sbjct: 89 FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHKH---NI 142
Query: 924 LHRDIKPSNILLDNNLNAYL---SDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
+HRD+KP N+LL++ L DFGL+ + GT Y+APE + +
Sbjct: 143 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKERLGTAYYIAPE-VLRKKY 199
Query: 981 SDKADVYSFGVVLLELI 997
+K DV+S GV+L L+
Sbjct: 200 DEKCDVWSCGVILYILL 216
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 57.0 bits (136), Expect = 5e-08, Method: Composition-based stats.
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF Y+ E+ G VV K + + Q ++ + EI + +P++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVP-KSMLLKPHQK-EKMSTEIAIHKSLDNPHVVGF 107
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPR 922
G+ + ++++ +L + + R+ V + + YLH+ R
Sbjct: 108 HGFFEDDDFVYVVLEICRRRSLLEL--HKRRKAVTEPEARYFMRQTIQGVQYLHNN---R 162
Query: 923 VLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSD 982
V+HRD+K N+ L+++++ + DFGLA + + + GT Y+APE S
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 983 KADVYSFGVVLLELISDKKALDPS 1006
+ D++S G +L L+ K + S
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETS 245
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 57.0 bits (136), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 23/201 (11%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+ D++S G ++ E+I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK 220
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 57.0 bits (136), Expect = 6e-08, Method: Composition-based stats.
Identities = 65/242 (26%), Positives = 108/242 (44%), Gaps = 34/242 (14%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IGSG G A + + G+ VAVK+LS FQ ++ E+ L V H N+++L+
Sbjct: 30 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 88
Query: 865 YHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYL 915
+ +++L+ L NL + I D R + +L+++ + +L
Sbjct: 89 VFTPQKTLEEFQDVYLVME-LMDANLCQVIHMELDHERMSY---LLYQMLC----GIKHL 140
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H ++HRD+KPSNI++ ++ + DFGLAR T+ T T Y APE
Sbjct: 141 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRYYRAPEVI 195
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTA 1035
+ + D++S G ++ EL+ F +I W ++ G P F A
Sbjct: 196 LGMGYKENVDIWSVGCIMGELVKGS-------VIFQGTDHIDQWNKVIEQLGTPSAEFMA 248
Query: 1036 GL 1037
L
Sbjct: 249 AL 250
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 57.0 bits (136), Expect = 6e-08, Method: Composition-based stats.
Identities = 46/201 (22%), Positives = 86/201 (42%), Gaps = 18/201 (8%)
Query: 809 IGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS 868
IG G FG Y V + + + ++ F E+ + +H N+V +G +S
Sbjct: 41 IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 869 EAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDI 928
+ +I + G L ++D + ++ + +IA ++ + + YLH + +LH+D+
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDL 156
Query: 929 KPSNILLDNNLNAYLSDFGLARLLGTSETHATTD----VAGTFGYVAPEYAMTCR----- 979
K N+ DN ++DFGL + G + D G ++APE
Sbjct: 157 KSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEE 215
Query: 980 ----VSDKADVYSFGVVLLEL 996
S +DV++ G + EL
Sbjct: 216 DKLPFSKHSDVFALGTIWYEL 236
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 57.0 bits (136), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 47/202 (23%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 64 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR + H A + YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 232
Query: 977 TCRVSDKADVYSFGVVLLELIS 998
+ + D ++ GV++ E+ +
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAA 254
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 57.0 bits (136), Expect = 6e-08, Method: Composition-based stats.
Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 34/236 (14%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV 854
N+ +G G FG +A+ G+ VAVK L G + +E++ L +
Sbjct: 30 LNLGKPLGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 88
Query: 855 -QHPNLVTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDR-----PRRTVE------WSML 901
H N+V L+G + +I + GNL +++ + P +T E ++
Sbjct: 89 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLE 148
Query: 902 HKI--ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETH 958
H I + VA+ + +L + +HRD+ NILL + DFGLAR + +
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 959 ATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
D ++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 117/249 (46%), Gaps = 31/249 (12%)
Query: 769 NSIADPGLVRKEVVICNNIGV--QLTYENVVRATAGFNVQNCIGSGGFGATYKA------ 820
NS L R +V + ++ V Q Y +R + + +GSG G A
Sbjct: 117 NSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDE--YIMSKTLGSGACGEVKLAFERKTC 174
Query: 821 EIIPGVVVAVKRLSVGRFQGVQ---QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877
+ + +++ ++ ++G + EI L ++ HP ++ + + +E + +++
Sbjct: 175 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLE 233
Query: 878 YLPGGNL-EKFIQDRPRRTVEWSM-LHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935
+ GG L +K + ++ + + +++ L A+ YLH+ + +HRD+KP N+LL
Sbjct: 234 LMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLHENGI---IHRDLKPENVLL 286
Query: 936 ---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM---TCRVSDKADVYSF 989
+ + ++DFG +++LG ET + GT Y+APE + T + D +S
Sbjct: 287 SSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 344
Query: 990 GVVLLELIS 998
GV+L +S
Sbjct: 345 GVILFICLS 353
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 34 IGSGAQGIVCAAYDA--ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGL 90
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 91 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 146
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T Y APE +
Sbjct: 147 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMVPFVVTRYYRAPEVILG 201
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E+I F +I W ++ G PC F L
Sbjct: 202 MGYKENVDIWSVGCIMGEMIK-------GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 254
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/249 (23%), Positives = 117/249 (46%), Gaps = 31/249 (12%)
Query: 769 NSIADPGLVRKEVVICNNIGV--QLTYENVVRATAGFNVQNCIGSGGFGATYKA------ 820
NS L R +V + ++ V Q Y +R + + +GSG G A
Sbjct: 103 NSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDE--YIMSKTLGSGACGEVKLAFERKTC 160
Query: 821 EIIPGVVVAVKRLSVGRFQGVQ---QFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYN 877
+ + +++ ++ ++G + EI L ++ HP ++ + + +E + +++
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLE 219
Query: 878 YLPGGNL-EKFIQDRPRRTVEWSM-LHKIALDVARALAYLHDECVPRVLHRDIKPSNILL 935
+ GG L +K + ++ + + +++ L A+ YLH+ + +HRD+KP N+LL
Sbjct: 220 LMEGGELFDKVVGNKRLKEATCKLYFYQMLL----AVQYLHENGI---IHRDLKPENVLL 272
Query: 936 ---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM---TCRVSDKADVYSF 989
+ + ++DFG +++LG ET + GT Y+APE + T + D +S
Sbjct: 273 SSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 990 GVVLLELIS 998
GV+L +S
Sbjct: 331 GVILFICLS 339
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 23/201 (11%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+ D++S G ++ E+I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK 220
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 23/201 (11%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDATLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+ D++S G ++ E+I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK 220
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 44 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 160 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 212
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 213 SKGYNKAVDWWALGVLIYEM 232
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 59/245 (24%), Positives = 107/245 (43%), Gaps = 43/245 (17%)
Query: 778 RKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR 837
RK +V+ +G + + VV+ATA F+++ G G+ VAVK L
Sbjct: 22 RKNLVLGKTLG-EGEFGKVVKATA-FHLK---GRAGY-----------TTVAVKMLKENA 65
Query: 838 FQG-VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ------- 889
++ +E L +V HP+++ L G + + LI Y G+L F++
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 890 --------------DRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934
D P R + L A +++ + YL + +++HRD+ NIL
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL 182
Query: 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVSDKADVYSFGVVL 993
+ +SDFGL+R + ++ ++A E + ++DV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 994 LELIS 998
E+++
Sbjct: 243 WEIVT 247
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 56.6 bits (135), Expect = 8e-08, Method: Composition-based stats.
Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 30 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 90 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 146 SL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 198
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 199 SKGYNKAVDWWALGVLIYEM 218
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 56.6 bits (135), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS V T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV--TRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGL 1037
+ D++S G ++ E++ K F I W ++ G PC F L
Sbjct: 200 MGYKENVDLWSVGCIMGEMVCHK-------ILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 252
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 56.2 bits (134), Expect = 9e-08, Method: Composition-based stats.
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 43/234 (18%)
Query: 797 VRATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ 855
+R + F +G G FG KA + A+K++ + + +E+ L +
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASLN 60
Query: 856 HP-------------NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWS 899
H N V ++ +F+ Y L I +R W
Sbjct: 61 HQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR--------- 950
+ +I AL+Y+H + ++HR++KP NI +D + N + DFGLA+
Sbjct: 121 LFRQIL----EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 951 ------LLGTSETHATTDVAGTFGYVAPEYA-MTCRVSDKADVYSFGVVLLELI 997
L G+S+ T GT YVA E T ++K D YS G++ E I
Sbjct: 174 KLDSQNLPGSSDN--LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 36/243 (14%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTLIG 864
IGSG G A + + G+ VAVK+LS FQ ++ E+ L V H N+++L+
Sbjct: 32 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQNQTHAKRAYRELVLLKCVNHKNIISLLN 90
Query: 865 YHVSEA------EMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAYL 915
+ +++L+ L NL + I D R + +L+++ + +L
Sbjct: 91 VFTPQKTLEEFQDVYLVME-LMDANLCQVIHMELDHERMSY---LLYQMLC----GIKHL 142
Query: 916 HDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYA 975
H ++HRD+KPSNI++ ++ + DFGLAR T+ T T Y APE
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVI 197
Query: 976 MTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFN-IVAWASMLLLQGRPCEFFT 1034
+ + D++S G ++ EL+ C G + I W ++ G P F
Sbjct: 198 LGMGYAANVDIWSVGCIMGELVKG--------CVIFQGTDHIDQWNKVIEQLGTPSAEFM 249
Query: 1035 AGL 1037
A L
Sbjct: 250 AAL 252
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 56.2 bits (134), Expect = 1e-07, Method: Composition-based stats.
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 20/213 (9%)
Query: 793 YENVVRATA---GFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRL---SVGRFQGVQQFA 845
+EN + TA F +G+G FG + + G A+K L V + + ++
Sbjct: 31 WENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTL 90
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK-- 903
E R L V P L L + ++++ Y PGG + + RR + H
Sbjct: 91 NEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHL----RRIGRFXEPHARF 146
Query: 904 IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDV 963
A + YLH +++RD+KP N+++D ++DFG A+ + T +
Sbjct: 147 YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXL 199
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
GT Y+APE ++ + D ++ GV++ E+
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 55.8 bits (133), Expect = 1e-07, Method: Composition-based stats.
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 809 IGSGGF-----------GATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHP 857
IG G F G Y A+II K+LS Q +++ E R ++H
Sbjct: 12 IGKGAFSVVRRCVKLCTGHEYAAKII-----NTKKLSARDHQKLER---EARICRLLKHS 63
Query: 858 NLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
N+V L E +L+++ + GG L + I R + E H I + A+ + H
Sbjct: 64 NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS-EADASHCIQ-QILEAVLHCHQ 121
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAY---LSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
V+HRD+KP N+LL + L+DFGLA + + A AGT GY++PE
Sbjct: 122 M---GVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEV 177
Query: 975 AMTCRVSDKADVYSFGVVLLELI 997
D+++ GV+L L+
Sbjct: 178 LRKEAYGKPVDIWACGVILYILL 200
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 55.8 bits (133), Expect = 1e-07, Method: Composition-based stats.
Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 36/243 (14%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 26 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 82
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQ---DRPRRTVEWSMLHKIALDVARALAY 914
+ + E + I L NL + IQ D R + +L+++ + +
Sbjct: 83 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY---LLYQMLC----GIKH 135
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEY 974
LH ++HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE
Sbjct: 136 LHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEV 190
Query: 975 AMTCRVSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFT 1034
+ + D++S G ++ E++ K L P G + I W ++ G PC F
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVC-HKILFP-----GRDY-IDQWNKVIEQLGTPCPEFM 243
Query: 1035 AGL 1037
L
Sbjct: 244 KKL 246
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 55.8 bits (133), Expect = 1e-07, Method: Composition-based stats.
Identities = 83/272 (30%), Positives = 120/272 (44%), Gaps = 37/272 (13%)
Query: 809 IGSGGFGATYKAEIIP-GVVVAVKRLSVGRFQGVQQFA---AEIRTLGRV-QHPNLVTLI 863
+G G +G +K G + AVKR S+ F+G + A AE+ + +V QHP V L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL- 122
Query: 864 GYHVSEAEMFLIYNYLPGGNLEKFIQ----DRPRRTVEWSMLHKIALDVARALAYLHDEC 919
E + + L G +L++ + P V W L D ALA+LH +
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQV-WGYLR----DTLLALAHLHSQ- 176
Query: 920 VPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCR 979
++H D+KP+NI L L DFGL LGT+ + G Y+APE +
Sbjct: 177 --GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPEL-LQGS 231
Query: 980 VSDKADVYSFGVVLLELISDKKALDPSFCSFGNGFNIVAWASMLLLQGRPCEFFTAGLWD 1039
ADV+S G+ +LE+ A + G G W L QG FTAGL
Sbjct: 232 YGTAADVFSLGLTILEV-----ACNMELPHGGEG-----WQQ--LRQGYLPPEFTAGL-S 278
Query: 1040 CGPHDDLIEML--NLAIMCTGESLSSRPSMRQ 1069
L+ ML + + T E+L + P +RQ
Sbjct: 279 SELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 55.8 bits (133), Expect = 1e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 62/129 (48%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 88 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T+ T YVAPE + D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 203 LGVIMYILL 211
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 23/201 (11%)
Query: 809 IGSGGFG---ATYKAEIIPGVVVAVKRLSVGRFQG---VQQFAAEIRTLGRVQHPNLVTL 862
IGSG G A Y A I VA+K+LS FQ ++ E+ + V H N++ L
Sbjct: 32 IGSGAQGIVCAAYDA--ILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 863 IGY-----HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+ + E + I L NL + IQ ++ + + + + +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +HRD+KPSNI++ ++ + DFGLAR GTS T T Y APE +
Sbjct: 145 AGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILG 199
Query: 978 CRVSDKADVYSFGVVLLELIS 998
+ D++S G ++ E+I
Sbjct: 200 MGYKENVDIWSVGCIMGEMIK 220
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
V + + ++ E R V P LV L + ++++ Y PGG + + RR
Sbjct: 80 VVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHL----RR 135
Query: 895 TVEWSMLHK--IALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLL 952
+S H A + YLH +++RD+KP N+L+D ++DFG A+ +
Sbjct: 136 IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAKRV 192
Query: 953 GTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLEL 996
T + GT Y+APE ++ + D ++ GV++ E+
Sbjct: 193 KGR----TWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEM 232
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR ++ H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 809 IGSGGFGATYKAEIIP------GVVVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNLV 860
+GSG FG A + VAVK L ++ +E++ + ++ H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 861 TLIGYHVSEAEMFLIYNYLPGGNL--------EKFIQDR-----PRRTVEWSMLHKI--- 904
L+G ++LI+ Y G+L EKF +D +R E L+ +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 905 -----ALDVARALAYLH-DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSET 957
A VA+ + +L CV HRD+ N+L+ + + DFGLAR ++ S
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCV----HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ ++APE + K+DV+S+G++L E+ S
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ ++
Sbjct: 212 SKGYNKAVDWWALGVLIYQM 231
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 55.1 bits (131), Expect = 2e-07, Method: Composition-based stats.
Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 43/245 (17%)
Query: 778 RKEVVICNNIGVQLTYENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGR 837
RK +V+ +G + + VV+ATA F+++ G G+ VAVK L
Sbjct: 22 RKNLVLGKTLG-EGEFGKVVKATA-FHLK---GRAGY-----------TTVAVKMLKENA 65
Query: 838 FQG-VQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQ------- 889
++ +E L +V HP+++ L G + + LI Y G+L F++
Sbjct: 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGP 125
Query: 890 --------------DRP-RRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNIL 934
D P R + L A +++ + YL + ++HRD+ NIL
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNIL 182
Query: 935 LDNNLNAYLSDFGLARLLGTSETHATTDVAGT-FGYVAPEYAMTCRVSDKADVYSFGVVL 993
+ +SDFGL+R + ++ ++A E + ++DV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 994 LELIS 998
E+++
Sbjct: 243 WEIVT 247
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+++D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIII 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 10 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNYL-PGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI + P +L FI +R ++ + V A+
Sbjct: 70 SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 127
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 128 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 181
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMV 208
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 58/229 (25%), Positives = 99/229 (43%), Gaps = 33/229 (14%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 37 LGRGAFGQVIEADAF-GIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW----------SMLHKI--AL 906
V L+G + +I + GNL +++ + V + ++ H I +
Sbjct: 96 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSF 155
Query: 907 DVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAG 965
VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 156 QVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 966 TFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 89 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 145
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 203
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 204 LGVIMYILL 212
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 88 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 203 LGVIMYILL 211
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 11/201 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
FN +G G FG +E V +K+ V + V+ E R L P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 859 LVT-LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+T L + ++ + Y+ GG+L IQ R ++ + A ++A L +L
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQS 460
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ + ++RD+K N++LD+ + ++DFG+ + + T GT Y+APE
Sbjct: 461 KGI---IYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAY 516
Query: 978 CRVSDKADVYSFGVVLLELIS 998
D ++FGV+L E+++
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLA 537
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 219 LGVIMYILL 227
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 95 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 151
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 210 LGVIMYILL 218
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 94 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 209 LGVIMYILL 217
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 205 LGVIMYILL 213
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 205 LGVIMYILL 213
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 96 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 211 LGVIMYILL 219
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR + H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR + H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR + H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 54.7 bits (130), Expect = 3e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 38 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR + H A + YLH
Sbjct: 98 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+APE +
Sbjct: 154 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIIL 206
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 207 SKGYNKAVDWWALGVLIYEM 226
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 22/198 (11%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG ++ E G AVK++ + F+ A E+ + P +V L G
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----AEELMACAGLTSPRIVPLYGAVR 155
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ + L GG+L + ++++ P + + + L YLH R+L
Sbjct: 156 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQAL-----EGLEYLHSR---RIL 207
Query: 925 HRDIKPSNILLDNN-LNAYLSDFGLARLL---GTSETHATTD-VAGTFGYVAPEYAMTCR 979
H D+K N+LL ++ +A L DFG A L G ++ T D + GT ++APE +
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 980 VSDKADVYSFGVVLLELI 997
K DV+S ++L ++
Sbjct: 268 CDAKVDVWSSCCMMLHML 285
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 54.3 bits (129), Expect = 3e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 72 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 130
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 190
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 191 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 54.3 bits (129), Expect = 3e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 37 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 95
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 96 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICY 155
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 156 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 263
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 54.3 bits (129), Expect = 3e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 35 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 9/164 (5%)
Query: 840 GVQQFAAEIRTLGRVQHPNLVTLIG--YHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVE 897
G EI+ L R++H N++ L+ Y+ + +M+++ Y G +++ + P +
Sbjct: 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFP 107
Query: 898 WSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSET 957
H + L YLH + + +H+DIKP N+LL +S G+A L
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
Query: 958 HATTDVA-GTFGYVAPEYA--MTCRVSDKADVYSFGVVLLELIS 998
T + G+ + PE A + K D++S GV L + +
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 54.3 bits (129), Expect = 4e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 26 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 85 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 54.3 bits (129), Expect = 4e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 35 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 54.3 bits (129), Expect = 4e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 35 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 154 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 11/157 (7%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLV 860
V+ + GGF Y+A+ + G A+KRL + + E+ + ++ HPN+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 861 TL-----IGYHVSEA--EMFLIYNYLPGGNLEKFIQDRPRR-TVEWSMLHKIALDVARAL 912
IG S+ FL+ L G L +F++ R + + KI RA+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLA 949
++H + P ++HRD+K N+LL N L DFG A
Sbjct: 150 QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 54.3 bits (129), Expect = 4e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 26 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 85 VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 54.3 bits (129), Expect = 4e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 26 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 85 VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 54.3 bits (129), Expect = 4e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT Y+AP +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 53.9 bits (128), Expect = 4e-07, Method: Composition-based stats.
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 809 IGSGGFGATYKAEIIPGV-------VVAVKRLSVGRFQGVQQ-FAAEIRTLGRV-QHPNL 859
+G G FG +A+ G+ VAVK L G + +E++ L + H N+
Sbjct: 26 LGRGAFGQVIEADAF-GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 84
Query: 860 VTLIGYHVSEA-EMFLIYNYLPGGNLEKFIQDRPRRTVEW------------SMLHKI-- 904
V L+G + +I + GNL +++ + V + ++ H I
Sbjct: 85 VNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 144
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDV 963
+ VA+ + +L + +HRD+ NILL + DFGLAR + + D
Sbjct: 145 SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFC 1008
++APE + ++DV+SFGV+L E+ S + +D FC
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 252
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 53.9 bits (128), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF ++ E+ G +V K L + Q ++ + EI + H ++V
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
G+ +F++ +L + + R T + L +I L YLH
Sbjct: 83 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRN-- 136
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RV+HRD+K N+ L+ +L + DFGLA + T + GT Y+APE
Sbjct: 137 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 194
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S + DV+S G ++ L+ K + S
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETS 220
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 53.9 bits (128), Expect = 4e-07, Method: Composition-based stats.
Identities = 48/207 (23%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
FN +G G FG A K + +K+ V + V+ E R L + P
Sbjct: 21 FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 859 LVTLIGYHVSEAE-MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+T + + ++ + Y+ GG+L IQ + ++ + A +++ L +LH
Sbjct: 81 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAEISIGLFFLHK 138
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+++RD+K N++LD+ + ++DFG+ + + T + GT Y+APE
Sbjct: 139 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMMDGVTTREFCGTPDYIAPEIIAY 194
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD 1004
D +++GV+L E+++ + D
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFD 221
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 11 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 71 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 128
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 129 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 182
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMV 209
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A 2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF ++ E+ G +V K L + Q ++ + EI + H ++V
Sbjct: 25 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 82
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
G+ +F++ +L + + R T + L +I L YLH
Sbjct: 83 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRN-- 136
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RV+HRD+K N+ L+ +L + DFGLA + T + GT Y+APE
Sbjct: 137 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 194
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S + DV+S G ++ L+ K + S
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPFETS 220
>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9B|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9B|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9C|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Xl413
Length = 361
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 66/272 (24%), Positives = 121/272 (44%), Gaps = 48/272 (17%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKA----EIIPGVVVAVKRLSVGRFQGVQQF 844
++ YE V + + F +++ IG G F + Y A ++ P +A+K L + ++
Sbjct: 9 IEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL-IPTSHPIR-I 66
Query: 845 AAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKI 904
AAE++ L + V + Y + + +I +P E F+ ++ + + +
Sbjct: 67 AAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA--MPYLEHESFLD--ILNSLSFQEVREY 122
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAY-LSDFGLAR--------LLGTS 955
L++ +AL +H + +HRD+KPSN L + L Y L DFGLA+ LL
Sbjct: 123 MLNLFKALKRIHQFGI---VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFV 179
Query: 956 ETHATTD-------------------VAGTFGYVAPEYAMTCRVSDKA-DVYSFGVVLLE 995
++ A + AGT G+ APE C A D++S GV+ L
Sbjct: 180 QSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239
Query: 996 LISDKKALDPSFCSFGNGFNIVAWASMLLLQG 1027
L+S + + + ++ A A ++ ++G
Sbjct: 240 LLSGR------YPFYKASDDLTALAQIMTIRG 265
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF ++ E+ G +V K L + Q ++ + EI + H ++V
Sbjct: 29 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 86
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
G+ +F++ +L + + R T + L +I L YLH
Sbjct: 87 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRN-- 140
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RV+HRD+K N+ L+ +L + DFGLA + T + GT Y+APE
Sbjct: 141 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGH 198
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S + DV+S G ++ L+ K + S
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPFETS 224
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 49/223 (21%), Positives = 98/223 (43%), Gaps = 22/223 (9%)
Query: 794 ENVVRATAGFNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQG--VQQFAAE 847
E+V+ F + +G G FG+ +A++ V VAVK L +++F E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 848 IRTLGRVQHPNLVTLIGYHVSEAEM------FLIYNYLPGGNLEKF-----IQDRPRRTV 896
+ HP++ L+G + +I ++ G+L F I + P +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF-NL 134
Query: 897 EWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSE 956
L + +D+A + YL +HRD+ N +L ++ ++DFGL+R + + +
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 957 THATTDVAGT-FGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
+ + ++A E + +DV++FGV + E+++
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 39 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 99 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 156
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 157 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMV 237
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 53.5 bits (127), Expect = 6e-07, Method: Composition-based stats.
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 35/175 (20%)
Query: 847 EIRTLGRVQHPNLVTLIGYHV----SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLH 902
EI ++H N++ I + S +++LI +Y G+L +++ T++ +
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSML 137
Query: 903 KIALDVARALAYLHDECV-----PRVLHRDIKPSNILLDNNLNAYLSDFGLAR--LLGTS 955
K+A L +LH E P + HRD+K NIL+ N ++D GLA + T+
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 956 ETHATTDV-AGTFGYVAPE-------------YAMTCRVSDKADVYSFGVVLLEL 996
E + GT Y+ PE Y M AD+YSFG++L E+
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-------ADMYSFGLILWEV 245
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 38 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 98 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 155
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 156 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 209
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMV 236
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 39 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 99 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 156
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 157 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMV 237
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 39 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 99 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 156
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 157 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMV 237
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 39 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 98
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 99 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 156
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 157 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 210
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMV 237
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 38 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 98 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 155
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 156 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 209
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMV 236
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 38 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 98 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 155
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 156 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 209
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMV 236
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKR-LSVGRFQGVQQFA-AEIRTLGRVQHPNLVTLIG- 864
IG G FG +KA G VA+K+ L +G A EI+ L ++H N+V LI
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 865 -------YHVSEAEMFLIYNY-------LPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
Y+ +A ++L++++ L L KF +R ++ +
Sbjct: 86 CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL---------N 136
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR---LLGTSETHATTDVAGTF 967
L Y+H ++LHRD+K +N+L+ + L+DFGLAR L S+ + + T
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 968 GYVAPEYAMTCR-VSDKADVYSFGVVLLEL 996
Y PE + R D++ G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 53 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 170
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 171 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 224
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMV 251
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 53.5 bits (127), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 162
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 163 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 216
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMV 243
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 25 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 85 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 142
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 143 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 196
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMV 223
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 25 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 85 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 142
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 143 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 196
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMV 223
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 26 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 86 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 143
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 144 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 197
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMV 224
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 38 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 97
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 98 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 155
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 156 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 209
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMV 236
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 53.5 bits (127), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 58 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 117
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 118 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 175
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 176 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 229
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 230 PEWIRYHRYHGRSAAVWSLGILLYDMV 256
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 26 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 86 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 143
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 144 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 197
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMV 224
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 53 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 112
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 170
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 171 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 224
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMV 251
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 196
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 254
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 255 LGVIMYILL 263
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 26 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 86 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 143
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 144 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 197
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMV 224
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 39/129 (30%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D++S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 989 FGVVLLELI 997
GV++ L+
Sbjct: 249 LGVIMYILL 257
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 21/206 (10%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIGYH 866
+G G + A + G AVK + + E+ TL + Q + N++ LI +
Sbjct: 21 LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 867 VSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHR 926
+ +L++ L GG++ IQ ++ ++ DVA AL +LH + HR
Sbjct: 81 EDDTRFYLVFEKLQGGSILAHIQ--KQKHFNEREASRVVRDVAAALDFLH---TKGIAHR 135
Query: 927 DIKPSNILLDNNLN---AYLSDFGLAR--LLGTSETHAT----TDVAGTFGYVAPEYA-- 975
D+KP NIL ++ + DF L L S T T T G+ Y+APE
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 976 ---MTCRVSDKADVYSFGVVLLELIS 998
+ D++S GVVL ++S
Sbjct: 196 FTDQATFYDKRCDLWSLGVVLYIMLS 221
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 10 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 70 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 127
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 128 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 181
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMV 208
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 33 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 856 --HPNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 93 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 150
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 151 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 204
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMV 231
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 11 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 71 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 128
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 129 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 182
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMV 209
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 53.1 bits (126), Expect = 8e-07, Method: Composition-based stats.
Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 905 ALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATT-DV 963
+ VAR + +L + +HRD+ NILL N + DFGLAR + + + D
Sbjct: 205 SFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 964 AGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELISDKKA------LDPSFCS 1009
++APE S K+DV+S+GV+L E+ S + +D FCS
Sbjct: 262 RLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCS 313
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 53.1 bits (126), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 11 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 856 H--PNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 71 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 128
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 129 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 182
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMV 209
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 53.1 bits (126), Expect = 9e-07, Method: Composition-based stats.
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 17/200 (8%)
Query: 803 FNVQNCIGSGGFG----ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
F+ +G+G FG +K + + + V + + ++ E R L V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 859 LVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHK--IALDVARALAYLH 916
LV L + ++++ Y+ GG + + RR +S H A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 917 DECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAM 976
+++RD+KP N+L+D ++DFG A+ + T + GT +APE +
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEIIL 211
Query: 977 TCRVSDKADVYSFGVVLLEL 996
+ + D ++ GV++ E+
Sbjct: 212 SKGYNKAVDWWALGVLIYEM 231
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 52.8 bits (125), Expect = 1e-06, Method: Composition-based stats.
Identities = 54/195 (27%), Positives = 82/195 (42%), Gaps = 15/195 (7%)
Query: 809 IGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGV--QQFAAEIRTLGRVQHPNLVTLIGY 865
IG G F YK + V VA L + Q+F E L +QHPN+V
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 866 HVSEAE----MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVP 921
S + + L+ G L+ ++ + + + +L + + L +LH P
Sbjct: 94 WESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQILKGLQFLHTR-TP 150
Query: 922 RVLHRDIKPSNILLDNNLNAY-LSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
++HRD+K NI + + + D GLA L S A V GT + APE +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFXAPEXYEE-KY 206
Query: 981 SDKADVYSFGVVLLE 995
+ DVY+FG LE
Sbjct: 207 DESVDVYAFGXCXLE 221
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 803 FNVQNCIGSGGFGATYKA-EIIPGVVVAVKRLSVGRFQGVQQFA------AEIRTLGRVQ 855
+ V +GSGGFG+ Y + + VA+K + R + E+ L +V
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 856 --HPNLVTLIGYHVSEAEMFLIYNY-LPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
++ L+ + LI P +L FI +R ++ + V A+
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 123
Query: 913 AYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVA 971
+ H+ C VLHRDIK NIL+D N L DFG LL + TD GT Y
Sbjct: 124 RHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSP 177
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE+ R + A V+S G++L +++
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMV 204
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 794 ENVVRATAGFNVQNCIGSGGFGATY-KAEIIPGVVVAVKR-LSVGRFQGVQQFAAEIRTL 851
E + F V+ G G FG E G+ VA+K+ + RF+ + ++ L
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE--LQIMQDL 73
Query: 852 GRVQHPNLVTLIGYHVSEAE-------MFLIYNYLPGGNLEKFIQDRPRRTVEWS-MLHK 903
+ HPN+V L Y + E + ++ Y+P L + ++ RR V +L K
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 904 IAL-DVARALAYLHDECVPRVLHRDIKPSNILLDN-NLNAYLSDFGLARLLGTSETHATT 961
+ L + R++ LH V V HRDIKP N+L++ + L DFG A+ L SE +
Sbjct: 133 VFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 962 DVAGTFGYVAPEYAM-TCRVSDKADVYSFGVVLLELI 997
+ + Y APE + D++S G + E++
Sbjct: 192 -ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 18/196 (9%)
Query: 809 IGSGGFG-ATYKAEIIPGVVVAVKRLSVGRF--QGVQQFAAEIRTLGRVQHPNLVTLIGY 865
IGSG FG A + + +VAVK + G + VQ+ R+L +HPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL---RHPNIVRFKEV 84
Query: 866 HVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLH 925
++ + +I Y GG L + I + R + + + L ++Y H ++ H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--LSGVSYCHSM---QICH 139
Query: 926 RDIKPSNILLDNNLNAYLS--DFGLARLLGTSETHAT-TDVAGTFGYVAPEYAMTCRVSD 982
RD+K N LLD + L DFG ++ +S H+ GT Y+APE +
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 983 K-ADVYSFGVVLLELI 997
K ADV+S GV L ++
Sbjct: 197 KIADVWSCGVTLYVML 212
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 52.4 bits (124), Expect = 1e-06, Method: Composition-based stats.
Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 901 LHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHAT 960
LH I + +A A+ +LH + ++HRD+KPSNI + + DFGL + E T
Sbjct: 167 LH-IFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 961 T-----------DVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELI 997
GT Y++PE S K D++S G++L EL+
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
Score = 34.3 bits (77), Expect = 0.43, Method: Composition-based stats.
Identities = 18/65 (27%), Positives = 34/65 (52%), Gaps = 2/65 (3%)
Query: 798 RATAGFNVQNCIGSGGFGATYKAE-IIPGVVVAVKRLSV-GRFQGVQQFAAEIRTLGRVQ 855
R F C+G GGFG ++A+ + A+KR+ + R ++ E++ L +++
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 856 HPNLV 860
HP +V
Sbjct: 63 HPGIV 67
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNL 859
F + IG G FG ++ + A+K L+ + A E R +
Sbjct: 92 FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 860 VTLIGYHVS-EAEMFLIYNYLPGGNL----EKFIQDRPRRTVEWSMLHKI-ALDVARALA 913
+T + Y E ++L+ +Y GG+L KF P + + + A+D L
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
Y+H RDIKP N+LLD N + L+DFG + T ++ GT Y++PE
Sbjct: 212 YVH---------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE 262
Query: 974 YAMTC-----RVSDKADVYSFGVVLLELI 997
+ + D +S GV + E++
Sbjct: 263 ILQAMEDGMGKYGPECDWWSLGVCMYEML 291
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 60/227 (26%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIG 864
+ +G G G G VAVKR+ + F + EI+ L HPN+ I
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIA--LMEIKLLTESDDHPNV---IR 73
Query: 865 YHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
Y+ SE +Y L NL K + D + + + +A +A+LH
Sbjct: 74 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 918 ECVPRVLHRDIKPSNILLDN-------------NLNAYLSDFGLARLLGTSETHATTDV- 963
+++HRD+KP NIL+ NL +SDFGL + L + ++ T++
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 964 --AGTFGYVAPE-------YAMTCRVSDKADVYSFGVVLLELISDKK 1001
+GT G+ APE R++ D++S G V ++S K
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 52.4 bits (124), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 23/209 (11%)
Query: 803 FNVQNCIGSGGFGATYKAEII-PGVVVAVKRLSVGRFQGVQQFAA--EIRTLGRVQHPNL 859
F + IG G FG ++ + A+K L+ + A E R +
Sbjct: 76 FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 860 VTLIGYHVS-EAEMFLIYNYLPGGNL----EKFIQDRPRRTVEWSMLHKI-ALDVARALA 913
+T + Y E ++L+ +Y GG+L KF P + + + A+D L
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 914 YLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPE 973
Y+H RDIKP N+LLD N + L+DFG + T ++ GT Y++PE
Sbjct: 196 YVH---------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE 246
Query: 974 YAMTC-----RVSDKADVYSFGVVLLELI 997
+ + D +S GV + E++
Sbjct: 247 ILQAMEDGMGKYGPECDWWSLGVCMYEML 275
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 52.0 bits (123), Expect = 2e-06, Method: Composition-based stats.
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 22/219 (10%)
Query: 803 FNVQNCIGSGGFGATYKA-------EIIPGVVVAVKRLSVGRFQG--VQQFAAEIRTLGR 853
++ + +GSG FG + A E++ + K L + + + EI L R
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 854 VQHPNLVTLIGYHVSEAEMFLIY-NYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
V+H N++ ++ ++ L+ + G +L FI PR ++ + I + A+
Sbjct: 86 VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAV 143
Query: 913 AYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAP 972
YL + ++HRDIK NI++ + L DFG A L + T GT Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAP 198
Query: 973 EYAM-TCRVSDKADVYSFGVVLLELISDKKALDPSFCSF 1010
E M + +++S GV L L+ ++ FC
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEEN----PFCEL 233
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase
1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase
1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF ++ E+ G +V K L + Q ++ + EI + H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 106
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
G+ +F++ +L + + R T + L +I L YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRN-- 160
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RV+HRD+K N+ L+ +L + DFGLA + + GT Y+APE
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S + DV+S G ++ L+ K + S
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETS 244
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKR-LSVGRFQGVQQFA-AEIRTLGRVQHPNLVTLIG- 864
IG G FG +KA G VA+K+ L +G A EI+ L ++H N+V LI
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 865 -------YHVSEAEMFLIYNY-------LPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
Y+ + ++L++++ L L KF +R ++ +
Sbjct: 86 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM---------LLN 136
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR---LLGTSETHATTDVAGTF 967
L Y+H ++LHRD+K +N+L+ + L+DFGLAR L S+ + + T
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 968 GYVAPEYAMTCR-VSDKADVYSFGVVLLEL 996
Y PE + R D++ G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKR-LSVGRFQGVQQFA-AEIRTLGRVQHPNLVTLIG- 864
IG G FG +KA G VA+K+ L +G A EI+ L ++H N+V LI
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 865 -------YHVSEAEMFLIYNY-------LPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
Y+ + ++L++++ L L KF +R ++ +
Sbjct: 86 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL---------N 136
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR---LLGTSETHATTDVAGTF 967
L Y+H ++LHRD+K +N+L+ + L+DFGLAR L S+ + + T
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 968 GYVAPEYAMTCR-VSDKADVYSFGVVLLEL 996
Y PE + R D++ G ++ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF ++ E+ G +V K L + Q ++ + EI + H ++V
Sbjct: 47 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 104
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
G+ +F++ +L + + R T + L +I L YLH
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRN-- 158
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RV+HRD+K N+ L+ +L + DFGLA + + GT Y+APE
Sbjct: 159 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 216
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S + DV+S G ++ L+ K + S
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETS 242
>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|B Chain B, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|C Chain C, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
pdb|1NXK|D Chain D, Crystal Structure Of Staurosporine Bound To Map Kap Kinase
2
Length = 400
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 8/124 (6%)
Query: 872 MFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPS 931
+ ++ L GG L IQDR + +I + A+ YLH + HRD+KP
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 932 NILLDN---NLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDKADVYS 988
N+L + N L+DFG A+ T+ ++ T T YVAPE + D +S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 989 FGVV 992
GV+
Sbjct: 249 LGVI 252
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK + + +F E + ++V
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 139
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYV 970
+AYL+ + +HRD+ N ++ ++ + DFG+ R + T ++
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +D++SFGVVL E+ S
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITS 224
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 48/208 (23%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK + + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYV 970
+AYL+ + +HRD+ N ++ ++ + DFG+ R + T ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors A29
Length = 270
Score = 51.6 bits (122), Expect = 3e-06, Method: Composition-based stats.
Identities = 52/172 (30%), Positives = 75/172 (43%), Gaps = 3/172 (1%)
Query: 95 SDKLSGNLSRAIGDLTQLRVLLLAFNGFSGELPLEI-GQLSLLEILDLSFNSFHGPIPPT 153
S+KLS S+A LT+LR+L L N LP I +L LE L ++ N
Sbjct: 46 SNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGV 104
Query: 154 LQNCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHIL 213
+L + L NQ P F +SL +N L S+P+ D SL+ +
Sbjct: 105 FDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELR 163
Query: 214 LAANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRN 265
L N L + TEL++L L +N L+ +F L L++L L N
Sbjct: 164 LYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
Score = 38.9 bits (89), Expect = 0.016, Method: Composition-based stats.
Identities = 36/148 (24%), Positives = 57/148 (38%), Gaps = 2/148 (1%)
Query: 527 NNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDXXXXXXXXXXHLQGPLPSY 586
N+ + +P+ + K ++ L + N+ L F L+ P
Sbjct: 69 NDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRV 128
Query: 587 INKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLNVLRL 646
+ + L +LSL N +L SL+ L L N L F KL L L+L
Sbjct: 129 FDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188
Query: 647 DHNNLTGRIPPG-FGTRSSLSIFDVSFN 673
D+N L R+P G F + L + + N
Sbjct: 189 DNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
Score = 35.8 bits (81), Expect = 0.12, Method: Composition-based stats.
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 2/110 (1%)
Query: 583 LPS-YINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHL 641
LPS +++ L+ L L+ N +L +LE L ++ N L F +L +L
Sbjct: 52 LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNL 111
Query: 642 NVLRLDHNNLTGRIPPGFGTRSSLSIFDVSFNNLSGSAPRNSLIKCENVQ 691
LRLD N L P F + + L+ + +N L S P+ K +++
Sbjct: 112 AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160
Score = 35.0 bits (79), Expect = 0.25, Method: Composition-based stats.
Identities = 46/196 (23%), Positives = 70/196 (35%), Gaps = 7/196 (3%)
Query: 523 FDIGNNKLIGEVPSDMGSHCKCMKFLSMAGNEFVGLIPQSFTNFDXXXXXXXXXXHLQGP 582
D+ +NKL +PS ++ L + N+ L F LQ
Sbjct: 42 LDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQAL 100
Query: 583 LPSYINKMEDLKFLSLSLNNFTGAIPWELTQLASLEVLELSANSLSGEIPSEFSKLEHLN 642
+++ +L L L N P L L L L N L F KL L
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK 160
Query: 643 VLRLDHNNLTGRIPPG-FGTRSSLSIFDVSFNNL----SGSAPRNSLIKCENVQGNPNLQ 697
LRL +NN R+P G F + L + N L G+ +K +Q NP
Sbjct: 161 ELRL-YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219
Query: 698 LCHTDPSSSEWERQHS 713
C+ ++W ++ +
Sbjct: 220 TCNGIIYMAKWLKKKA 235
Score = 33.5 bits (75), Expect = 0.64, Method: Composition-based stats.
Identities = 55/208 (26%), Positives = 79/208 (37%), Gaps = 15/208 (7%)
Query: 156 NCSSLRLINLSGNQFNGTIPAFFGQSPGFQVVSLSFNLLSGSVPEEFGDNCVSLEHILLA 215
+CSS +L + N IPA + + L N LS S+P + L + L
Sbjct: 22 DCSSKKLTAIPSN-----IPA------DTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLN 69
Query: 216 ANSLTGSIPPSLGNCTELRSLLLSSNMLQGDIPSSFGQLVNLEVLDLSRNFLSGIVPSEL 275
N L L +L ++ N LQ F QLVNL L L RN L + P
Sbjct: 70 DNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVF 129
Query: 276 GMCKQLKVLVLRNDYGPLYSREHGDLPIQPVVDGGEDYNFFDGGLPD-SITRLPNLRVFW 334
+L L L Y L S G + YN +P+ + +L L+
Sbjct: 130 DSLTKLTYLSL--GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK 187
Query: 335 APNLNLEGIFPQNWELCSKLEMLNLAHN 362
N L+ + ++ KL+ML L N
Sbjct: 188 LDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 51.6 bits (122), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)
Query: 794 ENVVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGR 853
E+V+ A VQ CI +I AVK + + E+ L +
Sbjct: 18 EDVLGEGAHARVQTCIN-----------LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 854 VQ-HPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR-RTVEWSMLHKIALDVARA 911
Q H N++ LI + E +L++ + GG++ I R +E S+ + DVA A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASA 123
Query: 912 LAYLHDECVPRVLHRDIKPSNILLD--NNLN-AYLSDFGLA---RLLGTSETHATTDV-- 963
L +LH++ + HRD+KP NIL + N ++ + DFGL +L G +T ++
Sbjct: 124 LDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLT 180
Query: 964 -AGTFGYVAPE----YAMTCRVSDK-ADVYSFGVVLLELIS 998
G+ Y+APE ++ + DK D++S GV+L L+S
Sbjct: 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK ++ + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYV 970
+AYL+ + +HRD+ N ++ ++ + DFG+ R + T ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 22/199 (11%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
+G G FG ++ E G AVK++ + F+ A E+ + P +V L G
Sbjct: 82 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----AEELMACAGLTSPRIVPLYGAVR 136
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDR---PRRTVEWSMLHKIALDVARALAYLHDECVPRVL 924
+ + L GG+L + ++++ P + + + L YLH R+L
Sbjct: 137 EGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQAL-----EGLEYLHSR---RIL 188
Query: 925 HRDIKPSNILLDNN-LNAYLSDFGLARLL---GTSETHATTD-VAGTFGYVAPEYAMTCR 979
H D+K N+LL ++ +A L DFG A L G + T D + GT ++APE +
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 980 VSDKADVYSFGVVLLELIS 998
K DV+S ++L +++
Sbjct: 249 CDAKVDVWSSCCMMLHMLN 267
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta
Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C Beta
Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 11/207 (5%)
Query: 803 FNVQNCIGSGGFGATYKAEIIPG----VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPN 858
FN +G G FG +E V +K+ V + V+ E R L P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 859 LVT-LIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
+T L + ++ + Y+ GG+L IQ R ++ + A ++A L +L
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQS 139
Query: 918 ECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMT 977
+ +++RD+K N++LD+ + ++DFG+ + + T GT Y+APE
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAY 195
Query: 978 CRVSDKADVYSFGVVLLELISDKKALD 1004
D ++FGV+L E+++ + +
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFE 222
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 49/212 (23%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK + + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--- 968
+AYL+ + +HRD+ N ++ ++ + DFG+ R + ++ + G G
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 195
Query: 969 --YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + +D++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 796 VVRATAGFNVQNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ 855
V+ F ++ +G G G + VAVKR+ F + +R +
Sbjct: 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD--E 76
Query: 856 HPNLVTLIGYHVSEAEMFLIYNYLP--GGNLEKFIQDRPRRTVEWSMLHKIAL--DVARA 911
HPN+ I Y +E + Y + L+++++ ++ L I L
Sbjct: 77 HPNV---IRYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSG 130
Query: 912 LAYLHDECVPRVLHRDIKPSNILLD-----NNLNAYLSDFGLARLL--GTSETHATTDVA 964
LA+LH ++HRD+KP NIL+ + A +SDFGL + L G + V
Sbjct: 131 LAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 965 GTFGYVAPEY-AMTCRV--SDKADVYSFGVVLLELISD 999
GT G++APE + C+ + D++S G V +IS+
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase
6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein Kinase
6 (Mapk6)
Length = 320
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 45/191 (23%), Positives = 87/191 (45%), Gaps = 25/191 (13%)
Query: 828 VAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL--------------IGYHVSEAEMF 873
VA+K++ + Q V+ EI+ + R+ H N+V + +G ++
Sbjct: 39 VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 874 LIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNI 933
++ Y+ +L ++ P + + R L Y+H VLHRD+KP+N+
Sbjct: 99 IVQEYMET-DLANVLEQGPLLEEHARLF---MYQLLRGLKYIHS---ANVLHRDLKPANL 151
Query: 934 LLDN-NLNAYLSDFGLARLLGTSETHATTDVAG--TFGYVAPEYAMTCRVSDKA-DVYSF 989
++ +L + DFGLAR++ +H G T Y +P ++ KA D+++
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 211
Query: 990 GVVLLELISDK 1000
G + E+++ K
Sbjct: 212 GCIFAEMLTGK 222
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIG 864
+ +G G G G VAVKR+ + F + EI+ L HPN+ I
Sbjct: 38 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIA--LMEIKLLTESDDHPNV---IR 91
Query: 865 YHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
Y+ SE +Y L NL K + D + + + +A +A+LH
Sbjct: 92 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 918 ECVPRVLHRDIKPSNILLDN-------------NLNAYLSDFGLARLLGTSETHATTDV- 963
+++HRD+KP NIL+ NL +SDFGL + L + + ++
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 964 --AGTFGYVAPEY---AMTCRVSDKADVYSFGVVLLELISDKK 1001
+GT G+ APE + R++ D++S G V ++S K
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine
Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex
With An Indirubin Ligand
Length = 429
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKA---EIIPGVVVAVKRLSVGRFQGVQQFA 845
VQ+ +++V + V IG G FG KA ++ V + + R + RF +Q A
Sbjct: 88 VQVPHDHVAYR---YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFH--RQAA 141
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY------LPGGNLEKFIQDRPRRTVEWS 899
EIR L ++ + + + E F N+ L NL + I+ +
Sbjct: 142 EEIRILEHLRKQDKDNTMNV-IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTSET 957
++ K A + + L LH R++H D+KP NILL + + DFG +
Sbjct: 201 LVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQ 254
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T + F Y APE + R D++S G +L EL++
Sbjct: 255 RVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLT 294
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 50.8 bits (120), Expect = 4e-06, Method: Composition-based stats.
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 13/148 (8%)
Query: 857 PNLVTLI----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
P++V ++ H + + +I + GG L IQ+R + +I D+ A+
Sbjct: 63 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 913 AYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
+LH + HRD+KP N+L + + L+DFG A+ + +A T Y
Sbjct: 123 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYY 176
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELI 997
VAPE + D++S GV++ L+
Sbjct: 177 VAPEVLGPEKYDKSCDMWSLGVIMYILL 204
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 50.8 bits (120), Expect = 4e-06, Method: Composition-based stats.
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 13/148 (8%)
Query: 857 PNLVTLI----GYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARAL 912
P++V ++ H + + +I + GG L IQ+R + +I D+ A+
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 913 AYLHDECVPRVLHRDIKPSNILL---DNNLNAYLSDFGLARLLGTSETHATTDVAGTFGY 969
+LH + HRD+KP N+L + + L+DFG A+ + +A T Y
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYY 195
Query: 970 VAPEYAMTCRVSDKADVYSFGVVLLELI 997
VAPE + D++S GV++ L+
Sbjct: 196 VAPEVLGPEKYDKSCDMWSLGVIMYILL 223
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH AN
Oligonucleotide
Length = 448
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 36/223 (16%)
Query: 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIG 864
+ +G G G G VAVKR+ + F + EI+ L HPN+ I
Sbjct: 38 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIA--LMEIKLLTESDDHPNV---IR 91
Query: 865 YHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
Y+ SE +Y L NL K + D + + + +A +A+LH
Sbjct: 92 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 918 ECVPRVLHRDIKPSNILLDN-------------NLNAYLSDFGLARLLGTSETHATTDV- 963
+++HRD+KP NIL+ NL +SDFGL + L + + ++
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 964 --AGTFGYVAPEY---AMTCRVSDKADVYSFGVVLLELISDKK 1001
+GT G+ APE + R++ D++S G V ++S K
Sbjct: 209 NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251
>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 55/177 (31%), Positives = 80/177 (45%), Gaps = 28/177 (15%)
Query: 823 IPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGG 882
+P VV +K++S G F GV IR L + P+ LI + P
Sbjct: 101 VPMEVVLLKKVSSG-FSGV------IRLLDWFERPDSFVLI-----------LERPEPVQ 142
Query: 883 NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNA 941
+L FI +R ++ + V A+ + H+ C VLHRDIK NIL+D N
Sbjct: 143 DLFDFITERG--ALQEELARSFFWQVLEAVRHCHN-C--GVLHRDIKDENILIDLNRGEL 197
Query: 942 YLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRVSDK-ADVYSFGVVLLELI 997
L DFG LL + TD GT Y PE+ R + A V+S G++L +++
Sbjct: 198 KLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41
Length = 417
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 789 VQLTYENVVRATAGFNVQNCIGSGGFGATYKA---EIIPGVVVAVKRLSVGRFQGVQQFA 845
VQ+ +++V + V IG G FG KA ++ V + + R + RF +Q A
Sbjct: 88 VQVPHDHVAYR---YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFH--RQAA 141
Query: 846 AEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNY------LPGGNLEKFIQDRPRRTVEWS 899
EIR L ++ + + + E F N+ L NL + I+ +
Sbjct: 142 EEIRILEHLRKQDKDNTMNV-IHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 900 MLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTSET 957
++ K A + + L LH R++H D+KP NILL + + DFG +
Sbjct: 201 LVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQ 254
Query: 958 HATTDVAGTFGYVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
T + F Y APE + R D++S G +L EL++
Sbjct: 255 RVYTXIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLT 294
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 50.8 bits (120), Expect = 4e-06, Method: Composition-based stats.
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 809 IGSGGFGATYKAE-IIPGVVVAVKR-LSVGRFQGVQQFA-AEIRTLGRVQHPNLVTLIG- 864
IG G FG +KA G VA+K+ L +G A EI+ L ++H N+V LI
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 865 -------YHVSEAEMFLIYNY-------LPGGNLEKFIQDRPRRTVEWSMLHKIALDVAR 910
Y+ + ++L++++ L L KF +R ++ +
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL---------N 135
Query: 911 ALAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR---LLGTSETHATTDVAGTF 967
L Y+H ++LHRD+K +N+L+ + L+DFGLAR L S+ + + T
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 968 GYVAPEYAMTCR-VSDKADVYSFGVVLLEL 996
Y PE + R D++ G ++ E+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 222
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRL-SVGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK + + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLAR-LLGTSETHATTDVAGTFGYV 970
+AYL+ + +HRD+ N ++ ++ + DFG+ R + T+ ++
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 971 APEYAMTCRVSDKADVYSFGVVLLELIS 998
APE + +D++SFGVVL E+ S
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 65/225 (28%), Positives = 93/225 (41%), Gaps = 56/225 (24%)
Query: 803 FNVQNCIGSGGFGATY-----------------KAEI-----------IPGVVVAVKRLS 834
+ V +GSGGFG+ Y K I +P VV +K++S
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
G F GV IR L + P+ LI + E P +L FI +R
Sbjct: 66 SG-FSGV------IRLLDWFERPDSFVLI---LERPE--------PVQDLFDFITERG-- 105
Query: 895 TVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLG 953
++ + V A+ + H+ VLHRDIK NIL+D N L DFG LL
Sbjct: 106 ALQEELARSFFWQVLEAVRHCHNX---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
Query: 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDK-ADVYSFGVVLLELI 997
+ TD GT Y PE+ R + A V+S G++L +++
Sbjct: 163 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 50.4 bits (119), Expect = 5e-06, Method: Composition-based stats.
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 56/225 (24%)
Query: 803 FNVQNCIGSGGFGATY-----------------KAEI-----------IPGVVVAVKRLS 834
+ V +GSGGFG+ Y K I +P VV +K++S
Sbjct: 9 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
G F GV IR L + P+ LI + E P +L FI +R
Sbjct: 69 SG-FSGV------IRLLDWFERPDSFVLI---LERPE--------PVQDLFDFITERG-- 108
Query: 895 TVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLG 953
++ + V A+ + H+ C VLHRDIK NIL+D N L DFG LL
Sbjct: 109 ALQEELARSFFWQVLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 165
Query: 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDK-ADVYSFGVVLLELI 997
+ TD GT Y PE+ R + A V+S G++L +++
Sbjct: 166 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 50.1 bits (118), Expect = 7e-06, Method: Composition-based stats.
Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 56/225 (24%)
Query: 803 FNVQNCIGSGGFGATY-----------------KAEI-----------IPGVVVAVKRLS 834
+ V +GSGGFG+ Y K I +P VV +K++S
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 835 VGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRR 894
G F GV IR L + P+ LI + E P +L FI +R
Sbjct: 66 SG-FSGV------IRLLDWFERPDSFVLI---LERPE--------PVQDLFDFITERG-- 105
Query: 895 TVEWSMLHKIALDVARALAYLHDECVPRVLHRDIKPSNILLD-NNLNAYLSDFGLARLLG 953
++ + V A+ + H+ C VLHRDIK NIL+D N L DFG LL
Sbjct: 106 ALQEELARSFFWQVLEAVRHCHN-C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162
Query: 954 TSETHATTDVAGTFGYVAPEYAMTCRVSDK-ADVYSFGVVLLELI 997
+ TD GT Y PE+ R + A V+S G++L +++
Sbjct: 163 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 87/194 (44%), Gaps = 14/194 (7%)
Query: 809 IGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IGSG FG A + +VAVK + G + EI ++HPN+V +
Sbjct: 27 IGSGNFGVARLMRDKQSNELVAVKYIERGE-KIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ + ++ Y GG L + I + R + + + + ++Y H +V HRD
Sbjct: 86 TPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCH---AMQVCHRD 140
Query: 928 IKPSNILLDNNLNAYLS--DFGLARLLGTSETHAT-TDVAGTFGYVAPEYAMTCRVSDK- 983
+K N LLD + L DFG ++ +S H+ GT Y+APE + K
Sbjct: 141 LKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 197
Query: 984 ADVYSFGVVLLELI 997
ADV+S GV L ++
Sbjct: 198 ADVWSCGVTLYVML 211
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 50.1 bits (118), Expect = 7e-06, Method: Composition-based stats.
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 809 IGSGGFGATYK------AEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTL 862
+G GGF ++ E+ G +V K L + Q ++ + EI + H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 80
Query: 863 IGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWS--MLHKIALDVARALAYLHDECV 920
G+ +F++ +L + + R T + L +I L YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQYLHRN-- 134
Query: 921 PRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFGYVAPEYAMTCRV 980
RV+HRD+K N+ L+ +L + DFGLA + + + GT Y+APE
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 981 SDKADVYSFGVVLLELISDKKALDPS 1006
S + DV+S G ++ L+ K + S
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETS 218
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 50.1 bits (118), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 14/194 (7%)
Query: 809 IGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IGSG FG A + +VAVK + G + + EI ++HPN+V +
Sbjct: 26 IGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 868 SEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECVPRVLHRD 927
+ + ++ Y GG L + I + R + + + + ++Y H +V HRD
Sbjct: 85 TPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCH---AMQVCHRD 139
Query: 928 IKPSNILLDNNLNAYLS--DFGLARLLGTSETHAT-TDVAGTFGYVAPEYAMTCRVSDK- 983
+K N LLD + L DFG ++ +S H+ GT Y+APE + K
Sbjct: 140 LKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKV 196
Query: 984 ADVYSFGVVLLELI 997
ADV+S GV L ++
Sbjct: 197 ADVWSCGVTLYVML 210
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 50.1 bits (118), Expect = 8e-06, Method: Composition-based stats.
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 28/201 (13%)
Query: 809 IGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHV 867
IG+G FG A + +VAVK + G + + EI ++HPN+V +
Sbjct: 27 IGAGNFGVARLMRDKQANELVAVKYIERGE-KIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 868 SEAEMFLIYNYLPGG-------NLEKFIQDRPRRTVEWSMLHKIALDVARALAYLHDECV 920
+ + ++ Y GG N +F +D R + + ++Y H
Sbjct: 86 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYAH---A 133
Query: 921 PRVLHRDIKPSNILLDNNLNAYL--SDFGLARLLGTSETHATTDVA-GTFGYVAPEYAMT 977
+V HRD+K N LLD + L +DFG ++ S H+ A GT Y+APE +
Sbjct: 134 MQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 978 CRVSDK-ADVYSFGVVLLELI 997
K ADV+S GV L ++
Sbjct: 191 KEYDGKVADVWSCGVTLYVML 211
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 798 RATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRL------SVGRFQGVQQFAAEIRT 850
R T F+ IGSG FG+ +K + + G + A+KR SV +++ A
Sbjct: 6 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-V 64
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--RTVEWSMLHKIALDV 908
LG QH ++V + M + Y GG+L I + R + + L + L V
Sbjct: 65 LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILL 935
R L Y+H + +H DIKPSNI +
Sbjct: 123 GRGLRYIHSMSL---VHMDIKPSNIFI 146
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 798 RATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRL------SVGRFQGVQQFAAEIRT 850
R T F+ IGSG FG+ +K + + G + A+KR SV +++ A
Sbjct: 6 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-V 64
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--RTVEWSMLHKIALDV 908
LG QH ++V + M + Y GG+L I + R + + L + L V
Sbjct: 65 LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 122
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILL 935
R L Y+H + +H DIKPSNI +
Sbjct: 123 GRGLRYIHSMSL---VHMDIKPSNIFI 146
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 49.7 bits (117), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 796 VVRATAGFNVQNCIGSGGFG-ATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRV 854
++ + + + IGSG FG A + +VAVK + G + + EI +
Sbjct: 14 IMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVKREIINHRSL 72
Query: 855 QHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAY 914
+HPN+V ++ + ++ Y GG L + I + R + + + + ++Y
Sbjct: 73 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSY 130
Query: 915 LHDECVPRVLHRDIKPSNILLDNNLNAYLS--DFGLARLLGTSETHAT-TDVAGTFGYVA 971
H +V HRD+K N LLD + L FG ++ +S H+ D GT Y+A
Sbjct: 131 CH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIA 184
Query: 972 PEYAMTCRVSDK-ADVYSFGVVLLELI 997
PE + K ADV+S GV L ++
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVML 211
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 49.7 bits (117), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 798 RATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRL------SVGRFQGVQQFAAEIRT 850
R T F+ IGSG FG+ +K + + G + A+KR SV +++ A
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-V 66
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--RTVEWSMLHKIALDV 908
LG QH ++V + M + Y GG+L I + R + + L + L V
Sbjct: 67 LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILL 935
R L Y+H + +H DIKPSNI +
Sbjct: 125 GRGLRYIHSMSL---VHMDIKPSNIFI 148
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 49.7 bits (117), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 798 RATAGFNVQNCIGSGGFGATYK-AEIIPGVVVAVKRL------SVGRFQGVQQFAAEIRT 850
R T F+ IGSG FG+ +K + + G + A+KR SV +++ A
Sbjct: 4 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA-V 62
Query: 851 LGRVQHPNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPR--RTVEWSMLHKIALDV 908
LG QH ++V + M + Y GG+L I + R + + L + L V
Sbjct: 63 LG--QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 120
Query: 909 ARALAYLHDECVPRVLHRDIKPSNILL 935
R L Y+H + +H DIKPSNI +
Sbjct: 121 GRGLRYIHSMSL---VHMDIKPSNIFI 144
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 806 QNCIGSGGFGATYKAEIIPGVVVAVKRLSVGRFQGVQQFAAEIRTLGRVQ-HPNLVTLIG 864
+ +G G G G VAVKR+ + F + EI+ L HPN+ I
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID-FCDIA--LMEIKLLTESDDHPNV---IR 73
Query: 865 YHVSEAEMFLIYNYLPGGNL-------EKFIQDRPRRTVEWSMLHKIALDVARALAYLHD 917
Y+ SE +Y L NL K + D + + + +A +A+LH
Sbjct: 74 YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 918 ECVPRVLHRDIKPSNILLDN-------------NLNAYLSDFGLARLLGTSETHATTDV- 963
+++HRD+KP NIL+ NL +SDFGL + L + + ++
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 964 --AGTFGYVAPE-------YAMTCRVSDKADVYSFGVVLLELISDKK 1001
+GT G+ APE R++ D++S G V ++S K
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 36/147 (24%), Positives = 70/147 (47%), Gaps = 12/147 (8%)
Query: 857 PNLVTLIGYHVSEAEMFLIYNYLPGGNLEKFIQDRPRRTVEWSMLHKIALDVARALAYLH 916
P ++ L + + +E+ LI Y GG + V + + ++ + + YLH
Sbjct: 89 PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 917 DECVPRVLHRDIKPSNILLDNNL---NAYLSDFGLARLLGTSETHATT--DVAGTFGYVA 971
++H D+KP NILL + + + DFG++R +G HA ++ GT Y+A
Sbjct: 149 QN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG----HACELREIMGTPEYLA 201
Query: 972 PEYAMTCRVSDKADVYSFGVVLLELIS 998
PE ++ D+++ G++ L++
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLT 228
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK ++ + +F E + ++V
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--- 968
+AYL+ + +HR++ N ++ ++ + DFG+ R + ++ + G G
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 195
Query: 969 --YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + +D++SFGVVL E+ S
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 809 IGSGGFGATYKA---EIIPG---VVVAVKRLS-VGRFQGVQQFAAEIRTLGRVQHPNLVT 861
+G G FG Y+ +II G VAVK ++ + +F E + ++V
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 862 LIGYHVSEAEMFLIYNYLPGGNLEKFIQD----------RPRRTVEWSMLHKIALDVARA 911
L+G ++ + G+L+ +++ RP T++ + ++A ++A
Sbjct: 86 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 143
Query: 912 LAYLHDECVPRVLHRDIKPSNILLDNNLNAYLSDFGLARLLGTSETHATTDVAGTFG--- 968
+AYL+ + +HR++ N ++ ++ + DFG+ R + ++ + G G
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR----KGGKGLLP 196
Query: 969 --YVAPEYAMTCRVSDKADVYSFGVVLLELIS 998
++APE + +D++SFGVVL E+ S
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 48.9 bits (115), Expect = 1e-05, Method: Composition-based stats.
Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 36/190 (18%)
Query: 826 VVVAVKRLSVGRFQGVQQFAAEIRTLGRVQHPNLVTLIGYHVS--EAEMFLIYNYLPGGN 883
+VV V ++ + + F E L HPN++ ++G S LI +++P G+
Sbjct: 36 IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGS 95
Query: 884 LEKFIQDRPRRTVEWSMLHKIALDVARALAYLH--DECVPRVLHRDIKPSNILLDNNLNA 941
L + + V+ S K ALD+AR +A+LH + +PR + ++++D ++ A
Sbjct: 96 LYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPR---HALNSRSVMIDEDMTA 152
Query: 942 YLSDFGLARLLGTSETHATTDVAGTF---------GYVAPEYAMTCRVSD----KADVYS 988
+S DV +F +VAPE A+ + D AD++S
Sbjct: 153 RIS---------------MADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWS 196
Query: 989 FGVVLLELIS 998
F V+L EL++
Sbjct: 197 FAVLLWELVT 206
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.319 0.137 0.416
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 32,095,207
Number of Sequences: 62578
Number of extensions: 1352915
Number of successful extensions: 5532
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 858
Number of HSP's successfully gapped in prelim test: 304
Number of HSP's that attempted gapping in prelim test: 2600
Number of HSP's gapped (non-prelim): 1568
length of query: 1082
length of database: 14,973,337
effective HSP length: 109
effective length of query: 973
effective length of database: 8,152,335
effective search space: 7932221955
effective search space used: 7932221955
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 57 (26.6 bits)